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ABSTRACT 
Myelination of axons can adaptively change in response to nervous system activity, with 
implications for structure and function of neural circuits. New myelin is made by the 
differentiation of specified oligodendrocyte precursors cells (OPCs). OPCs constitute an 
abundant population throughout the central nervous system (CNS) lifelong, but only some of 
these cells differentiate to myelinating oligodendrocytes at any given time. It is known that 
OPCs express neurotransmitter receptors through which they can sense neuronal activity, 
which affects OPC proliferation as well as their differentiation to myelinating oligodendrocytes. 
However, it remained unclear whether all OPCs communicate with axons in the same way, or 
whether differences exist between OPCs to integrate and respond to nervous system activity. 
Therefore, the aim of my PhD work was to investigate mechanisms of axon-OPC interactions 
to understand whether all OPCs similarly integrate neural activity and if they all contribute to 
myelination. 
I used existing transgenic lines and I generated new transgenic reagents to specifically label 
OPCs and axons with fluorescent reporters and genetically encoded calcium indicators in 
zebrafish. This approach allowed me to visualise these two cell types in the CNS and to study 
their calcium signatures to investigate their interaction. Two subpopulations of OPCs with 
distinct cellular behaviours and fates have been identified in the spinal cord. One OPC 
subgroup was primed to differentiate, while the other one not. Therefore, I wondered whether 
OPCs also differentially communicate with axons. I have generated lines that allowed me for 
the first time to perform in vivo calcium imagining of OPCs at high resolution from subcellular 
domains to whole tissue population levels using the genetically encoded calcium sensor 
GCaMP6. My analysis of OPC calcium signatures at the single cell and population level using 
light-sheet imaging revealed different types of GCaMP signals. Most OPCs exhibited GCaMP 
transients in process microdomains. However, in some OPCs, calcium transients spread 
throughout the entire cell. Dual colour imaging using GCaMP in OPCs and the red shifted 
calcium indicator RGECO in neurons showed that whole cell calcium transients in OPCs 
frequently occurred in response to neuronal calcium rises. I used pharmacological approaches 
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to manipulate neural activity and found that the frequency of OPC GCaMP signals was 
increased and decreased when neuronal activity was enhanced and blocked, respectively. I 
investigated OPC calcium signatures at the population level using volumetric timelapse 
imaging in animals where all OPCs express GCaMP. These experiments revealed that whole 
cell GCaMP signals could appear in different patterns, in which only single cells, groups of 
cells, or the entire OPC population within a field of view light up. In order to investigate these 
signals over even larger distances, I developed assays for whole animal analysis of the OPC 
calcium signatures using encoded Calcium Modulated Photoactivatable Ratiometric Integrator 
(CaMPARI). Using this additional approach, I could detect characteristic boundaries between 
neighbouring OPCs which displayed similar intracellular calcium level. Together, my single cell 
and population analysis of OPC calcium signatures showed that the probability and amplitude 
of somatic calcium transients was significantly higher in non-myelinating OPCs when 
compared to OPCs that are primed to differentiate. In order to further explore possible functions 
of these OPCs calcium signatures, I manipulated neural activity using 4-Aminopyridine (4-AP), 
which specifically increased proliferation of OPCs that do not directly differentiate. 
Furthermore, by expressing a calcium exporting pump in OPCs, I could demonstrate that OPC 
divisions triggered by 4-AP required intracellular calcium signaling.   
In summary, my studies show that OPCs exhibit different types of calcium transients and that 
OPCs with different properties and fates differentially communicate with axons. This provides 
new insights into mechanisms of axon-OPC communication and the mechanisms by which 




Table of contents 
 
ACKNOWLEDGMENT .......................................................................................................... iv 
ABSTRACT ........................................................................................................................... v 
LIST OF ABBREVIATIONS ................................................................................................... ix 
1 INTRODUCTION ............................................................................................................ 1 
1.1 Functions of oligodendrocytes ................................................................................. 1 
1.2 History and markers for oligodendrocyte lineage cells ............................................. 5 
1.3 Oligodendrocyte lineage dynamics throughout life ................................................... 8 
1.4 Functional properties of oligodendrocyte precursor cells ........................................ 10 
1.4.1 Regional differences - grey and white matter .................................................. 10 
1.4.2 Electrophysiological and gene expression differences .................................... 12 
1.5 Regulation of oligodendrocyte dynamics by neuronal activity ................................ 16 
1.5.1 Experience-dependent OPC behaviour ........................................................... 16 
1.5.2 Activity-dependent OPC behaviour ................................................................. 18 
1.5.3 Role of axon-OPC synaptic contacts in regulating OPC behaviour ................. 19 
1.6 The role of calcium in oligodendrocyte lineage cells .............................................. 23 
1.6.1 Calcium in axon-OPC interactions .................................................................. 23 
1.6.2 Visualising calcium signalling dynamics in oligodendrocyte lineage cells ........ 26 
1.7 Summary ............................................................................................................... 28 
1.8 Aims and experimental strategy ............................................................................. 29 
2 MATERIAL AND METHODS......................................................................................... 30 
2.1 Cloning .................................................................................................................. 30 
2.2 Transgenic lines .................................................................................................... 35 
2.3 mRNA transposase synthesis and DNA microinjection for sparse labelling ........... 36 
2.4 Immunostaining and imaging of fixed samples ....................................................... 37 
2.5 Live cell imaging .................................................................................................... 39 
2.6 Assessment of zebrafish swimming behaviour ....................................................... 42 
2.7 Mivacurium chloride treatment ............................................................................... 42 
2.8 Capsaicin treatment ............................................................................................... 43 
2.9 4-amminopyridine treatment .................................................................................. 43 
2.10 Tetrodotoxin treatment ........................................................................................... 43 
2.11 Splitomicin treatment ............................................................................................. 43 
2.12 UV-light treatment .................................................................................................. 44 
2.13 Image processing .................................................................................................. 44 
2.14 Data analysis ......................................................................................................... 44 
2.15 Statistics ................................................................................................................ 47 
viii 
2.16 Buffers and Solutions ............................................................................................. 47 
3 RESULTS ..................................................................................................................... 50 
3.1 OPC characterisation in the zebrafish spinal cord .................................................. 50 
3.1.1 OPC localisation in the zebrafish spinal cord .................................................. 50 
3.1.2 OPC properties within the zebrafish spinal cord and their contribution to 
myelination ................................................................................................................... 57 
3.1.3 Axon-OPC synaptic contacts in zebrafish ....................................................... 61 
3.2 OPC calcium dynamics .......................................................................................... 70 
3.2.1 GCaMP transients of individual OPCs ............................................................ 70 
3.2.2 Somatic GCaMP transients at the cell population level ................................... 77 
3.2.3 Integrating calcium dynamics in OPCs using CaMPARI ................................. 85 
3.3 Neuron – OPC interactions .................................................................................... 90 
3.3.1 Neural activity manipulation ............................................................................ 90 
3.3.2 Calcium events in OPCs induced by neural stimulation .................................. 96 
3.3.3 Neural activity manipulation effects on OPC cell fate ...................................... 99 
4 DISCUSSION ............................................................................................................. 107 
4.1 Key questions and findings .................................................................................. 107 
4.2 OPC properties and fates .................................................................................... 109 
4.3 Hierarchy between OPC subgroups ..................................................................... 114 
4.4 Integration of external stimuli by OPCs ................................................................ 117 
4.5 OPC calcium dynamics ........................................................................................ 120 
4.6 Neuronal manipulation effects on OPC ................................................................ 126 
4.7 Future perspective ............................................................................................... 130 
5 REFERENCES ........................................................................................................... 132 
6 PUBLICATIONS ......................................................................................................... 143 
7 EIDESTATTLICHE VERSICHERUNG ........................................................................ 144 
8 DECLARATION OF AUTHOR CONTRIBUTION ......................................................... 145 
 
ix 
LIST OF ABBREVIATIONS 
4-AP…………………………………………………………………………………4-amminopyridine 
AMPA/KA………………………...α-amino-3-hydroxy-5-methyl isoxazole propionic acid/ kainate 
Ca2+……………………………………………………………………………………………...calcium 
CaMPARI…………………….……..Calcium Modulated Photoactivatable Ratiometric Integrator 
CNO…………………………………………………………………………………clozapine-N-oxide 
CNPase……………………………………………....2′, 3′-cyclic-nucleotide 3′-phosphodiesterase 
CNS…………………………………………………………………………...central nervous system 
Csn…………………………………………………………………………………………….capsaicin 
Cspg4…………………………………………………………….Chondroitin sulfate proteoglycan 4 
Cx…………….………………………………...................................................................connexin 
dpf…………………………………………………………………………………day post fertilisation 
DREADD…………………………..Designer Receptor Exclusively Activated by a Designer Drug 
EAE…………………………………………………..experimental autoimmune encephalomyelitis 
EdU…………………………………………………………………………5-ethynyl-2’-deoxyuridine 
ER……………………………………………………………………………...endoplasmic reticulum 
FCS……………………………………………………………………………..………fetal calf serum 
FingR…………………………………………Fibronectin intrabody generated with mRNA display 
GABAA……………………………………………………………………..gamma-aminobutyric acid 
GECI………………………………………………………….genetically encoded calcium indicator 
GM…………………………………………………………………………………………..grey matter 
GPR17…………………………………………………………………………..G-protein receptor 17 
HDAC……………………………………………………………………………..histone deacetylase 
K+…….........................................................................................................................potassium 
KV…………………………………………………………………………….voltage gated potassium 
MAG………………………………………………………………….myelin associated glycoprotein 
MAP2……………………………………………………………..microtubules-associated protein 2 
MBP……………………………………………………………………………….myelin basic protein 
MCT1…………………………………………………………………monocarboxylate transporter 1 
MS……………………………………………………………………………………multiple sclerosis 
MYRF…………………………………………………………………………myelin regulatory factor 
Na+……………………………………………………………………………………………….sodium 
x 
NaV………………………………………………………………………………voltage gated sodium 
NCX……………………………………………………………………………..Na+/Ca2+ exchanger 
NG2…………………………………………………………………………….Neuron-glial antigen 2 
Nkx2.2………………………………………………………………………………NK2 Homeobox 2 
NMDAR……………………………………………………………..N-methyl-D-aspartate receptors 
O-2A…………………………………………….oligodendrocyte-type-2 astrocyte progenitor cells 
Olig1…………………………………………………………..oligodendrocyte transcription factor 1 
Olig2…………………………………………………….........oligodendrocyte transcription factor 2 
OPC………………………………………………………………….oligodendrocyte precursors cell 
P…………………………………………………………………………………………..postnatal age 
PDGF…………………………………………………………………..platelet-derived growth factor 
PFC……………………………………………………………………………………prefrontal cortex 
PLP………………………………………………………………………….myelin proteolipid protein 
PNS………………………………………………………………………..peripheral nervous system 
PSD95……………………………………………………………….postsynaptic density protein 95 
ROIs…………………………………………………………………………………regions of interest 
scRNA-seq………………………………………………………………single cell RNA-sequencing 
Sox10……………………………………………………………………………..Sry-like HMG box10 
TRPV1……………………….transient receptor potential cation channel subfamily V member 1 
TTX…………………………………………………………..……………………………..tetrodotoxin 
VGCCs………………………………………………………………….voltage-gated Ca2+ channels 









The nervous system plays a role in almost every aspect of our life, allowing our body to sense 
messages from distal anatomical regions and to transform them into reactions. The nervous 
system can be subdivided in the central nervous system (CNS), which consists of brain and 
spinal cord, and the peripheral nervous system (PNS), which comprises the nerves that 
connect the CNS to the peripheral organs. Neurons and glia cells are the two main cell types 
of the nervous system. Neurons are specialised for electrical signalling over long distances, 
while glial cells provide support, electrical insulation to neurons, and remove debris. The term 
“neuroglia” was at first coined by Rudolf Virchow and refers to the connective non-neuronal 
structures that join the neurons together. This was the only function recognised to glial cells. 
Indeed, glia derives from the ancient Greek word “γλία” which means “glue” (Virchow, 1856). 
In the last decade of the 19th century, glial cells stopped being considered one homogeneous 
population. In the early 1900s Ramón y Cajal described the presence in the neuroglia 
population of astrocytes and a third element. In 1919 Pío del Río-Hortega found that the third 
element consisted of two different cell types, which he named microglia and oligodendrocytes 
(Sierra et al., 2016). Since their discovery, nothing major happened, until recently when it was 
discovered that astrocytes, microglia and oligodendrocytes are also diverse within their 
populations, having as well different physiological roles. Therefore, glia cells are beginning to 
be considered as crucial regulators of neuronal structure and function (Khakh and Deneen, 
2019; Foerster et al., 2019; Masuda et al., 2020).  
 
1.1 Functions of oligodendrocytes 
 
Most axons in our CNS are surrounded by an insulating structure called myelin, composed 
primarily of lipids and proteins. The area of the CNS that contains myelinated axons is named 
white matter because myelin is enriched in lipids and appears white. Differently, the grey matter 
2 
area mostly consists of neuronal cell bodies. Myelin is made by oligodendrocytes, a glia cell 
type. One first major function of oligodendrocytes is to produce myelin to wrap the axons and 
enable fast nerve conduction. Myelin does not wrap continuously the whole axon but creates 
intermittent gaps, between consecutive myelin sheaths, called nodes of Ranvier. Nodes are 
rich in voltage gated sodium and potassium channels which open when an action potential 
propagates through an axon. As a consequence, myelin allows the axon to conserve energy 
as the depolarisation is happening only at the nodes, and not along the entire axon. In addition 
to myelination, oligodendrocytes provide axonal metabolic support by transferring energy 
metabolites from their cell bodies to axons (Fünfschilling et al., 2012; Lee et al., 2012). Indeed, 
oligodendrocytes express monocarboxylate transporter 1 (MCT1), a transporter of 
monocarboxylic acids like lactate and pyruvate. The loss of this transporter in oligodendrocytes 
caused axon degeneration, suggesting to play a crucial role in axon survival (Lee et al., 2012). 
The formation of new myelin is a dynamic process and increases in myelination occur almost 
lifelong in response to neural activity, or to restore myelin to repair demyelinated axons. Myelin 
changes, in terms of sheath elongation and myelin thickness, can modulate the conduction 
velocity, to optimise the synchronisation of action potentials arrival from connected circuits 
(Fields, 2015). New myelin is formed by the differentiation of specified oligodendrocyte 
precursor cells (OPCs) during postnatal development (Zhu et al., 2008) and throughout life 
(Dimou et al., 2008; Young et al., 2013). OPCs constitute a big portion of the total CNS cell 
population, in white matter (8–9%) and in grey matter (2–3%). OPCs tile the entire brain, are 
the major dividing cell population of the CNS and maintain constant their density (Fig. 1.1) 




Fig. 1.1 Oligodendrocytes in the CNS 
Schematic representing OPCs in the CNS. A) OPCs tile the entire brain and they constitute a large part of the CNS 
population, being present both in white matter and grey matter. B) OPCs (in green) are very proliferative and they 
can differentiate to give rise to myelinating oligodendrocytes (in blue) which are the cell that myelinate axons. 
Myelinated axons are located in the white matter region of the CNS. Neurons (in grey) are the cells that get 
myelinated, myelin (in blue) wrap around the axon and increases speed conduction through the gaps created 
between consecutive myelin sheaths called nodes of Ranvier.  
 
OPCs respond to neural activity to increase myelination and differentiate into myelinating 
oligodendrocytes, but most of them don’t differentiate. Also in demyelinating diseases such as 
multiple sclerosis (MS), or other neurological conditions such as spinal cord injury, myelin gets 
disrupted and OPCs respond by differentiating into myelinating oligodendrocytes to restore 
myelination (Duncan et al., 2009). However, it has been shown that OPCs often fail to 
differentiate into oligodendrocytes, causing a persisting demyelinated condition (Wolswijk et 
al. 1998). This arises the question whether some OPCs receive the signal that triggers their 
differentiation and others don’t, or whether not all OPCs have the same properties and are 
able to sense brain activity. Many studies are now focusing on OPC features and on their 
lineage progression, to understand which factors regulate their cell fate.  
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Oligodendrocytes are important not only to mediate fast signal conduction in the nervous 
system, but also because they provide essential metabolic support for the axons. 
Oligodendrocytes derive from the differentiation of OPCs. However, OPCs constitute a large 
population of the CNS and not all of them differentiate in response to neural activity, or in 
demyelinating condition, suggesting that not all OPCs are identical. The next sections will 
provide an overview of oligodendrocyte precursor cell biology, their features in their lineage 
progression towards myelinating oligodendrocytes, their heterogeneity and how their lineage 




1.2 History and markers for oligodendrocyte lineage cells 
 
Since the beginning of the 20th century, astrocytes, oligodendrocytes and microglia were 
considered the major population of glial cells in the CNS. At that time, the existence of OPCs 
was still unknown due to the lack of markers able to label these cells in histological analysis. 
In 1976, using electron microscopic autoradiograms, cells referred to as “oligodendroblasts” 
were described in the optic nerve. These cells differ from mature oligodendrocytes by their 
more diffuse and lightly stained chromatin (Skoff et al., 1976). The transition from OPCs to 
myelinating oligodendrocytes follows characteristic changes identified according to their 
increase in complex morphology, the expression pattern of specific markers and their ability to 
proliferate, migrate and differentiate. Three major states along oligodendrocyte lineage 
progression can be defined: OPCs, premyelinating oligodendrocytes and myelinating 
oligodendrocytes. Different states can be traced using different markers (Fig. 1.2). These 
markers comprise of cell surface antigens and transcription factors. OPCs were at first 
recognised using the A2B5 antibody, which is a cell surface ganglioside epitope, utilised to 
label the oligodendrocyte-type-2 astrocyte progenitor cells (O-2A). These cells in serum-free 
medium were shown to differentiate into oligodendrocytes, but in fetal calf serum (FCS) 
medium were reported to give rise to type II astrocytes, for this reason they were called O-2A. 
Another prominent surface antigen to label OPCs is NG2 (Neuron-glial antigen 2), a chondroitin 
sulfate proteoglycan, which was originally found to be expressed by neural cells (Stallcup, 
1981). NG2-positive cells in culture were indeed O-2A cells and were also differentiating into 
oligodendrocytes under serum-free conditions. The NG2 expression was then lost during 
differentiation into mature oligodendrocytes (Raff et al., 1983). After migration from the 
germinal zone, NG2-positive cells were distributed in the CNS by the end of the first postnatal 
week (Nishiyama et al., 1996a, b). These cells are still present in the adult CNS, are mitotic 
and can also differentiate into oligodendrocytes (Levison et al., 1999). For all these features, 
NG2-expressing cells are also called oligodendrocyte precursor cells (OPCs). NG2 is currently 
used as a marker to label oligodendrocyte lineage at early developmental stages, but with the 
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caveat that NG2-expressing cells can also be pericytes (Ozerdem et al., 2001). Another 
commonly used antigen surface to label OPC is PDGFR-α, the receptor for platelet-derived 
growth factor α. NG2-expressing cells expressed also PDGFR-α in vivo in the rat CNS (Pringle 
et al., 1992). The survival and proliferation of NG2 cells is dependent on the platelet-derived 
growth factor (PDGF) in vitro (Richardson et al., 1988). In addition to surface antigens, there 
are also transcription factors used to label oligodendrocyte lineage cells. In particular, two of 
them, Olig2 (Oligodendrocyte transcription factor 2) and Sox10 (Sry-like HMG box10), are 
expressed throughout the oligodendrocyte lineage (Lu et al., 2000; Zhou et al., 2000; Kuhlbrodt 
et al. 1998). Olig2 expression is also expressed in immature neuronal progenitors 
(Takebayashi et al., 2000). The transcription factor Olig1 (Oligodendrocyte transcription factor 
1) was also found to be localised to the OPC nucleus, and in the cytoplasm of myelinating 
oligodendrocytes in the white matter of the adult mouse (Arnett et al., 2004). Another 
transcription factor, upregulated in OPCs, is Nkx2.2 (NK2 Homeobox 2) which is 
downregulated once OPCs differentiate (Fu et al., 2002).  
As OPCs start to differentiate, they are called pre-myelinating oligodendrocytes and start to 
downregulate some OPC markers and express new markers. Amongst them are the surface 
antigens 2′, 3′-cyclic-nucleotide 3′-phosphodiesterase (CNPase) and myelin proteolipid protein 
(PLP). (Kuhn et al., 2019). Interestingly, PLP is also an early marker for OPCs and it is 
important for OPCs process integrity and migration (Harlow et al., 2014). Myelinating 
oligodendrocytes expressed the surface antigens myelin basic protein (MBP) which appears 
together with myelin associated glycoprotein (MAG) as well as the transcription factor myelin 
regulatory factor (MYRF) (Linnington et al., 1984; Barbarese et al., 1988; Emery et al., 2009). 
To summarise, after the discovery of OPCs, several markers have been identified to label 
oligodendrocyte lineage cells, allowing the discrimination among different developmental 
stages along the lineage progression. However, it is necessary to combine different markers 
to discern among the different stages, as some of the markers overlap. Moreover, marker 




Fig. 1.2 Oligodendrocyte lineage markers 
Markers to label oligodendrocyte lineage cells during their cell progression towards mature oligodendrocytes. Cells 
in the OPC state are proliferative cells. When OPCs start to differentiate they acquire a more complex morphology, 
they start to touch axons and are called pre-myelinating oligodendrocytes. In the last state of the lineage 
progression, myelinating oligodendrocytes wrap the axons with myelin sheaths. SOX10 and Olig2 are expressed 
throughout the whole oligodendrocyte lineage. NG2 and the A2B5 label OPCs. Nkx2.2, PDGFR—α and 
Olig1(nuclear) are used to label oligodendrocyte at early developmental stages. CNPase and PLP are early markers 
of myelinating oligodendrocytes. Finally, Olig1(cytoplasmic), MBP, MYRF and MAG are expressed in myelinating 
oligodendrocytes. Adapted from Kuhn et al., 2019.  
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1.3 Oligodendrocyte lineage dynamics throughout life 
 
The identification of several OPC markers, done by histological analysis, paved the way to in 
vivo studies. This allowed for a more detailed characterisation of oligodendrocyte lineage cell 
progression and gave the chance to study OPCs in their physiological environment. 
After arising from the ventricular germinal zones of the brain and the spinal cord, OPCs migrate 
throughout the tissue to populate the CNS (Richardson et al., 2006). During and after 
migration, OPC behaviour has been characterised both in the developing zebrafish spinal cord 
and adult mouse cortex in vivo. Time lapse imaging revealed that OPCs constantly remodel 
their processes to continuously explore the environment around them and retract them when 
they get in contact with other OPCs (Kirby et al. 2006; Hughes et al., 2013). OPCs have shown 
proliferative features comparable to stem cells, being the most proliferative cells of the brain 
parenchyme (Dimou et al., 2008). OPCs continue to maintain their density and to differentiate 
into myelinating oligodendrocytes also throughout adulthood, confirming a strong fate 
interrelation between these two populations (Dimou et al., 2008; Young et al., 2013). OPCs in 
the adult somatosensory cortex maintain their numbers under physiological conditions by 
symmetrical divisions to generate two daughter OPCs, or by asymmetric divisions where they 
give rise to one daughter oligodendrocyte and one OPC (Hughes et al., 2013; Zhu et al., 2011). 
In the developing mouse brain, the majority of recently divided OPCs differentiate into 
oligodendrocytes during a specific temporal window of 3–8 days (Hill et al., 2014). In the cortex 
of young rats, around 20 % of pre-myelinating oligodendrocytes die and in adult mouse cortex 
around 78% degenerate within two days after differentiation (Trapp et al., 1997; Hughes et al., 
2018). Once OPCs start the differentiation process, they extend their processes to establish 
contacts with target axons. Afterwards, oligodendrocyte processes start to form a myelin 
sheath around the axon by adding new wrap underneath previous ones and elongating along 
the axon (Snaidero et al., 2014). 
Studies in developing zebrafish and in rodent cell cultures have reported that each 
oligodendrocyte has a narrow time window to establish myelin sheaths once generated 
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(Czopka et al., 2013; Watkinset al., 2008). While differentiating into myelinating 
oligodendrocytes, OPCs produce several short myelin sheaths, which then start elongating 
and/or retracting around target axons. In zebrafish, each individual oligodendrocyte makes 
new myelin sheaths during a short time frame of about 5 hours. After this time window, no 
additional myelin segments are formed (Czopka et al., 2013). 
Under disease conditions such as demyelination models, it was found that in the adult rat 
spinal cord, 5-bromo-2’-deoxyuridine (BrdU) is incorporated by proliferating OPCs around the 
lesion, as these cells migrate into the lesion and differentiate into oligodendrocytes (Watanabe 
et al., 2002). This output was further corroborated by a condition in which two-photon laser 
ablation of several OPCs triggered an immediate proliferative OPC response in order to 
replace the lost cells and restore their density (Hughes et al., 2013).  
To summarise, OPCs, after migration and proliferation, become uniformly distributed 
throughout the grey and white matter of the CNS. They have a strong proliferative potential 
and they differentiate into myelinating oligodendrocytes during development, adulthood and in 
demyelinating conditions. Therefore, OPCs of different intrinsic age, newly born, quiescent in 
OPC state or differentiating toward myelinating oligodendrocytes are present at the same time 
in different brain regions. It thus appears that OPC population might be constituted by OPCs 
with different properties which I will describe in details in the next section.  
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1.4 Functional properties of oligodendrocyte precursor cells 
 
OPCs constitute a large cell population and not all of them differentiate into myelinating 
oligodendrocytes. Moreover, OPCs are generated in multiple waves from the ventricular 
germinal zones and populate different regions of the CNS (Kessaris et al., 2006). This suggests 
that already from their origin there might be differences amongst OPC populations. Moreover, 
depending on the surrounding environment, OPCs located in different regions of the CNS 
might have different properties. This has important implications in myelination because 
different OPC phenotypes may contribute differently to differentiation and proliferation. It is 
therefore necessary to investigate the OPC properties and to focus on their ability to integrate 
signals from neurons, as myelination can be activity-dependent. Investigations into OPC 
heterogeneity have reported conflicting results. Even if some studies have claimed that OPCs 
in the hippocampus and corpus callosum show homogeneous electrophysiological properties, 
more recent studies have recognised OPCs as a heterogeneous cell population (Clarke et al., 
2012; De Biase et al., 2010; Spitzer et al., 2019).  
 
1.4.1 Regional differences - grey and white matter  
 
Differences in the ability of OPCs whether to proliferate or to differentiate have been found 
between OPCs localised to white matter (WM) and grey matter (GM) regions. A fate mapping 
study, using the tamoxifen-induced Cre-recombination system driven by olig2 to label OPCs 
in the cerebral cortex has revealed differences in terms of proliferation and differentiation 
between WM and GM OPCs. In the WM, most OPCs differentiated to give rise to myelinating 
oligodendrocytes, whereas GM OPCs were mostly proliferating but remained undifferentiated 
(Dimou et al., 2008). To clarify whether the different differentiation properties were linked to 
intrinsic cell diversity or whether they rather resulted from environmental factors, homotopic 
and heterotopic transplantations in the mouse cerebral cortex were performed. 
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WM-derived OPCs differentiate more frequently than GM-derived cells, even when 
transplanted in the GM environment (Viganó et al., 2013). This indicates that there are intrinsic 
differences between these cells, though, at the same time, environmental cues could have 
influenced their nature before the transplantation. Despite being highly differentiating cells, 
WM OPCs were also shown to be more proliferative than the GM ones and that their rate of 
division decreased with age (Young et al., 2013). Moreover, it was reported that WM OPCs 
exhibit a greater proliferative response to PDGF, previously shown to regulate OPC 
proliferation, and which induced a stronger response in the younger WM OPCs (Hill et al., 
2013). G-protein receptor 17 (GPR17) has also been observed to be differently expressed in 
OPCs and to influence their contribution to myelination. Indeed, GPR17 inhibited OPC 
differentiation and it is considered as an intrinsic timer of myelination (Chen et al., 2009). A 
fate map tracing of GPR17 expressing OPCs, revealed that GPR17 was expressed only in a 
portion of OPCs, predominantly more common in GM than WM OPCs. Cells expressing 
GPR17 remained in an undifferentiated state for a long period, compared to OPCs that were 
not expressing this receptor.  
However, after stab wound injury or cortical ischemia, OPCs expressing GPR17 start to 
differentiate at higher rate compared to physiological conditions, meaning that OPCs change 
their behaviour when more myelin is required (Viganó et al., 2016). 
Differences between OPCs have also been found in the spinal cord. During development, most 
OPCs in the spinal cord originate from the ventricular zone, while only a minority arises from 
the dorsal zone. Interestingly, even if during perinatal period ventrally derived cells were found 
in the whole spinal cord, including the dorsal axonal tracts, in adulthood these dorsal tracts 
became predominantly populated by dorsally derived oligodendrocytes. This suggests that the 
dorsally-derived oligodendrocytes preferentially myelinate dorsal tract axons (Tripathi et al., 
2011). Moreover, dorsally-derived OPCs exhibited enhanced recruitment and differentiation, 
in response to demyelination. It was also shown that dorsally-derived OPCs are less able to 
differentiate with ageing, while ventrally-derived OPCs continue to show the same 
differentiation rate during the life span (Crawford et al., 2016).  
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Differences amongst OPCs in terms of cell fate have been identified between white and grey 
matter OPCs, even if both have proliferative capacity, the first ones have a higher 
differentiation potential. These data recognise local environment as an extrinsic factor in 
determining OPC cell fate.  
 
1.4.2 Electrophysiological and gene expression differences 
 
OPCs express a wide range of neurotransmitter receptors, which makes them responsive to 
neuronal activity. Differences in electrophysiological properties have been found within the 
oligodendrocyte lineage. Despite the expression of sodium (Na+) and potassium (K+) channels, 
OPCs are not able to trigger action potentials and the expression of these channels is 
downregulated as OPCs differentiate into myelinating oligodendrocytes (De Biase et al., 2010; 
Kukley et al., 2010). However, in another study, two distinct types of OPCs were identified in 
the rat white matter CNS. One type receives synaptic inputs and express voltage-gated sodium 
(NaV) and voltage-gated potassium (KV) channels that can generate action potentials, the other 
type lacks both these features (Káradóttir et al., 2008). This OPC ability in showing action 
potential has not been identified in other model systems yet, suggesting that this might be a 
rat specific feature. Independent of whether subsets of OPCs can fire action potential or not, 
electrophysiological differences have also been found between white and grey matter OPCs. 
A whole-cell patch-clamp study in cortical slices demonstrated that white matter and grey 
matter OPCs exhibit different K+ and Na+ channel expression profiles (Chittajallu et al., 2004). 
In a recent work, physiological properties of OPCs have been characterised in detail across 
different brain regions and ages, using single cell electrophysiological recordings. OPCs 
acquired KV channels at first, followed by NaV channels and N-methyl-D-aspartate receptors 
(NMDAR) which reached their peak of expression at the time when OPCs start to differentiate 
into myelinating oligodendrocytes, and declined when OPCs lose their myelination potential. 
α-amino-3-hydroxy-5-methyl isoxazole propionic acid/ kainate (AMPA /KA) receptors were 
identified in almost all OPCs after birth and their densities increased with age. (Spitzer et al., 
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2019). In the same study, bulk RNA sequencing analysis were performed and OPCs with 
different electrophysiological properties express as well different molecular signatures 
depending on the age. Embryonic OPCs have more migrating signatures, at postnatal age 12 
(P12) OPCs expressed genes involved in proliferation and differentiation, which then 
decreased at P80. Genes for cell cycle regulation were similarly downregulated in OPCs from 
older animals. The authors also focused on the expression of genes related to NaV channel 
and glutamatergic NMDAR and found that their expressions were increasing in OPCs from 
embryonic until post-natal age and remained constant further on (Spitzer et al., 2019). 
However, these were bulk studies at different developmental stages which did not take into 
account that there are cells at different stages of their lineage progression within the tissue. 
Therefore, it remains still unresolved whether these cells constitute different types of OPCs or 
whether they rather represent OPCs at different cell stages.  
In the last few years, several studies have taken advantage of single cell RNA-sequencing 
(scRNA-seq) to investigate gene expression with single cell resolution, and better characterise 
the function of individual cells, but also to identify differences among the OPC cell population. 
In the first scRNA-seq oligodendrocyte lineage cells study, the transcriptome of about 5000 
cells was analysed. Oligodendrocyte lineage cells were isolated from 10 distinct regions of the 
anterior-posterior and dorsal-ventral axis of the mouse juvenile and adult CNS. Thirteen 
distinct cell populations were found and further analysis identified a path connecting all the 
different populations from OPCs to myelinating oligodendrocytes. In the juvenile CNS, across 
different regions, distinct cell populations were similarly expressed, whereas in the adult brain 
a group of mature oligodendrocyte was enriched in specific regions. OPCs were recognised 
as one cell type and were co-expressing PDGFR-α and Cspg4 (Chondroitin sulfate 
proteoglycan 4, known also as NG2). 10 % of OPCs also expressed cycling genes consistent 
with their proliferative behaviour. 
Instead, myelinating oligodendrocytes could be categorised into six mature distinct states, 
suggesting heterogeneity amongst them (Marques et al., 2016). A subsequent study from the 
same group, focused on the transcriptome of OPCs from the mouse forebrain and spinal cord 
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at embryonic, juvenile and adult stages using bulk and single-cell RNA-seq. They found that 
embryonic OPCs appear as a heterogeneous population. However, scRNA-seq revealed 
similar transcriptional profiles of OPCs in the post-natal spinal cord and brain, concluding that 
OPCs arising from different parts of the embryonic germinal zones are in the end similar to 
each other during development (Marques et al., 2018). This means that the heterogeneity 
found amongst different brain regions is not cell intrinsic and it does not depend on OPC origins 
but rather induced by local environment at later timepoint. 
 
To conclude, OPCs have been identified as a functionally heterogeneous population, in 
particularly, when looking at their gene expression and electrophysiological properties, which 
differ between brain regions and animal age. These differences might also explain distinct 
abilities for OPCs to differentiate.  
However, it remains unclear whether different OPC properties mirror different states along 
lineage progression, or whether represent different subtypes of OPCs. A link between different 
gene expression profiles together with their electrophysiological responses and the cell fate 
potential of different OPCs is still missing. The Spitzer et al. study was based on bulk RNA 
sequencing to compare OPC population at different ages, however, to identify differences 
between cell types, a single cell resolution study is necessary. This would allow us to better 
delineate a complete profile of the characteristics of different OPC subpopulations, to 
understand whether they are following their lineage progression or if they represent different 
subtypes. Therefore, it will be useful to understand how OPCs sense neuronal activity and 
contribute to myelination (Fig. 1.3). 
In the next section, I will illustrate mechanisms that trigger OPC differentiation and proliferation, 




Fig. 1.3 OPC heterogeneity: open questions 
Schematic explaining the open questions about OPC heterogeneity and functions. OPCs are not homogenous, they 
have differences amongst regions, ages and also different physiological properties and gene expression. The 
correlation amongst these differences and OPC fates and functions are still not clear. It would be useful to associate 





1.5 Regulation of oligodendrocyte dynamics by neuronal activity 
 
OPCs are able to proliferate and differentiate not only during development, but also during 
adulthood and in demyelinated conditions. OPCs have been shown to play an active role in 
what is called adaptive myelination, which are the changes in myelination that occur in 
response to neural activity and which have the potential to modify circuit function. Changes in 
myelination have been documented to depend on social experience, motor learning, and 
experimental manipulation of neuronal activity (Mount and Monje, 2017). The proliferation of 
OPCs, their differentiation to myelinating oligodendrocytes and/or the selection of target axons 
by differentiating OPCs are the major cellular events underlying adaptive myelination. 
 
1.5.1 Experience-dependent OPC behaviour 
 
Recent studies suggest that adaptive myelination can be modulated by learning a new task, 
as well as by social and sensory experiences. On a macro level, white matter changes have 
been identified in human adult brain following training of a complex visual-motor skill or after 
learning to play the piano (Scholz et al., 2009; Steele et al., 2013). Increases in myelin was 
also identified in adults after learning a new language (Schlegel et al., 2012). Rats trained to 
learn a single-pellet reaching task showed higher white matter in the sensory motor cortex, as 
well as an increase in myelin staining, which correlated with the learning rate (Sampaio-
Baptista et al., 2013). Oligodendrocyte contribution to enhanced myelination after motor skill 
learning was studied in mice that had to learn a new complex motor skill. Increased OPC 
proliferation and differentiation into myelinating oligodendrocytes was found in mice that 
learned to run on a wheel with irregularly spaced rungs. Blocking the myelin regulatory 
transcription factor in OPCs, prevented new oligodendrocyte formation and new motor skill 
learning, thus suggesting that new oligodendrocyte and myelin generation is fundamental for 
learning a new motor complex skill (McKenzie et al., 2014). 
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In a subsequent study, from the same group, it was shown that new oligodendrocytes are 
required both in early and late stages of motor skill learning (Xiao et al., 2016). In a more recent 
study, the importance of motor learning to modulate myelination was further investigated in 
developmental and remyelinating conditions. Immediately after motor learning, no increase in 
OPC proliferation was detected, instead oligodendrogenesis was enhanced in a time-
dependent manner and OPCs were directly differentiating to give rise to new myelinating 
oligodendrocytes. In addition, motor learning improved remyelination in a demyelination model, 
involving both new and mature oligodendrocytes (Bacmeister et al., 2020). 
Despite learning, another external cue that can influence myelination and oligodendrocyte 
lineage cells is related to social experience. Social isolation of juvenile mice after weaning 
resulted in alterations in white matter development. In particular, oligodendrocytes showed 
reduced ramification, shorter process length and each cell formed less internodes. Myelin 
thickness was also reduced in isolated mice despite no differences being found in axon 
diameters (Makinodan et al., 2012). Impaired myelination and decrease in myelin gene 
transcripts were also found in the prefrontal cortex (PFC) of prolonged socially deprived adult 
mice and importantly, re-integration of social contacts was sufficient to restore myelination (Liu 
et al., 2012). 
Sensory experience also modulates myelin plasticity. Unilateral whisker clipping in mice 
increased OPC proliferation in the deprived barrel cortex (Mangin et al., 2012). In a following 
study, it was shown that whisker deprivation increased apoptosis of newly generated OPCs 
and the number of mature oligodendrocytes was decreased. These data suggest that the 
increase in OPC proliferation was happening to compensate for the loss of oligodendrocytes. 
The subsequent apoptosis might be explained as an OPC response to maintain their constant 
cell population number (Hill et al. 2014). Investigation of myelin plasticity in adult mice revealed 
that sensory enrichment increased oligodendrocyte integration and new myelin formation, 
without changes in pre-existing myelin sheath length in the somatosensory cortex (Hughes et 
al. 2018).  
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1.5.2 Activity-dependent OPC behaviour 
 
Axons play an important role in regulating their own myelination. Despite the fact that 
myelination depends on axonal diameter, where larger axons are myelinated before small 
ones, not all axons of the same diameter are necessarily myelinated (Hildebrand et al., 1993; 
Tomassy et al., 2014). Cultured OPCs differentiate into oligodendrocytes also in presence of 
synthetic fibers similar to neurons in shape and size. This suggests that differentiation can 
happen also in absence of axo-glial signalling, with only the physical presence of an axon-like 
structure. Moreover, fiber diameter appeared to be critical for OPC differentiation, as fibers 
with at least 0.4 µM were preferred to smaller ones (Lee et al. 2012). However, since 
oligodendrocytes in the CNS myelinate axons, it would make sense that axons control their 
numbers and instruct OPCs to differentiate. This idea has been investigated since the early 
90s when Barres and Raff showed that a transection of the developing rat optic nerve results 
in significantly reduced OPC proliferation, suggesting the role of axonal electrical activity in 
inducing OPC division (Barres and Raff, 1993). Following studies highlighted the effects of 
activity on axon-choice when OPC differentiated to myelinating oligodendrocytes. Neurotoxins 
that block or increase neuron action potential, prevent or enhance respectively myelinogenesis 
in vitro (Demerens et al., 1996). Other experiments carried out using root ganglion cell cultures 
confirmed an activity-dependent regulation of myelination, in which glutamate released from 
synaptic vesicles along axons induced myelin formation around electrically activated axons 
(Wake et al., 2011). The first study to prove the potential role of neuronal activity in vivo was 
done using optogenetic stimulation of the premotor cortex in awake mice. Stimulation of 
neuronal activity, once again, induced OPC proliferation, differentiation and myelination; 
notably, myelin sheaths were thicker after optogenetic stimulation. In addition to these effects, 
oligodendrogenesis and myelination induced by neuronal activity correlated with motor 
behavioural improvement (Gibson et al., 2014). Neuronal activity plays a key role in 
determining which axons get myelinated and the myelin sheaths number and length. Indeed, 
an in vivo zebrafish study shows that blocking activity of specific axons, reduces the number 
of axons that get myelinated. Oligodendrocytes that wrapped silenced neurons formed shorter 
19 
sheaths that were also retracting more frequently (Hines et al., 2015). In another in vivo 
zebrafish study, it was shown that inhibition of synaptic vesicle release from neurons 
decreased the number of myelinated axons, in particular each oligodendrocyte produced 30% 
less myelin sheaths (Mensch et al., 2015). These effects were also described in mammalian 
CNS using a pharmacogenetic approach to stimulate neuronal activity, which resulted in an 
increase of OPC proliferation and differentiation in juvenile and adult mice, enhancing 
myelination of stimulated axons (Mitew et al., 2018). The role of neuronal activity was also 
studied in demyelinated conditions. Repeated optogenetic stimulation of demyelinated axons 
in mice corpus callosum induces OPC differentiation into myelinating oligodendrocytes, and 
remyelination, restoring axonal conduction (Ortiz et al., 2019).  
 
1.5.3 Role of axon-OPC synaptic contacts in regulating OPC behaviour 
 
Neuronal activity plays an important role to modulate myelination by influencing the behaviour 
of oligodendrocyte lineage cells. The mechanisms that regulate the interaction between 
neurons and oligodendrocyte lineage cells are still not fully described. Since 2000 it is known 
that OPCs make functional synapses with neurons. Bergles et al. used patch-clamp recordings 
of OPCs in hippocampal slices and showed that stimulation of excitatory axons induced OPC 
depolarisation. The release of glutamate vesicles from axons elicited currents in OPCs 
mediated by AMPA receptors. Glutamatergic activity was linked to calcium (Ca2+) rises in 
OPCs which were blocked using a selective antagonist of Ca2+-permeable AMPA/kainate 
receptors. Axon-OPC synapses were further confirmed by electron microscopy in the 
hippocampus which identified typical synaptic features like pre- and post-synaptic vesicle 
densities (Bergles et el., 2000). OPCs also receive GABAergic synapses from inhibitory 
interneurons in hippocampus. Interneuronal firing leads to transient activation of GABAA 
(gamma-aminobutyric acid) receptors on OPCs (Lin and Bergles, 2004). Moreover, 
oligodendrocyte lineage cells exhibit functional NMDA receptors in the cerebellum and corpus 
callosum (Káradóttir et al., 2005). Disruption of NMDAR specifically in OPCs and 
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oligodendrocytes in vitro and in vivo does not alter OPC proliferation, differentiation and 
myelination neither in experimental autoimmune encephalomyelitis (EAE), a model of human 
MS (Biase et al. 2011; Guo et al. 2012 ) The role of NMDA-mediated currents in OPCs and 
differentiation into oligodendrocytes is still unclear, since NMDAR ablations showed increased 
Ca2+ mediated by AMPAR, suggesting that NMDARs and AMPARs can functionally 
compensate across their roles (De Biase et al. 2011).  
Axon-OPC synapses have been found also in white matter brain regions. Two studies 
described that vesicular release of glutamate, from unmyelinated axons, is detected by 
glutamate receptors in OPCs in the corpus callosum (Kukley et al., 2007; Ziskin 2007). 
Interestingly, OPCs, unlike other cells in the CNS, relocated after division and kept in their 
processes synaptic junctions which were inherited by the daughter cells. This result suggests 
that OPCs were born with synapses and could immediately establish connections with neurons 
(Kukley et al., 2008). OPCs form a transient and highly organised network with interneurons in 
the developing neocortex, showing a peak in connectivity that coincides with 
oligodendrogenesis (Orduz et al., 2015). Recently, a study of the effects of hypoxia on OPCs 
revealed that hypoxia causes loss of GABAA receptor-mediates synapses, increased OPC 
proliferation and delayed oligodendrocyte myelination. This result indicates that GABAergic 
signalling can modulate OPC behaviour in mice in vivo (Zonouzi et al., 2015). The role of axon-
OPC synapses has been investigated in vivo also in a toxin-induced demyelination model. 
Demyelinated axons form synaptic contacts to OPCs, glutamatergic activity instructs OPCs to 
differentiate into new myelinating oligodendrocytes that recover their lost function (Gautier et 
al., 2015). OPC-axon synaptic contacts modulate both proliferation and differentiation, and this 
can be regulated by different patterns of neuronal activity. High neuronal firing in the corpus 
callosum increases OPC proliferation, low frequencies increase the numbers of pre-
myelinating oligodendrocytes and all stimulations promoted differentiation of OPCs in 
oligodendrocytes, suggesting that neurons through their firing can tune OPC behaviour (Nagy 
et al., 2017). The functional role of AMPARs in oligodendrocyte lineage cells was identified 
manipulating these receptors specifically at the level of axon-OPC synapses in vivo. Point 
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mutation of the GluA2 subunit, which increase the calcium-permeability of AMPA receptors, 
enhanced OPC proliferation and reduced their differentiation into oligodendrocytes (Chen et 
al., 2018). Loss of AMPA receptor signalling specifically in oligodendrocyte lineage cells via 
double and triple knockouts of the gria2-4 genes encoding AMPAR subunits, did not alter OPC 
proliferation but also decreased the survival of mature oligodendrocytes (Kougioumtzidou et 
al., 2017). 
All together, these studies illustrate that axon-OPC establish synaptic contacts. However, the 
function of these contacts is still not clear, as neuronal activity through glutamatergic and 
GABAergic signalling via axon-OPC synapses modulate both OPC proliferation and 
differentiation.  
 
In this section, changes in myelination were highlighted focusing on the conditions that can 
influence OPC differentiation. In particular, myelination is regulated by neuronal activity 
modulated in different ways associated with animal experience, such as learning and social 
interaction (Fig. 1.4). Neuronal activity induces changes in oligodendrocyte lineage cell 
progression, affecting both proliferation and differentiation of OPCs and alters as well myelin 
sheath structure. OPCs sense neuronal activity through the expression of neurotransmitter 
receptors and they receive synaptic inputs from neurons. The mechanisms by which neuronal 
activity affects OPC cell fate and myelination have to be further investigated, taking into 
account OPC heterogeneity and considering that OPC subtypes may respond differently to 
neuronal activity. In this way, it will be possible to reach a better understanding of the 
relationship between changes in oligodendrocyte lineage cells, and functional alterations to 




Fig. 1.4 Factors that modulate OPC behaviour 
A) Schematic showing the factors that influence myelination. Neuronal activity, different types of learning (motor 
learning, juggling and practicing the piano) and social interaction modulate positively myelin changes. B) Effects of 
the cues showed in A on oligodendrocyte lineage cells and myelination. Neuronal activity and experience induce 




1.6 The role of calcium in oligodendrocyte lineage cells 
 
In the previous sections, I discussed the synaptic features of OPCs and their physiological 
properties. Despite the fact that OPCs express several voltage-gated ion channels (VGCs), 
the function of these channels and in general the role of OPC synaptic contacts is not clear 
yet. In neurons, synaptic signals can trigger action potentials and calcium signalling. Calcium 
is an important second messenger related to various cellular processes including cell 
migration, proliferation and neurotransmission. Intracellular calcium rises induced by synaptic 
signalling are also present in oligodendrocyte lineage cells, but the functions and mechanisms 
that involve calcium signalling need to be further investigated in oligodendrocytes.  
 
1.6.1 Calcium in axon-OPC interactions 
 
Synaptic stimulations to elicit calcium in OPCs were not able to produce action potentials, 
suggesting that synaptic inputs are too weak in OPCs. In OPCs, calcium rises are dynamic 
and can derive from intracellular or extracellular sources (Haberlandt et al., 2011). Ca2+-
permeable AMPA-receptors are the main source of Ca2+ in OPCs and this was confirmed by 
the elevated expression level of gria2 gene that encodes the AMPA receptor subunit 
responsible for calcium permeability (Marques et al., 2016). However, OPCs also express 
voltage-gated Ca2+ channels (VGCCs) through which Ca2+ can enter from the extracellular 
space (Fulton et al., 2010). Additionally, Ca2+ can be released from intracellular stores upon 
different stimulations. OPCs express voltage-gated Na+ channels but fail to produce action 
potentials typical of neurons, this might be due to the weakness of the synaptic input, which 
might be not sufficient to cause the required depolarisation in the cell to activate the VGCCs 
(Velez-Fort et al., 2010; Sun et al., 2016). However, Káradóttir et al., described a type of OPCs 
in the CNS white matter capable to generate action potential (Káradóttir et al. 2008). 
Stimulation-induced Ca2+ elevations in slice hippocampal OPCs can be achieved through 
several pathways: VGCCs, Ca2+-permeable AMPA-receptors, group I metabotropic glutamate-
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receptors and calcium release from the endoplasmic reticulum (ER). Moreover, electrical 
stimulation of presynaptic neurons caused post-synaptic Ca2+ elevations in the highly motile 
OPC arborisations, and not in the soma region (Haberlandt et al., 2011). Ca2+ rises evoked by 
the activation of Na+ channels and Na+/Ca2+ exchangers (NCX) in OPCs have been also found 
to be involved in cell migration and to be triggered through GABAergic receptors (Tong et al., 
2009). VGCCs can also impact OPC migration as shown by an in vitro study in which OPC 
migration was blocked by pharmacological inhibition of Cav1.2, a L-type VGCC (Paez et al. 
2009). In a recent and well described work, Sun et al. used hippocampal slices to investigate 
the role of calcium in OPCs to integrate neuronal activity. In this study, glutamatergic synaptic 
input generated a linear response in OPCs which gradually increased dendritic calcium 
elevations depending on the stimulus strength, meaning that OPC calcium levels reflect the 
level of synaptic activity. Both somatic and localised to OPC processes calcium signals had a 
much slower decay time compared to neurons. This was the first evidence describing calcium 
as an important signal to link synaptic input through neurotransmitter release with a stimulus-
dependent neuronal activity (Sun et al., 2016). Two-photon in vivo imaging of genetically 
encoded Ca2+ indicators expressed in OPCs revealed that olfactory sensory stimulation 
triggers a strong Ca2+ response in OPC processes that are input specific (Rungta et al., 2018). 
To summarise, calcium is involved in several pathways in oligodendrocyte lineage cells related 
to axon-OPC interactions. I have given a general overview about how intracellular calcium can 
be mediated in OPCs by individual receptors and channels (Fig. 1.5). Calcium localisation, 
amplitude and signal transduction pathways might regulate different cellular functions amongst 
the oligodendrocyte lineage. Not much is known about how calcium rises modulate OPC 
behaviour and myelination. In the next section I will illustrate the influence of calcium changes 




Fig. 1.5 Calcium in axon-OPC contacts  
Upper schematic: Axon-OPC synaptic contacts. a) zoom in of the axon-OPC synapse. OPCs receive both 
glutamatergic and GABAergic synaptic inputs from neurons through the expression of several neurotransmitter 
receptors. AMPAR (α-amino-3-hydroxy-5-methyl isoxazole propionic acid receptor), NMDAR (N-methyl-D-
aspartate receptor), GABAR (gamma-aminobutyric acid receptor). Through these receptors, intracellular calcium 
rises in OPCs as well as through VGCC (voltage gated calcium channel) and the NCX (Na+/Ca2+ exchangers). 
Black arrows indicate the direction of ion flux through channels. b) zoom in of the axon-OPC non-synaptic contact. 
Active axons can also signal to OPCs via non-synaptic contacts, through vesicular release of neurotransmitters or 
growth factors, indeed OPCs express also growth factor receptors. Adapted from Paez and Lyons, 2020 and Faria 
et al., 2019.  
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1.6.2 Visualising calcium signalling dynamics in oligodendrocyte lineage cells 
 
Different mechanisms can regulate changes in intracellular Ca2+ but it is still unclear how this 
can affect aspects of OPC function. This section will highlight the effects of calcium changes 
during oligodendrocyte formation and myelin formation. At the beginning of my PhD, no data 
on calcium imaging in oligodendrocyte lineage in vivo were available. Recently, in vivo calcium 
imaging studies in zebrafish showed that the characteristics of calcium transients in myelin 
sheaths of newly formed oligodendrocyte correlated with their behaviour (Baraban et al., 2018; 
Krasnow et al., 2018). High-amplitude, long-duration Ca2+ transients preceded retraction of 
sheaths mediated by calpain, a Ca2+-dependent non-lysosomal protease (Baraban et al., 
2018). In contrast, lower-amplitude, shorter-duration calcium events were indicative of sheath 
elongation, and their frequency correlated with sheath growth speed (Baraban et al., 2018; 
Krasnow et al., 2018). In the study from Krasnow and colleagues, calcium activity in developing 
oligodendrocytes was analysed, starting with pre-myelinating oligodendrocytes. Process and 
cell soma calcium transients decreased while maturation towards oligodendrocytes occurred. 
Moreover, calcium transients correlated with neuronal electric stimulation and their firing rates 
were reduced by approximately 50% after Tetrodotoxin (TTX) injection which blocks action 
potentials (Krasnow et al., 2018). Another recent work examined calcium transients in myelin 
sheath formation in the mouse somatosensory cortex. The authors similarly identified high-rate 
spontaneous calcium transients propagating along the myelin sheaths which decreased with 
sheath maturation, but which were again more active during remyelination following cuprizone-
induced demyelination. In contrast to the previous work, microdomain Ca2+ transients in myelin 
sheaths did not correlate with neuronal activity, but they were almost completely abolished 
when the mitochondrial permeability transition pores have been pharmacologically inhibited 
(Battefeld et al., 2019). The mechanisms that regulate calcium-mediated myelin formation and 
elongation need to be further explored to clarify the role of neuronal activity and the other 
factors involved in this process. Furthermore, a complete calcium activity description of 
oligodendrocyte lineage cells is still missing, since the calcium response profile of OPCs that 
receive synaptic contacts from axons has been not described in the previous in vivo studies. 
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As OPCs receive both glutamatergic and GABAergic synaptic inputs from neurons and 
express various voltage gated ion channels, it would be interesting to characterise their calcium 




1.7 Summary  
 
CNS myelin, formed by oligodendrocytes, allows fast and precise axon conduction to fine tune 
neural circuits. In the last twenty years, oligodendrocyte precursor cells (OPCs) have been 
widely studied for different reasons: they constitute one of the major cell population in the CNS, 
their density is maintained constant throughout life and some, but not all, OPCs differentiate 
into myelinating oligodendrocytes. Previous studies have demonstrated that myelin can be 
modulated throughout life, and have identified several cues that can influence myelination, 
such as neuronal activity, learning and social experiences. OPCs integrate neuronal activity 
by expression of different neurotransmitter receptors and voltage gated ion channels. A key 
role in sensing neuronal activity is played by calcium. Indeed, intracellular calcium rises have 
been detected in OPCs upon neuronal activity. Axon-OPC interactions modulate changes in 
the oligodendrocyte lineage cell fate, but it is still unclear how this is regulated since increased 
neuronal activity triggers both proliferation and differentiation of OPCs. One possible 
explanation is based on the heterogeneity found across the OPC population, especially with 
regard to their differential ability in sensing axonal activity through the appearance of diverse 
electrophysiological properties. This would consequentially affect OPC cell fate response to 
axonal activity. Moreover, differences amongst OPCs have already been described across 
several brain regions and time windows, arising the question of whether OPCs being 
intrinsically diversified or if they are at differential states during their lineage progression but 
not functionally different.  
A work that combines the study of OPC heterogeneity together with functional readouts of their 




1.8 Aims and experimental strategy 
 
Oligodendrocyte precursor cells (OPCs) represent a heterogeneous population with different 
gene expression profiles, physiological properties and behavioural fates. However, these 
features have not yet been directly correlated. In particular, neuronal activity appears to have 
different effects on OPCs by promoting both proliferation and differentiation. This arises the 
question whether amongst OPCs are indeed subtypes, some of which proliferate in response 
to neural activity while others differentiate, or whether the apparent OPC diversity reflects other 
features that cells can have or acquire. Therefore, the general aim of my thesis was to 
investigate mechanisms of axon-OPC interactions to understand whether all OPCs similarly 
sense neural activity and if they all contribute to myelination.  
In order to address this question, the aims of my PhD project were the following: 
1) To characterise OPC cell morphology and position in the zebrafish spinal cord, and to 
identify synapse-like axon-OPC contacts in vivo focusing on possible differences between 
OPCs.  
2) To describe OPC calcium dynamics at both single cell and population levels in order to 
identify potential differing calcium properties amongst OPCs.  
3) To explore neuronal-induced effects on OPC calcium dynamics and cell fates to define 
possible differential responses amongst OPCs in sensing neural activity. 
To address these aims, I used zebrafish as a model organism considering its well-known 
advantages. Zebrafish larvae are optically transparent and permit non-invasive in-vivo imaging 
of OPC morphology, physiology and fate over time using transgenic reporters and biosensors. 
Moreover, it is a relatively small animal model, allowing large volume imaging in a short amount 
of time with a light-sheet microscopy. This animal model is also ideal for pharmacological 
manipulations permitting a precise control of drug delivery and dosage. Furthermore, up to 
70% of human genes are conserved, and zebrafish has been previously used to study 
myelination.   
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The cloning performed for this study was done in collaboration with Dr. Tim Czopka, Wenke 
Barkey, Tobias Hoche and Dr. Laura Hoodless. The entry clones generated are listed below 
and their respective primers are in Table 2.1. 
p5E_mfap4: The 5’ entry clone p5E_mfap4 was generated by PCR amplification of a 1.5 kb 
DNA fragment of mfap4 upstream regulatory sequence (Walton et al., 2015) from zebrafish AB 
wild-type genomic DNA and subsequently recombined with a pDONRP4P1R plasmid using a 
BP-reaction.  
pME_GCaMP6m: To generate the middle entry clone pME_GCaMP6m the coding sequence 
was PCR amplified from a template plasmid (Chen et al., 2013) and subsequently recombined 
with a pDONR221 plasmid using a BP-reaction. 
pME_GCaMP6m-CAAX: To generate the middle entry clone pME_GCaMP6m-CAAX the 
coding sequence was PCR amplified from a template plasmid (Chen et al., 2013) and 
subsequently recombined with a pDONR221 plasmid using a BP-reaction. 
pME_mCherry-CalEx: To generate the middle entry clone pME_mCherry-CalEx the coding 
sequence was PCR amplified from a template plasmid (Yu et al., 2018) and subsequently 
recombined with a pDONR221 plasmid using a BP-reaction. 
pME_mScarlet: The middle entry clone pME_mScarlet was generated using a BP-reaction, 
the coding sequence with appropriate sites for recombination with pDONR221 was 
commercially synthesized by BioCat. 
pME_PSD95_nostop: To generate the middle entry clone pME_PSD95_nostop the coding 
sequence was PCR amplified from a template plasmid (Niell et al., 2004) and subsequently 
recombined with a pDONR221 plasmid using a BP-reaction. 
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pME_synaptophysin-nostop: To generate the middle entry clone pME_synaptophysin-
nostop the coding sequence was PCR amplified from a template plasmid (Meyer et al., 2006) 
and subsequently recombined with a pDONR221 plasmid using a BP-reaction. 
p3E_tagRFPt-pA: To generate the 3’ entry clone p3E_tagRFPt-pA the coding sequence was 
PCR amplified using the primer combination attB2_tagRFPt_F and attB3R_pA_R and 
subsequently recombined with a pDONR_P2P3R plasmid using a BP-reaction. 
pME_CaMPARI: To generate the middle entry clone pME_CaMPARI the coding sequence 
was PCR amplified from a template plasmid (Fosque et al., 2015) and subsequently 
recombined with a pDONR221 plasmid using a BP-reaction. 
pME_TRPV1-tagRFPt: The middle entry clone pME_TRPV1-tagRFPt was generated using a 
BP-reaction, the coding sequence with appropriate sites for recombination with pDONR221 
plasmid was commercially synthesized by BioCat. 
pME_jRGECO1a: To generate the middle entry clone pME_jRGECO1a the coding sequence 
was PCR amplified from a template plasmid (Dana et al., 2016) and subsequently recombined 
with a pDONR221 plasmid using a BP-reaction. 
pTol2_olig1(4.2):nls-mApple: The expression construct pTol2_olig1(4.2):nls-mApple was 
generated with the 5’ entry clone p5E_olig1(4.2) (Auer et al., 2018) and the Tol2Kit entry clones 
pME_nls-mApple, p3E-pA and pDestTol2_pA (Kwan et al., 2007) using Multisite LR 
recombination reactions. 
pTol2_elavl3:mCherry: The expression construct pTol2_elavl3:mCherry was generated with 
the 5’ entry clone p5E_elavl3 (Mensch et al., 2015) and the Tol2Kit entry clones pME_mCherry, 
p3E-pA and pDestTol2_pA (Kwan et al., 2007) using Multisite LR recombination reactions. 
pTol2_elavl3:synaptophysin-tagRFP: The expression construct 
pTol2_elavl3:synaptophysin-tagRFP was generated with the 5’ entry clone p5E_elavl3 
(Mensch et al., 2015), the generated middle entry clone pME_synaptophysin-nostop, the 3’ 
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entry clone tagRFP and the Tol2Kit entry clones p3E-pA and pDestTol2_pA (Kwan et al., 
2007) using Multisite LR recombination reactions. 
pTol2_olig1(4.2):KalTA4: The expression construct pTol2_olig1(4.2):KalTA4 was generated 
with the 5’ entry clone p5E_olig1(4.2) (Auer et al., 2018), the middle entry clone pME_KalTA4 
(Almeida et al., 2015) and the Tol2Kit entry clones p3E-pA and pDestTol2CG2 (Kwan et al., 
2007) using Multisite LR recombination reactions. 
pTol2_UAS:PSD95-YFP: The expression construct pTol2_UAS:PSD95-YFP was generated 
with the 5’ Tol2Kit entry clone p5E_UAS(10x) (Kwan et al., 2007), the generated middle entry 
clone pME_PSD95_nostop, the 3’ entry clone p3E_EYFPpA (Auer et al., 2018) and the Tol2Kit 
plasmid pDestTol2_pA (Kwan et al., 2007) using Multisite LR recombination reactions. 
pTol2_olig1(4.2):GCaMP6m: The expression construct pTol2_olig1(4.2):GCaMP6m was 
generated with the 5’ entry clone p5E_olig1(4.2) (Auer et al., 2018), the generated middle entry 
clone pME_GCaMP6m and the Tol2Kit entry clones p3E-pA and pDestTol2_pA (Kwan et al., 
2007) using Multisite LR recombination reactions. 
pTol2_olig1(4.2):GCaMP6m-CAAX: The expression construct pTol2_olig1(4.2):GCaMP6m-
CAAX was generated with the 5’ entry clone p5E_olig1(4.2) (Auer et al., 2018), the generated 
middle entry clone pME_GCaMP6m-CAAX and the Tol2Kit entry clones p3E-pA and 
pDestTol2_pA (Kwan et al., 2007) using Multisite LR recombination reactions. 
pTol2_olig1(4.2):CaMPARI: The expression construct pTol2_olig1(4.2):CaMPARI was 
generated with the 5’ entry clone p5E_olig1(4.2) (Auer et al., 2018), the generated middle entry 
clone pME_CaMPARI and the Tol2Kit entry clones p3E-pA and pDestTol2_pA (Kwan et al., 
2007) using Multisite LR recombination reactions. 
pTol2_UAS:TRPV1-tagRFPt: The expression construct pTol2_UAS:TRPV1-tagRFPt was 
generated with the 5’ Tol2Kit entry clone p5E_UAS(10x) (Kwan et al., 2007), the generated 
middle entry clone pME_TRPV1-tagRFPt, the 3’ entry clone p3E-pA (Auer et al., 2018) and 
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the Tol2Kit plasmid pDestTol2_pA (Kwan et al., 2007) using Multisite LR recombination 
reactions. 
pTol2_cntn1b:jRGECO1a: The expression construct pTol2_cntn1b:jRGECO1a was 
generated with the 5’ entry clone p5E_cntn1b (Czopka et al., 2013), the generated middle entry 
clone pME_jRGECO1a and the Tol2Kit entry clones p3E-pA and pDestTol2_pA (Kwan et al., 
2007) using Multisite LR recombination reactions. 
pTol2_elavl3:jRGECO1a: The expression construct pTol2_elavl3:jRGECO1a was generated 
with the 5’ entry clone p5E_elavl3 (Mensch et al., 2015), the generated middle entry clone 
pME_jRGECO1a and the Tol2Kit entry clones p3E-pA and pDestTol2_pA (Kwan et al., 2007) 
using Multisite LR recombination reactions.  
pTol2_mfap4:memCerulean: The expression construct pTol2_mfap4:memCerulean was 
made with the generated 5’ entry clone p5E_mfap4, the middle entry clone 
pME_memCerulean (Auer et al., 2018) and the Tol2Kit entry clones p3E-pA and pDestTol2_pA 
(Kwan et al., 2007) using Multisite LR recombination reactions.  
pTol2_UAS:mCherry-CalEx: The expression construct pTol2_UAS:mCherry-CalEx was 
generated with the 5’ Tol2Kit entry clone p5E_UAS(10x) (Kwan et al., 2007), the generated 
middle entry clone pME_mCherry-CalEx, and the Tol2Kit entry clones p3E-pA and 
pDestTol2_pA (Kwan et al., 2007) using Multisite LR recombination reactions.  
pTol2_UAS:mScarlet: The expression construct pTol2_UAS:mScarlet was generated with 
the 5’ Tol2Kit entry clone p5E_UAS(10x) (Kwan et al., 2007), the generated middle entry clone 
pME_mScarlet, and the Tol2Kit entry clones p3E-pA and pDestTol2_pA (Kwan et al., 2007) 
using Multisite LR recombination reactions.  
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Table 2.1 Primers used for cloning 


















































att recombination site, Kozak sequence, coding sequence 
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2.2 Transgenic lines  
 
All animals were kept at 28.5° with a 14/10 hour light/dark cycle according to local animal 
welfare regulations. AB and nacre wild-type animals were used for this study. All transgenic 
lines used are listed in Table 2.2.  
 





Tg(olig1:memEYFP) generated (Marisca et al., 2020) 
Tg(olig1:nls-mApple) generated (Marisca et al., 2020) 
Tg(mbp:memCerulean) (Auer et al., 2018) 
Tg(mbp:EGFP-CAAX) (Almeida et al., 2011) 
Tg(elavl3:synaptophysin-tagRFP) generated (Marisca et al., 2020) 
Tg(mbp:nls-EGFP) (Karttunen et al., 2017) 
Tg(cntn1b:KalTA4) (Mensch et al., 2015) 
Tg(olig1:KalTA4) generated (Marisca et al., 2020) 
Tg(UAS:GCaMP6s) mpn101 (Thiele et al., 2014) 
Tg(olig1:GCaMP6m) generated (Marisca et al., 2020) 
Tg(mbp:KillerRed) (Auer et al., 2018) 
Tg(olig1:CaMPARI) generated 
Tg(mfap4:memCerulean) generated (Marisca et al., 2020) 
Tg(elavl3:h2b-GCaMP6s) (Freeman et al., 2014) 
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2.3 mRNA transposase synthesis and DNA microinjection for 
sparse labelling 
 
Transposase plasmid (Tol2Kit) (Kwan et al., 2007) was linearized with NotI (New England 
BioLabs). Afterwards, it was purified with a PCR purification kit (Qiagen) following the protocol. 
The mRNA synthesis was done with the mMessage mMachine SP6 kit (Invitrogen) and then 
purified with an RNAeasy Mini kit (Qiagen) according to the protocol. RNA concentration was 
then measured at the spectrophotometer and stored at -80°C. 
One cell stage eggs were microinjected with 1nl of injection solutions containing 5-25 ng/ µl 
DNA, 25-50 ng/ µl Tol2 transposase mRNA and 10 % phenol red (Sigma Aldrich). The needle 
for microinjection was always calibrated using a micrometer and injecting the solution in a drop 
of mineral oil. 
 
Generation of new transgenic lines 
A fluorescent dissecting microscope (Nikon SMZ18) was used to screen embryos for the 
expression of the injected construct. Injected animals were used for single cell experiments or 
raised to generate the full transgenic line. To generate stable transgenic lines, injected F0 
embryos were raised and when they reached adulthood were outcrossed to wild-type 




2.4 Immunostaining and imaging of fixed samples 
 
Tissue preparation and cryosectioning 
5-7 days post fertilisation zebrafish larvae were euthanised with 4mg/ml tricaine (MS-222) and 
then fixed overnight at 4˚C in 4% paraformaldehyde (PFA). Fixed animals were incubated for 
a minimum of three days in an increasing concentration of sucrose (10%, 20%, 30%), until the 
larvae sank to the bottom of the well plate. Afterwards zebrafish larvae were embedded in OCT 
medium (Tissue-Tek) and frozen on dry ice. The samples were then stored at -80°C until 
sectioning. Trasversal section of the spinal cord with a thickness of 14-16 µm were obtained 




Slides were kept at RT 1 hour before starting the washes to remove the residual OCT medium. 
Afterwards, sections were washed three times with PBS and then were blocked for 1.5 hour at 
room temperature in PBS, 0.1% Tween20, 10% FCS, 0.1% BSA and 3% normal goat serum. 
Sections were placed in a humid chamber and incubated in primary antibodies diluted in 
blocking solution overnight at 4˚C. Subsequently, sections were washed three times in PBS, 
0.1% Tween20 and then incubated for 2 hours at RT in the dark with the corresponding Alexa 
Fluor-conjugated secondary antibodies (Invitrogen). Antibodies and dilutions are listed in Table 
2.3. Stained sections were washed two times in PBS, 0.1% Tween20 and once in PBS and 
subsequently mounted with ProLong Diamond Antifade Mountant with DAPI (Thermo Fisher 
Scientific). Nail polish was applied at the border of the coverslip to prevent the embedding 
medium to evaporate. Sections were stored at 4˚C. 
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Table 2.2 Antibodies used 
Name Organism / type Diluition Company 
anti-DSRed polyclonal rabbit IgG 1:1000 Takara/Clontech 
anti-mCherry polyclonal chicken IgY 1:1000 Novus Biologicals 
anti-GFP polyclonal chicken IgY 1:2000 Abcam 






monoclonal mouse IgG2b 1:2000 Sigma-Aldrich 
anti-MAP2 monoclonal mouse IgG1 1:5000 Abcam 
anti-gephyrin monoclonal mouse IgG1 1:500 Synaptic systems 
anti- PSD95 polyclonal rabbit IgG 1:1000 Abcam 
anti-chicken Alexa 
Fluor 488 
polyclonal goat IgG 1:1000 Thermo Fisher 
anti-chicken Alexa 
Fluor 555 
polyclonal goat IgG 1:1000 Thermo Fisher 
anti-rabbit 
AlexaFluor 555 
polyclonal goat IgG 1:1000 Thermo Fisher 
anti-rabbit Alexa 
Fluor 633 
polyclonal goat IgG 1:1000 Thermo Fisher 
anti-mouse Alexa 
Fluor 633 
polyclonal goat IgG 1:1000 Thermo Fisher 
anti-mouse IgG1 
Alexa Fluor 555 
polyclonal goat IgG 1:1000 Thermo Fisher 
anti-mouse IgG2b 
Alexa Fluor 633 




EDU incorporation assay 
At 4 dpf Tg(olig1:nls-mApple, mbp:nls-EGFP) zebrafish embryos were incubated in 0.4 mM 5-
ethynyl-2’-deoxyuridine (EDU) in Danieau’s solution. After 6 h incubation, embryos were 
incubated for 15 minutes in 2mg/ml Pronase (Sigma Aldrich) and subsequently fixed for 2h in 
4% PFA. Whole embryos or spinal cord sections were stained for EDU using the Click-IT Alexa 
Fluor 647 Imaging Kit (ThermoFisher Scientific) as detailed in the kit protocol, with the 
exception of a 1.5h Click-IT reaction incubation time. Afterwards, immunofluorescence staining 
was performed for transgene detection. 
 
Slide imaging  
To image stained cryosections a Leica TCS SP8 confocal microscope was used. Images were 
acquired using 63x/1.3NA glycerol and 63x/1.2NA H2O objectives with at least 100 nm pixel 
size (xy) and 1 µm z-spacing. When images were acquired for subsequent deconvolution, x/y/z 
parameters were adjusted to be suitable for processing with Huygens software. Overview 
images (i.e. EDU experiment) were taken using 10x/0.4NA (acquisition with 568nm pixel size 
(xy), 2 µm z-spacing) and 20x/0.7NA (acquisition with 142nm pixel size (xy), 1 µm z-spacing) 
objectives. 488nm excitation wavelength was used to detect DAPI; 488 nm for EGFP and Alexa 
Fluor(AF) 488; 514 nm for EYFP; 552 and 561 nm for Alexa Fluor 555; 633 nm for Alexa Fluor 
633. 
 
2.5 Live cell imaging 
 
Zebrafish mounting for confocal imaging 
Prior mounting, fish were screened at a fluorescent dissecting microscope (Nikon SMZ18). 
When specified, fish were treated with 1:200 BODIPY 630/650-X (Thermo Fisher) 1 hour 
before imaging. Fish were anaesthetized with 0.2mg/ml tricaine (PHARMAQ) in Danieau’s 
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buffer and mounted laterally in 1% low melting point (LMP) agarose (Invitrogen) on a glass 
coverslip. The coverslip was flipped over on a glass slide with a ring of high-vacuum grease 
filled with 0.2mg/ml tricaine in Danieau’s buffer to prevent drying out of the agarose. For 
confocal calcium imaging embryos were previously immobilised with 0.5 mg/ml mivacurium 
chloride (Abcam), a non-depolarising neuromuscular-blocking drug diluted in Danieau’s buffer. 
Afterwards, animals were laterally embedded in 1% LMP agarose in a glass bottom dish filled 
with 0.5 mg/ml mivacurium chloride in Danieau’s buffer. 
 
Confocal imaging 
Confocal z-stacks were acquired as 12bit images with a pixel size between 114 and 151 nm 
x/y and a z-spacing of 1μm on Leica TCS SP8 laser scanning microscopes. When images 
were acquired for subsequent deconvolution, resolutions were increased to be suitable for 
processing with Huygens software. 448 nm was used for excitation of Cerulean; 488 nm for 
EGFP; 514 nm for EYFP; 552 and 561 nm for mApple, mScarlet, mCherry, tagRFP; 633 nm 
for BODIPY630/650. Z-stacks of PSD95-positive cells were acquired every minute for 15-20 
minutes to timelapse PSD95 puncta. 
For calcium imaging single plane timelapses were acquired as a 12bit images with a pixel size 
between 114 and 151 nm x/y at 2Hz. 488nm excitation wavelength was used to detect GCaMP 
fluorescence. For fast confocal live cell imaging of cell motility and GCaMP imaging 8 kHz 
resonant scanner was used.  
To test capsaicin (Csn, Sigma-Aldrich) effects on TRPV1-positive cells, a baseline timelapse 
of 5 minutes was acquired. Afterwards, Csn was added to the glass bottom dish to reach the 
indicated concentration (2.5-6 uM) and after 15 minutes a second timelapse was acquired. 
To study the effects of 4-amminopyridine (4-AP, Sigma-Aldrich) on neurons, a baseline 
timelapse was acquired. Embryos were incubated overnight in 0.1 mM 4-AP. After 4-AP 
treatment, another timelapse was acquired. To study the effects of tetrodotoxin (TTX, Abcam) 
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on neurons, a baseline timelapse was acquired. Afterwards, 10 µM TTX was added to the 
glass bottom dish and after 1 hour incubation a second timelapse was recorded.   
To study the effects of the pharmacological manipulations on OPCs, a baseline timelapse was 
acquired. Afterwards 4-AP, was added to the glass bottom dish to reach the final concentration 
(0.5 mM) and after 15 minutes a second 5-10 minute timelapse was taken. Subsequently, 4-
AP solution was removed and tetrodoxin (TTX, Abcam) working solution was added. After 1 
hour a third timelapse was recorded.   
After imaging, the animals were either sacrificed or released from the agarose using 
microsurgery blades and kept individually in Danieau´s buffer until further use. 
 
Zebrafish mounting for light-sheet imaging 
3 dpf fish were screened at a fluorescent dissecting microscope (Nikon SMZ18) for the 
expression of GCaMP6m. At 4dpf, before imaging, larvae were paralised using mivacurium 
chloride at the final concentration of 0.5mg/mL diluted in Danieau’s buffer. Fish were laterally 
or dorsally embedded in u-shaped glass capillary in 1% LMP agarose. The u-shaped glass 
capillary was placed in a glass bottom dish filled with Danieau’s buffer.  
 
Light-sheet imaging 
To characterise GCaMP transients in OPCs light-sheet images were acquired at a Leica TCS 
SP8 DLS using a 2.5x/0.07NA illumination objective and 10X/0.3NA and 25X/0.95NA detection 
objectives with 2.5 mm deflection mirrors. GCaMP fluorescence was acquired using 488nm 
excitation wavelength. A ROI was drawn around either individual cells or a portion (5-7 
somites) of whole zebrafish spinal cord tissue. Time-lapses of z-stacks were taken with a frame 
rate of 0.5-1Hz for 2x10 minutes, with a break of 10 minutes in between. 
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To explore neuron-OPC calcium calcium transients, 4 dpf fish were screened for GCaMP6m 
expression in OPCs and RGECO expression in neurons. Selected fish were imaged using a 
2.5x/0.07NA illumination objective and 10X/0.3NA detection objective with 2.5 mm deflection 
mirrors. A single plane ROI of 2-4 somites was recorded for 10 minutes at 2 Hz. When 
specified, fish were treated, 15 minutes prior imaging, with 0.5 mM 4-AP. 
Tile scan images of CaMPARI fish were acquired using 10X/0.3NA detection objective with 5 
mm deflection mirrors. CaMPARI green and red fluorescence were acquired using 488nm and 
552 excitation wavelength respectively. 
 
2.6 Assessment of zebrafish swimming behaviour  
 
Single 4 dpf zebrafish were placed in a 3 cm dish in 3 ml Danieau’s solution (± 0.1 mM 4AP 
and/or 50 μM TTX) and imaged for two minutes at 16 frames per second using a Hamamatsu 
Orca-05G camera equipped with a Kowa LM35JC10M objective. 
 
2.7 Mivacurium chloride treatment 
 
Mivacurium chloride working solution was prepared prior imaging from the 100uM stock 
solution (Abcam). Mivacurium chloride was used at the final working concentration of 1 μM 
(0.5 mg/mL) dissolved in Danieau’s buffer. 4dpf zebrafish embryos were incubated in the 
solution for 5 minutes and subsequently embedded for imaging.   
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2.8 Capsaicin treatment 
 
Capsaicin (Csn, Sigma) 1mM stock solution was prepared by dissolving the compound in 
dimethyl sulfoxide (DMSO). 2.5-6 uM Csn working solution was made from the stock solution 
and dissolved in Danieau’s solution reaching 0.2 % DMSO.  
 
2.9 4-amminopyridine treatment 
 
4-amminopyridine (4-AP, Sigma-Aldrich) working solution was prepared prior imaging from the 
500mM stock solution. 3 and 4 dpf were incubated in 4-AP dissolved in Danieau’s solution. 
For long-term treatments (6-48 hours), 4-AP was used at 0.1 mM. For short-term treatments 
(<1 hour), 4-AP was used at 0.5 mM. 
 
2.10 Tetrodotoxin treatment 
 
Tetrodotoxin (TTX, Abcam) working solution was prepared from the 1mM stock solution. 
Zebrafish embryos at 3 and 4 dpf were incubated in TTX diluted in Danieau’s solution. For 
long-term treatments (6-48 hours) TTX was used at 50 µM. For short-term treatments (<1 
hour), TTX was used at 10 µM. 
 
2.11 Splitomicin treatment 
 
Splitomicin (Sigma Aldrich) working solution was prepared from the 10mM stock solution. 
Zebrafish embryos were incubated from 2/3 dpf in 4-5 uM Splitomicin until analysis.  
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2.12 UV-light treatment 
 
Five embryos were placed into a glass bottom dish with a diameter of 2 cm. A 405 nm LED for 
photoconversion was placed above the dish at a fixed distance and evenly illuminated the 
entire dish. Light intensity was measure prior every UV-light treatment using a power meter. 
To test the CaMPARI technique various light intensities (50 to 800 mW/cm2) and exposure 
times (2-10 minutes) were used. For experiments an intensity of 100 mW/cm2 and an exposure 
time of 5 minutes were applied. Fish were exposed to photoconversion light under various 
conditions, including freely swimming in Danieau’s buffer, in 0.5 mM 4-AP, in 10 uM TTX or 
anaesthetized in 0.2mg/ml tricaine. 
 
2.13 Image processing 
 
Images were analysed using Fiji and Imaris 8.4.2 (Bitplane). Deconvolution was done with 
the Huygens Essentials version 16.10 1p2 (Scientific volume imaging, the Netherlands, 
__http://svi.nl__). Fiji was used to adjust the brightness and to perform all measurements. 
The plugin StackReg was sometimes used to register the images and timelapses. Adobe 
Illustrator C6 was used to arrange the figures. 
 
2.14 Data analysis 
 
Cell reconstruction 
OPC morphology reconstruction was done using the Imaris Filament Tracer. At first, OPC 
processes were traced using the automatic dendrite detection combined with manual 
correction. This analysis automatically provided the information about total process length. 
To quantify the process length only in the axo-dendritic areas, processes were traced taking 
into account the BODIPY staining and using the 3D viewer in Imaris. 
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Counting of cell and post-synaptic puncta 
All cell number quantifications were done manually using Fiji. For a precise estimation cells 
were counted taking into account the z-stack images. To evaluate EDU positive cells, a 
transgenic line with a nuclear-targeted fluorescence protein was used. Macrophages and EDU 
positive cells were quantified using the Cell Counter Fiji plugin. Post-synaptic densities were 
manually quantified using the Point tool on Fiji. 
 
Fluorescent intensity measurement 
To measure the intensity of post-synaptic puncta, a rectangular ROI was drawn around a 
dendrite. The pixel intensity was measure using the Plot Profile in Fiji and the measurements 
were exported in Graphpad Prism to plot the graph.  
 
GCaMP imaging analysis 
To trace the GCaMP transients, for single cell analysis, regions of interest (ROIs) were drawn, 
using the Fiji ROI manager, around the somata and processes of single OPCs. To trace the 
GCaMP transients, for cell population analysis, ROIs were drawn only around OPC somata. 
Traces of individual ROI are shown as F/F0 given by the maximum fluorescent intensity of 
individual ROI at each time point and normalised to the first 100 frames of each ROI using 
Matlab. To count GCaMP transients as events, a threshold of 40% above average 
fluorescence was established for the frequency of somatic transients, and of 30% for all other 
analysis. The duration of GCaMP transients was quantified considering the half-width of the 
maximum F/F0 for each event. 
To analyse dual color calcium imaging, ROIs were drawn around axons and neuron cell bodies 
(RGECO-positive) and around OPC somata (GCaMP-positive). Traces of individual ROI are 
shown as F/F0 given by the maximum fluorescent intensity of individual ROI at each time 
point and normalised to the first 100 frames of each ROI using Matlab. 
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To assess changes in GCaMP after capsaicin treatment, I used maximum intensity of GCaMP 
fluorescence of ROI that were drawn around the same cells/processes in the baseline and in 
the capsaicin-treated timelapses. For each ROI, fluorescence was normalised to the first 100 
frames in Matlab. 
To analyse changes in GCaMP frequency after pharmacological treatments, I used mean 
intensity of GCaMP fluorescence traces in ROI that were drawn around the same 
cells/processes in each treatment condition (baseline, after 4-AP, after TTX). For each ROI, 
fluorescence was normalised to the first 100 frames using Matlab, and GCaMP events were 




Quantification of red/green ratio was done using Fiji. ROIs were drawn, using ROI manager, 
around OPC somata and the mean fluorescence intensity was measured in the red and in the 
green channels of each ROI. An additional ROI was drawn as reference for the background 
subtraction and the mean fluorescence intensity was measured. All data were exported into 





Statistical analysis was done with Graphpad Prism. All data were tested for normal distribution 
using the Shapiro-Wilk normality test. In the figures, normally distributed data are shown as 
mean ± standard deviation (SD) or 95% confidence intervals (CI), whereas non-normally 
distributed data are given as median with the 25% and 75% percentiles. When data were 
normally distributed to compare two groups unpaired t-test was performed. Non-normally 
distributed data were analysed for statistical significance using Mann-Whitney U test (unpaired 
data) and Wilcoxon signed-rank test (paired data). To compare multiple (>2) groups ANOVA 
was used in combination with Tukey’s (paired data) or Kruskal-Wallis (unpaired data) multiple 
comparisons test. To analyse contingency tables, Fisher’s exact test was used. P-values are 
indicated as *(p < 0.05), **(p < 0.01), ***(p < 0.001 ) in the figures. 
 
2.16 Buffers and Solutions 
 
Danieau’s Buffer 
Working solution: 1x Danieau´s 10ml 30x Stock solution plus 990ml distilled water 
 
Reagent Quantity for 900ml 30X stock solution 
NaCl (Roth) 91.52g 
KCl (Roth) 1.41g 
MgSO4 (VWR Chemicals) 2.66g 
Ca(NO3)2 (Roth) 3.83g 
Hepes (Roth) 32.17 
Distilled Water Ad 900ml 





Mivacurium Chloride  
100x Stock solution  
Reagent Quantity for 50mg/mL stock solutions 
Mivacurium Chloride (Abcam) 25 mg 
Distilled water 500µl 
 
Working solution 
Reagent Quantity for 400µl of 0.5mg/mL solution 
Mivacurium chloride stock solution (100µM) 4µl 




Stock solution  
Reagent Quantity for 100mM Stock solution 
Capsaicin (Sigma Aldrich) 50 mg 
DMSO (Sigma Aldrich) 1.637ml 
 
 
Reagent Quantitiy for xM Tricaine solution 
Tricaine/MS-222 (PharmaQ, UK) 400mg 
Distilled water 100ml 
Tris (Alfa Aesar) pH adjusted to 9 2ml 
Adjust pH to 7  
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4-amminopyridine  
Stock solution  
Reagent Quantity for 500mM Stock solution 
4-amminopyridine (Sigma-Aldrich) 1 g 
Distilled water 21.2ml 
 
Tetrodotoxin  
Stock solution  
Reagent Quantity for 1mM Stock solution 
Tetrodotoxin (Abcam) 1 mg 
Distilled water 3.123ml 
 
Splitomicin  
Stock solution  
Reagent Quantity for 10mM Stock solution 
Splitomicin (Sigma Aldrich) 5 mg 








3.1 OPC characterisation in the zebrafish spinal cord 
3.1.1 OPC localisation in the zebrafish spinal cord 
 
Oligodendrocyte Precursor Cells (OPCs) can differentiate to myelinating oligodendrocytes, 
which form electrically isolating myelin sheaths around axons and are essential for rapid nerve 
conduction. Myelination is a dynamic and activity-dependent process. OPCs sense axonal 
activity through the expression of neurotransmitter receptors and they form functional synaptic 
contacts with neurons (Bergles 2000). Neural activity regulates OPC fate, proliferation and 
differentiation, thereby controlling their potential contribution to myelination (Gibson et al., 
2014). 
To better understand the mechanisms by which neural activity is integrated by OPCs, I started 
characterising the OPC population within the zebrafish spinal cord, with regard to OPC 
morphology and position. The main purpose of these experiments was to define OPC position 
in the zebrafish spinal cord at different developmental ages to study if OPCs in different 
locations in the spinal cord have the same morphology. Moreover, I also characterised the 
environment and different cell types by which OPCs are surrounded. As in the mammalian 
CNS, differences in OPC ability to differentiate have been identified between white and grey 
matter. White matter OPCs in the cerebral cortex have a higher differentiation and proliferation 
rate than grey matter ones suggesting that the environment surrounding OPCs plays an 
important role in determining their behaviour (Viganó and Dimou 2016). Therefore, the 
description of OPC position in the spinal cord, related to their surroundings, is necessary to 
delineate any type of analogy with the mammalian CNS and to highlight possible location and 
environmental differences between OPCs. 
I labelled OPCs using a double transgenic line in which nuclear- and membrane-targeted 
fluorescence proteins (nls-mApple and memEYFP, respectively) were expressed in OPCs 
under control of olig1 gene regulatory sequences (oligodendrocyte transcription factor 1) 
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(Schebesta et al., 2009). Whole animal imaging of this OPC line revealed that OPCs constitute 
a dense population throughout the zebrafish CNS (Fig. 3.1A). 
 
Fig. 3.1 Oligodendrocyte Precursor Cells in the zebrafish spinal cord 
A) Lightsheet microscopy image of whole Tg(olig1:memEYFP) transgenic animal at 5 days post-fertilisation (dpf). 
Scale bar: 1mm. B) Confocal image of a Tg(olig1:memEYFP), Tg(olig1:nls-mApple) zebrafish, lateral view of the 
spinal cord at 5 dpf. Scale bar: 50 µm. C) Confocal image of a Tg(olig1:memEYFP), Tg(olig1:nls-mApple) zebrafish, 
lateral view of the spinal cord at 21 dpf. Scale bar: 50 µm. D) Dorsal confocal image of a Tg(olig1:memEYFP) 
zebrafish stained with BODIPY showing OPC processes projecting in the lateral side of the spinal cord at 5 dpf. 
Scale bar: 10 µm. E) Cross-sectional view of the spinal cord showing the distribution of OPC processes in 
Tg(olig1:memEYFP) at 7dpf. Scale bar: 10 µm. (Marisca et al., 2020) 
 
Higher magnification imaging highlighted a dense network of OPC processes in the zebrafish 
spinal cord at 5 days post fertilisation (dpf) (Fig. 3.1 B). This network was maintained at the 
later age of 21 dpf (Fig. 3.1 C). 
Furthermore, I combined OPC dorsal imaging with BODIPY (4,4-Difluoro-4-Bora-3a,4a-Diaza-
s-Indacene) staining to delineate the outlines of the different parts of the spinal cord. The 
medial part is recognisable by the central canal and the area where all neuron cell bodies are, 
identified by the incorporation of BODIPY in the cell membrane. The lateral side of the spinal 
cord is where most of OPC processes reside (Fig. 3.1 D). Cross section images of the 
membrane targeted OPC line, stained also with DAPI (4′,6-diamidino-2-phenylindole) a 
nuclear dye, confirmed that OPCs project their processes into the lateral spinal cord and almost 
no processes were found in the cell body region of the medial spinal cord (Fig. 3.1 E).   
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To describe the area where OPCs extend their processes and what they contact, I also wanted 
to look at axons and co-label them using a myelin and an axon labelling.  
The axons in the zebrafish spinal cord run in stereotypic position along the lateral side with the 
myelinated axons located mostly in the ventral and dorsal spinal cord tracts.   
To identify myelinated axons, I used a transgenic line where a fluorescence protein 
(memCerulean) was driven by the promoter mbp (myelin basic protein) (Auer et al., 2018) 
combined with an OPC line. Lateral spinal cord imaging allowed me to observe myelinating 
oligodendrocytes mostly at the ventral and dorsal side of the spinal cord (Fig. 3.2 A). 
 
Fig. 3.2 OPCs, axons and myelin in the zebrafish spinal cord  
A) Confocal image of a Tg(olig1:memEYFP), Tg(mbp:memCerulean) zebrafish, lateral view of the spinal cord at 5 
dpf. Scale bar: 50 µm. B) Confocal image of a Tg(olig1:memEYFP) fish injected with elavl3:mCherry, lateral view 
of the spinal cord at 4 dpf. Scale bar: 10 µm. C) Single plane confocal images of a Tg(olig1:memEYFP), 
Tg(mbp:memCerulean) + elavl3:mCherry lateral view of the spinal cord at 5 dpf, showing that OPC processes are 
located in the lateral spinal cord with myelinated and unmyelinated axons. Scale bar: 10 µm.  
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Furthermore, I injected mCherry under the elavl3 promoter, a neuron-specific RNA-binding 
protein (Coolen et al., 2012), into Tg(olig1:memEYFP) to transiently label axons and OPCs. 
OPCs form a dense network in the lateral spinal cord where also axons are (Fig. 3.2 B). The 
combination of axons, OPCs and myelin labelling in the same animal and high-resolution single 
plane images revealed that OPC processes reside in the same region as myelin and axons 
(Fig. 3.2 C). In addition to lateral views which highlight the process network that OPCs create 
within the lateral axonal tract, I used cross sectional immunostaining to identify the position of 
myelinated and unmyelinated axons within the spinal cord volume. Myelinated axons, labelled 
by using the Tg(mbp:EGFP-CAAX) line, were located mostly ventrally and dorsally in both side 
of the spinal cord stained with DAPI (Fig. 3.3 A). To have a closer analysis of the axonal tracks, 
to further describe the environment where OPC processes project, I labelled axons and 
dendrites using antibodies against acetylated tubulin and MAP2 (microtubules-associated 
protein 2) respectively. Both of them constituted the lateral spinal cord. The DAPI staining 
highlighted the position of the cell bodies in the central part of the spinal cord (Fig. 3.3 B). As 
both OPC processes and axons create a dense network in the lateral spinal cord and they also 
form synaptic contacts (Bergles et al., 2000), I also wanted to visualise synapse position in the 
zebrafish spinal cord using pre- and post-synaptic markers. I generated the 
Tg(elavl3:synaptophysin-tagRFP) transgenic line to label the presynaptic site in neuron under 
the elavl3 promoter, a widely used pan-neuronal marker. Synaptophysin is a synaptic vesicle 
protein which localises to pre-synaptic sites. I performed immunostaining using gephyrin as a 
post-synaptic marker to detect synaptic structures which were also located in the lateral spinal 




Fig. 3.3 Lateral spinal cord consists of myelinated and unmyelinated axons and synapses 
A) Cross-sectional view of the spinal cord showing the distribution of myelin in Tg(mbp:EGFP-CAAX), stained with 
DAPI. Scale bar: 10 µm. B) Cross-sectional view of the spinal cord showing the distribution of axons and dendrites 
stained respectively with anti-acetylated tubulin and anti-MAP2 and DAPI at 7dpf. Scale bar: 10 µm. C) Cross-
sectional view at the level of the spinal cord showing the distribution of pre- and post-synapses 
(Tg(elavl3:synaptophysin-RFP) and anti-gephyrin). Scale bar: 10 µm. (Marisca et al., 2020) 
 
To summarise, OPCs have a characteristic morphology with several process ramifications that 
form a dense network within the lateral spinal cord. Myelinated and unmyelinated axons have 
stereotypical positions in the lateral spinal cord with the myelinated axons occupying mostly 
the ventral and dorsal axonal tracks. The lateral spinal cord includes also pre- and post-
synaptic sites as well as dendrites, axons and OPC processes suggesting that most of the 
contacts can be found in the lateral spinal cord. The lateral spinal cord, where OPC processes 
reside, is constituted of myelinated, unmyelinated axons, dendrites and synapses and I will 
refer to it as ‘axo-dendritic areas’. The medial region of the spinal cord is mostly composed of 
cell bodies, highlighted by DAPI staining, and I will describe it as ‘neuron-rich areas’ throughout 
this thesis. 
OPCs extend several processes in the axo-dendritic area of the zebrafish spinal cord which is 
composed of myelinated as well as unmyelinated axons. To further investigate single OPC 
morphology and to look at possible differences in terms of shape and position amongst OPCs 
in the zebrafish spinal cord, we transiently injected olig1:memYFP to sparsely label OPCs (Fig. 
3.4 A). In the image example presented here, five distinct OPCs were detected using transient 
injections. 3D reconstruction of two OPCs (cell#1 – cell#2) using Imaris software allowed us to 
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discriminate between these cells that were located in the same area and to define their process 
ramification. Cell#1 presented a relatively simpler process ramification compared to cell#2 (Fig. 
3.4 A). Images taken were rotated for 90 degrees and combined with BODIPY staining to 
analyse OPC soma position of cell#1 and cell#2 in the spinal cord. The rotation showed that 
one OPC cell body (cell#1) resides in the axo-dendritic areas and the other one (cell#2) in the 
neuron-rich areas (Fig. 3.4 B). Independent of soma position, all OPC processes projected into 
the axo-dendritic areas. There was no difference in the percentage of OPC processes 
occupying the axo-dendritic areas between OPCs with their somata in the axo-dendritic areas 
and OPCs with their somata residing in the neuron-rich areas (mean 91.3% ± 2.3 SD neuron-
rich vs. 98.9% ± 0.7 SD axo-dendritic; n=5 cells/condition from 6 animals) (Fig. 3.4 C). 
 
Fig. 3.41 OPC processes reside in the axo-dendritic areas of the spinal cord, independent of OPC soma 
position 
A) Top: sparse labelling of olig1:memEYFP expressing OPCs at 4dpf. Bottom: Tracing of two neighbouring 
exemplary OPCs and the spinal cord outlines. Dotted lines indicate the position of the y-axis rotations shown in B. 
B) 90° y-axis rotations of at the level of the soma of each of the two cells shown to the left with a BODIPY 
counterstain to reveal the position of OPC somata in axo-dendritic (cell #1) and neuron-rich (cell#2) regions. Dotted 
lines indicate axo-dendritic areas. Scale bar: 20 µm. C) High-magnification view showing the proximity of the 
processes made by the two OPCs shown in panel A within axo-dendritic areas. Quantification shows the percentage 
of cell processes resident in axo-dendritic areas formed by OPCs with their soma in neuron-rich and axo-dendritic 
regions at 4-5dpf. (mean 91.3% ± 2.3 SD neuron-rich vs. 98.9% ± 0.7 SD axo-dendritic); n=5 cells/condition from 6 
animals. (Marisca et al., 2020) 
  
                                               
1 All images in this figure are from the work of my colleague Tobias Hoche. Tracing and quantification 
of OPCs in the graph of panel C were done by me. 
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Therefore, even if OPC processes were found in the same local environment, we found 
differences in morphology and process dynamics and the different features corresponded to 
OPC soma position localised to different areas within the spinal cord. One hour time-lapse of 
single labelled OPCs revealed that axo-dendritic area OPCs continuously remodelled all their 
processes, whereas neuron-rich area OPCs remodelled only the terminal portion of their 
processes maintaining stable their main branches. Neuron-rich area OPCs had stable and 
highly ramified processes. On the other hand, axon-dendritic area OPCs presented highly 
dynamic processes and simpler morphology (Fig. 3.5) (Marisca et al., 2020).  
 
Fig. 3.5 OPC process remodelling 
A) Schematic overview depicting the positioning of OPCs in the zebrafish spinal cord. B) 2Projections of 60 minutes 
time-lapse imaging of olig1:memYFP positive cells to show remodelled and stable processes of OPCs with their 
soma in different regions. (Marisca et al., 2020) 
To summarise, single OPC labelling showed that OPC cell bodies can have different soma 
position either in the axon-dendritic areas or in the neuron-rich areas. However, all OPC 
processes projected in the axo-dendritic areas, sharing the same environment. The two 
different OPC cell body positions correlated with differences in morphology and process 
dynamics. OPCs with their soma residing in the axo-dendritic areas showed simpler process 
ramification and faster process remodeling compared to OPCs with their soma located in the 
neuron-rich areas. This suggested the presence of two different subgroups showing different 
morphology and soma position in the zebrafish spinal cord. 
                                               
2 Images from the work of my colleague Tobias Hoche  
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3.1.2 OPC properties within the zebrafish spinal cord and their contribution to 
myelination 
 
The previous descriptive experiments and analyses showed that in the zebrafish spinal cord 
OPCs can be grouped in two categories. OPCs that have their somata located in the neuron-
rich areas, which have a rather complex morphology and more stable processes compared to 
OPCs with their somata located in the axo-dendritic areas that have a simpler morphology and 
dynamic processes. Both OPC types extended their processes in the same axo-dendritic areas 
in the lateral spinal cord (Fig. 3.6 A). 
Longitudinal studies, done by my colleague Tobias Hoche, following single OPCs, investigated 
the contribution of these two different groups of OPCs to myelination. It was shown that neuron-
rich area OPCs usually do not differentiate directly to myelinating oligodendrocytes. In contrast, 
axo-dendritic area OPCs can directly differentiate to generate myelinating oligodendrocytes. 
However, neuron-rich area OPCs can also contribute to myelination but only after a recent cell 
division. Therefore, these data highlight two factors, one extrinsic and one intrinsic, that define 
the differentiation potential of the two OPC subgroups. The extrinsic determinant is 
represented by the local environment surrounding the cell body. Neuron-rich area OPCs have 
theirs somata surrounded by other cell bodies. On the other hand, the environment 
surrounding the somata of axo-dendritic area OPCs is constituted by the neuropil. The intrinsic 
determinant is characterised by the recent cell division which is necessary to enable a neuron-
rich area OPCs to indirectly contribute to myelination. Moreover, these analyses defined the 
interrelation between the two OPC subgroups. Neuron-rich area OPCs need to divide to give 
rise to new daughter cells which could have axo-dendritic OPC features and be primed to 
differentiation. After acquiring one of the two OPC subgroup features, OPCs do not switch 




Fig. 3.6 Schematic of OPC subgroups properties 
A) Cartoon representing the location of the two groups of OPCs in spinal cord from the dorsal view. OPCs with their 
somata in the axon-dendritic area and OPCs which somata reside in the neuron-rich area. Both OPC groups expand 
their processes in the axo-dendritic area. B) Schematic representing the relationship between the two OPC groups 
and their behaviour. Neuron-rich area OPCs, which have a more complex morphology, do not directly differentiate 
but they can proliferate to give rise to a axo-dendritic area OPCs. Axo-dendritic areas OPCs, have a simpler 
morphology and are the cells that more likely differentiate to give rise to myelinating oligodendrocytes. (Marisca et 
al., 2020) 
 
To further study how necessary division events to form OPCs that can differentiate into 
myelinating oligodendrocytes are, we increased oligodendrocyte differentiation using 
splitomicin. Splitomicin is a selective inhibitor of the Sir2p, a NAD+-dependent histone 
deacetylase (HDAC), which was identified in an automated screen in zebrafish as a compound 
that increments oligodendrogenesis and myelination (Early et al., 2018). This is important to 
understand whether neuron-rich area OPCs in an enhanced oligodendrogenesis condition, 
behave differently and if they differentiate directly into myelinating oligodendrocytes or if they 
need to divide before. As increases in oligodendrogenesis are often combined also with an 
increase in OPC proliferation, several different outcomes are expected from this experiment. 
On the one hand, neuron-rich area OPCs, treated with splitomicin, could differentiate directly 
into myelinating oligodendrocyte, which would suggest that neuron-rich area OPCs do have 
the intrinsic potential to directly form new myelinating oligodendrocytes if oligodendrogenesis 
is increased. On the other hand, these OPCs could still need a preceding division event before 
they can differentiate into oligodendrocytes. The latter would strengthen the differential 
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differentiating potential of the two OPC subgroups and would create a link as well between the 
two subgroups. 
At first, we tested splitomicin effects in our system, and incubation with splitomicin (4-5 µM) , 
from 2 to 4 dpf indeed had a 1.5-fold increase of myelinating oligodendrocyte number (13.60.9 
cells/field vs. 20.41.0 cells/field, p<0.001, unpaired t-test) (Fig. 3.7 A). Then, I followed 
individual neuron-rich area OPCs from 3 to 5 dpf in control condition or treated with splitomicin 
(4-5 µM) to test which OPCs account for the increase in myelinating oligodendrocyte formation. 
The daily imaging is a good temporal resolution to detect division or differentiation events of 
sparsely labelled OPCs. More OPCs in control condition were quiescent compared to the ones 
treated with splitomicin (control vs splitomicin: 64% (21/33) vs. 45% (15/33) quiescent, p=0.22, 
two-tailed Fisher’s exact test). Neuron-rich area OPCs treated with splitomicin gave rise to 
myelinating oligodendrocytes only after a cell division and their contribution to myelination was 
significantly higher than the control neuron-rich area OPCs (control vs splitomicin: 0% (0/33) 
vs. 18% (6/33) differentiation following division, p= 0.02, two-tailed Fisher’s exact test). None 
of the neuron-rich area OPCs directly differentiated into a myelinating oligodendrocyte (Fig. 
3.7 B). From these cell fate data, I confirmed that neuron-rich area OPCs do not directly 
contribute to myelination but they can proliferate and one or both daughter cells can have the 
ability to differentiate into a myelinating oligodendrocyte. Moreover, the increase in myelinating 
oligodendrocytes, triggered by splitomicin treatment, derives from recently divided neuron-rich 




Fig. 3.7 Neuron-rich area OPCs contribute to myelination only after a division event  
A) 3Representative images and quantification of increased oligodendrocyte differentiation in control upon splitomicin 
treatment from 2 to 4 dpf. Data shown as mean  95% confidence interval (13.60.9 cells/field vs. 20.41.0 
cells/field, p<0.001 (unpaired t-test, two tailed, t=4.184, df=41), n=14/29 animals. Scale bar: 20 µm. B) 
Quantification of fates of OPCs in neuron-rich areas between 3-5 dpf, with and without splitomicin (control vs 
splitomicin: 64% (21/33) vs. 45% (15/33) quiescent, p=0.22 (two-tailed Fisher’s exact test); 0% (0/33) vs. 18% (6/33) 
differentiation following division, p= 0.02 (two-tailed Fisher’s exact test); n=23 animals per group. B’) Example 
confocal images of possible fates of individual neuron-rich area OPCs after splitomicin treatment. Scale bar: 10 µm. 
(Marisca et al., 2020) 
 
  
                                               
3 Data shown in panel A are from the work of my colleague Laura Hoodless 
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3.1.3 Axon-OPC synaptic contacts in zebrafish 
 
In the previous section, I showed that OPCs with their soma in the neuron-rich areas have a 
complex morphology, show slow process remodelling and they need to proliferate before 
differentiating into myelinating oligodendrocytes. Conversely, OPCs with their soma residing 
in the axo-dendritic areas, have a simpler morphology, show faster process remodelling and 
can differentiate directly into myelinating oligodendrocytes (Marisca et al., 2020). 
Oligodendrogenesis and OPC proliferation are regulated by axon activity, OPCs integrate the 
neural signalling through the expression of neurotransmitter receptors (Lin and Bergles, 2004; 
Káradóttir et al., 2005; Kukley et al., 2007). Indeed, OPCs interact with axons through synaptic 
contacts, which were for the first time described by electron microscopy (Bergles et al., 2000). 
The functions of these contacts are not yet clear; although one hypothesis is that such axon-
OPC contacts are involved into regulating activity-dependent adaptive myelination. 
Since we identified two different OPC subpopulations, I wondered whether they also had 
distinct ability to form synaptic contacts. Since synapses should be quite stable, I would expect 
that OPCs that show less process remodelling dynamics and that do not directly differentiate 
are potentially the cells able to form such contacts. In contrast, OPCs primed for differentiation 
are very motile which could prevent the formation of stable synaptic contacts with axons. 
Before looking at differences between the two OPC subpopulations, I needed to address if 
zebrafish OPCs form synapses at all and if I could identify them in the spinal cord. To label 
synapse-like sites, I used histological analysis to localise the post-synaptic marker PSD95 
(postsynaptic density protein 95) in OPCs of the zebrafish spinal cord. Cross section 
immunostaining of olig1:memEYFP fish with anti-PSD95 revealed that PSD95 expression was 
found in the somata of the medial as well as in the lateral spinal cord (Fig. 3.8 A). By looking 
at the 3D stack images, it was difficult to localise PSD95 expression in OPC processes as most 
of the PSD95 puncta were probably expressed in neurons. Some of them may also be found 
inside OPC processes, however it was not possible to draw a clear conclusion from this type 
of analysis (Fig. 3.8 B). 
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Fig. 3.8 Post-synaptic expression in the zebrafish spinal cord revealed by immunostaining 
A) Single plane cross-sectional view of the spinal cord showing an overview of the distribution of PSD95 (anti-
PSD95) in Tg(olig1:memEYFP) and DAPI staining at 5dpf. Scale bar: 10 µm. B) Left: Higher resolution and 
deconvolved 3-D representation of Tg(olig1:memEYFP) spinal cord cross-section stained with anti-PSD95 and 
DAPI. Scale bar: 2 µm. Top right: single plane of the area indicated on the left by a dashed rectangle, showing a 
PSD95 puncta in a OPC process (white arrow). Scale bar: 2 µm. Bottom: projection and 3-D rotation of the puncta 
indicated in the top panel inside the OPC process. Scale bar: 1 µm. 
 
Therefore, I used the UAS:PSD95-EYFP construct where PSD-95 is linked to a fluorescent 
protein (EYFP) to localise PSD95 in vivo (Niell et al., 2004). I transiently injected this construct 
into a gal4 line to get sparse cell labelling in zebrafish spinal cord. As a control, I injected the 
PSD95 construct into a neuronal gal4 line, under the contactin 1b promoter (cntn1b) which 
labels a subset of neurons. PSD95 expression in neurons in vivo was characterised by several 




Fig. 3.9 PSD95 expression is stable in neurons  
A) Projection of Tg(cntn1b:KalTA4) +UAS:PSD95-YFP showing PSD95-positive neuron in the zebrafish spinal cord. 
Scale bar: 10 µm. A’) Close up of the box area expressing PSD95 in the neuron somata. Scale bar: 5 µm. A’’) 
Close up of the dashed box area in A and fluorescence plot profile. Scale bar: 5 µm.  B) Left: confocal images of 
the first and the last frame of a 15 minutes of PSD95 puncta in neurons (Tg(cntn1b:KalTA4) +UAS:PSD95-YFP) 
confirming that PSPD95 puncta are stable. Scale bar: 10 µm. Right: close up of the dashed box area on the right 
to highlight the position of PSD95 puncta before and after 15 minutes, same coloured arrow depicts the same 
puncta. Scale bar: 5 µm. 
 
PSD95 sites appeared quite clear, thus allowing to almost always discriminate between 
neighbouring puncta, this is highlighted by the close up and the fluorescence plot profile (Fig. 
3.9 A’-A’’). To confirm that indeed the PSD95 expression was reliable and that the PSD95-
positive puncta were not moving vesicles, I performed single cell short timelapses to assess 
the stability of PSD95, since synaptic sites are known to be stable in a cell. In a 15 minute 
timelapse I verified that PSD95 puncta were quite stable in neurons (Fig. 3.9 B). I therefore 
expressed PSD95 also in OPCs to verify the stability of PSD95 puncta also in these cells. 
PSD95 puncta appeared less dense as well less bright and clear in OPCs compared to 
neurons, but most of them were stable during the timelapses (Fig. 3.10).  
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Fig. 3.10 PSD95 expression is stable in OPCs  
A-B) Two timelapse examples of PSD95 in OPCs. Left: confocal images of the first and the last frame of a 15 
minutes of PSD95 puncta expression in OPCs (Tg(olig1:KalTA4) +UAS:PSD95-YFP) confirming that PSPD95 
puncta are stable. Scale bar: 10 µm. Right: close up of the dashed box area on the right to highlight the position of 
PSD95 puncta before and after 15 minutes, same coloured arrow depicts the same puncta. Scale bar: 5 µm 
 
The utilisation of a post-synaptic labelling alone is meaningless to identify synaptic contacts if 
this does not appose a pre-synapse. Hence, I used a pre-synaptic labelling in neurons to 
identify axon-OPC contacts. I injected the UAS:PSD95-YFP construct into the OPC Gal4, 
Tg(olig1:KalTA4) and I crossed it with the Tg(elavl3:synaptophysin-tagRFP) line that I have 
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generated. Therefore, I could label axon-OPC synaptic contacts expressing a pre-synaptic 
marker in neurons and a post-synaptic marker in OPCs. PSD95 expression in OPCs was 
characterised by puncta, as well, which were less dense along the cell compared to neurons. 
Going through single planes of the z-stacks I identified sites in which the pre- and post-synaptic 
markers were in close proximity (Fig. 3.11).  
This suggests that I could detect potential axon-OPC synaptic contacts in the zebrafish spinal 
cord using synaptophysin and PSD95 as pre- and post-synaptic markers, respectively. 
 
 
Fig. 3.11 Axon-OPC synaptic-like contacts in vivo 
Top panel: confocal single channel projection of PSD-95 positive OPC (left) and Tg(elavl3:synaptophysin-tagRFP) 
line (right) labelling pre-synaptic sites in neurons at 5 dpf. Scale bar: 10 µm. Bottom panel: Confocal image of the 
two merged channels in the upper panel showing expression of pre-synaptic marker in neurons and a post-synaptic 
marker in OPC Scale bar: 10 µm. Bottom-right: Close up and single plane of the dashed box area showing close 
proximity of the pre- and post-synaptic markers. Scale bar: 1 µm. 
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Since we previously found differences in terms of morphology and fate amongst OPCs in the 
spinal cord, I wondered whether the post-synaptic marker PSD95 was also differentially 
expressed in the two types of cells. The hypothesis would be that axo-dendritic area OPCs 
which showed fast remodelling would have less chances to form a stable synaptic contact with 
neurons compared to the neuron-rich area OPCs which have instead stable processes.  
Axo-dendritic and neuron-rich area OPCs differ in cell morphology and soma position, but 
another hallmark to distinguish these two OPC subgroups is their cell body shape. Using an 
OPC nuclear-membrane labelling combination, I identified examples for each OPC subgroup 
within the spinal cord. The cell body shape of neuron-rich area OPCs (cell#1), characterised 
by a complex process morphology, presented a round morphology. Instead, the soma of axo-
dendritic area OPCs (cell#2), delineated by the typical simple process morphology, had an 
elongated shape (Fig. 3.12 A). To confirm the correlation between soma shape and position, I 
combined OPCs labelling with BODIPY staining and 90° rotations to localise the soma position 
of the two previous cells within the spinal cord (Fig. 3.12 B). 
OPCs with their cell body in the axo-dendritic areas of the spinal cord presented an elongated 
cell body shape. In contrast, OPCs with their cell body in the neuron-rich areas showed a 
rounded soma shape. 
 
Fig. 3.12 Neuron-rich and axo-dendritic area OPCs are distinguished by their cell body shape 
A) Example image of two neighbouring OPCs labelled with a membrane and a nuclear fluorescent proteins 
(Tg(olig1:memEYFP), Tg(olig1:nls-mApple)) showing that OPCs with their soma in neuron-rich (cell #1) and axo-
dendritic areas (cell #2) can be distinguished by the shape of their cell body. Scale bar: 10 µm. B) 90° rotation of 
the two cells labelled in A to correlate the soma shape with the soma position using BODIPY staining. Scale bar: 
10 µm.  
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To test whether there was any difference between PSD95 expression in axo-dendritic area 
and neuron-rich area OPCs, I injected the UAS:PSD95-EYFP construct into Tg(olig1:KalTA4) 
line. To discriminate between the axo-dendritic area and the neuron-rich area OPCs I looked 
at the cell body shape that, as I illustrated in the previous paragraph, was elongated in the axo-
dendritic area OPCs and round in the neuron-rich area ones. Confocal imaging of sparsely 
labelled PSD95-positive cells revealed that PSD95 expression was mostly punctate and 
variable among different cells (Fig. 3.13A, B). PSD95 puncta were mostly restricted to OPC 
processes and a few of them were also localised in the cell soma (Fig. 3.13A’, B’). In one cell, 
PSD95 expression spread in the whole cell without showing the typical punctate labelling (Fig. 
3.13B). Moreover, manual quantification analysis in ImageJ to count PSD95 puncta in each 
OPCs combined with cell reconstruction done with the Imaris software showed that neuron-
rich area OPCs have more PSD95 puncta/100 µm compared to axo-dendritic area OPCs (2.9 







Fig. 3.13 PSD95 expression in OPCs  
A) Example images of PSD95 expression in neuron-rich area OPCs (tg(olig1:KalTA4) +UAS:PSD95-EYFP) Scale 
bar: 10 µm. A’) Close up of PSD95 expression in soma and processes of neuro-rich area OPCs. Scale bar: 5 µm. 
B) Example images of PSD95 expression in axo-dendritic area OPCs (tg(olig1:KalTA4) +UAS:PSD95-EYFP) Scale 
bar: 10 µm. B’) Close up of PSD95 expression in soma and processes of axo-dendritic area OPCs. Scale bar: 5 
µm. C) Graph showing the quantification of number of puncta/100 µm, each data point represents a cell. Data are 
expressed as median ± interquartile range (2.9 ±2.6/7.0 neuron-rich areas vs 2.2 ±0.5/2.5 axo-dendritic areas, 




In this section, I showed that OPCs have a typical morphology with process ramification. OPCs 
extend their processes in the zebrafish lateral spinal cord which is characterised by myelinated 
and unmyelinated axons that are in a stereotypical position. Looking at single OPC 
morphology, position and dynamics we could categorise OPCs in two subgroups. Axo-dendritic 
area OPCs with elongated somata that reside in the lateral spinal cord, present a simple 
morphology and fast process remodelling. Neuron-rich area OPCs with rounded somata 
localise to the medial spinal cord, they have a complex morphology and show slow process 
remodelling. These two OPC subgroups have also different potential to give rise to myelinating 
oligodendrocytes. Axon-rich area OPCs can differentiate directly into myelinating 
oligodendrocytes, instead neuron-rich area OPCs do not differentiate directly but they can 
proliferate to form a cell with differentiation potential. Moreover, I could identify axon-OPC 
synaptic-like contacts in the zebrafish spinal cord. Differences in post-synaptic marker 
expression where also found between OPCs, neuron-rich area OPCs showed more post-
synaptic sites compared to the axo-dendritic area ones.  
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3.2 OPC calcium dynamics  
3.2.1 GCaMP transients of individual OPCs 
 
In the previous sections, I showed that the zebrafish spinal cord presents two groups of OPCs. 
The cells with their somata in the axo-dendritic areas with a simpler morphology which are 
more likely to differentiate into myelinating oligodendrocytes, and the OPCs with their somata 
in neuron-rich areas with a more stable and complex morphology which do not directly 
differentiate. The latter seem to form more synapses than the other group. Moreover, from our 
RNA single-cell sequencing data we found that neuron-rich area OPCs are enriched in genes 
involved in neurotransmitter signalling (Marisca et al., 2020). Hence, we wondered if OPCs 
differently sense neuronal activity. In particular, neuron-rich area OPCs which showed less 
process remodelling and more synaptic sites might be able to integrate more signals from 
neurons. To investigate this hypothesis, I decided to use a genetically encoded calcium 
indicator (GECI) in OPCs and perform GCaMP imaging to establish calcium activity of OPCs. 
This method enables non-invasive measurements of cell activity in vivo. Specifically, I used 
the green fluorescent protein (GFP)-based GECIs GCaMP6m which has a good signal-to-




Fig. 3.14 GCAMP-positive cells show typical OPC morphology and consequently no myelin sheaths 
A) Example light-sheet image of GCAMP6m-CAAX labelled axo-dendritic area OPCs showing no sign of 
myelinating sheaths. Scale bar: 10 µm. B) Example light-sheet images of GCAMP6m-CAAX labelled neuron-rich 
area OPCs showing no sign of myelinating sheaths. Scale bar: 10 µm. (Marisca et al., 2020) 
 
To describe GCAMP dynamics in single cell OPCs, I expressed GCAMP6m-CAAX, a 
membrane targeted GCAMP, under the olig1 promoter. GCaMP6m-CAAX positive OPCs in 
both axo-dendritic and neuron-rich areas, do not have any signs of early myelination, no myelin 
sheaths were detectable in z-stacks projection of example cells (Fig. 3.14 A-B). 
My first aim was to investigate the duration of calcium transients in OPCs using GCaMP6m to 
adjust the frequency imaging setting in order to detect all GCaMP transients without neglecting 
any signals. GCaMP transient duration can be variable depending on the different cell types 
and on the calcium indicators. In neurons, GCaMP transients can last from 0.2 until 3 seconds, 
whereas in astrocytes the mean duration is 8.5 seconds (Chen et al., 2013, Agarwal et al., 
2017). Therefore, I performed single plane fast calcium imaging (10 Hz) using light-sheet 
microscopy to understand the average duration of calcium transients in OPCs and to establish 
the appropriate imaging setting to look at OPC GCaMP events (Fig. 3.15 A). GCaMP transient 
dynamics in OPC processes and somata were variable. After rising, some GCaMP transients 
remained elevated for several seconds, forming a plateau, and then descending smoothly 
afterwards. Some others rose and decayed shortly afterwards, thus creating a sharper peak 
(Fig. 3.15 C). Similarly, the duration of GCaMP transients also displayed variability. Overall, 
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OPCs showed slow calcium transients at the level of the processes as well as at the soma 
which lasted for 2-4 seconds (average duration=2.95±0.5 SD) (Fig. 3.15 B-D).  
 
 
Fig. 3.15 Duration of OPC GCAMP events 
A) Experiment paradigm B) Different timepoints of a single GCaMP6m-positive OPC at 4 dpf showing calcium 
transient going through the all cell. Scale bar: 10 µm. B’) ROIs analysed of OPC in B. C) Example traces of GCaMP 
transients in cell processes and soma of Tg(olig1:GCaMP6m) animals at 4 dpf (n=6 ROI from 2 animals). D) 
Quantification of the duration of GCaMP transient in OPC soma and processes (average duration=2.950.5 SD). 
(Marisca et al., 2020) 
 
OPC GCaMP transients of both somata and processes showed slow kinetics, suggesting that 
0.5 Hz imaging frequency will be sufficient to detect all GCaMP events.  
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Next, I wanted to focus on single OPCs to describe more in details the dynamics of GCaMP 
transients at a single cell resolution and identify possible differences between OPC subgroups. 
To characterise single cell GCaMP activity in OPCs, I injected the olig1:GCaMP6m-CAAX 
construct into nacre fish to sparsely label individual cells and I took 10 minute timelapses for 
each sample using a slower imaging frequency (0,5-1 Hz) at the light-sheet microscope(Fig. 
3.16 A). Often, during 10 minutes of timelapse imaging, GCaMP transients were restricted to 
process subdomains (cell #1). Sometimes, the cells remained silent showing no signs of 
GCaMP activity (cell #2) (Fig. 3.16 B). Interestingly, two neighbouring cells did not show the 
same degree of GCaMP activity in the processes, suggesting that their calcium activity in the 
processes is unrelated to OPCs in their vicinity. The GCaMP activity of whole cells was 
described by taking a volumetric timelapse. GCaMP transients in OPCs were analysed 
manually drawing ROIs around processes and somata (Fig. 3.16 B’). Looking at the GCaMP 
traces of these two neighbouring OPCs, calcium transients appeared to be of different shapes 
and amplitudes. A clear peak was detectable in all GCaMP transients, higher amplitude and 
longer duration were visible comparing one transient (in magenta) with the other (in green) 





Fig. 3.16 GCaMP transients restricted to process subdomains 
A) Experiment paradigm B) Three time points of two individual olig1:GCaMP-CAAX expressing cells showing 
transients in the process subdomain (cell#1) or being silent (cell#2). Scale bar: 10 µm.  B’) Left: projection of the 
three timepoints of two olig1:GCamP-CAAX expressing cells at 4dpf. Scale bar: 10 µm. Right: measured ROI 
indicated by the dotted lines around the reconstructed cells, active ROI are highlighted in green and magenta. B’’) 
Traces of cells in B-B’. (Marisca et al., 2020) 
 
In a few cases, the GCaMP transients spread also throughout the whole cell (Fig. 17). Somatic 
GCaMP transients lasted for several seconds and even after 4 seconds elevated GCaMP 
levels were detectable in the somata of the cells compared to baseline (time 0), suggesting 
that the transients were slow and gradually decreasing. Moreover, in this example, the somatic 





Fig. 3.17 GCaMP transients spreading through the whole cells 
Three time points of two individual olig1:GCaMP-CAAX expressing cells showing transients spreading throughout 
the cells. Scale bar: 10 µm. 
 
Within the 10 minute timelapse of about 50 single OPCs, the majority (67%) showed GCaMP 
transients that were restricted to process subdomains. Whole cell GCaMP transients were very 
rare (6%) and the rest of the cells (27%) did not have any GCaMP transients during the 
timelapse (Fig. 3.18 A).  
I classified GCaMP data obtained from single OPCs in the two groups based on cell 
morphology and soma position. Most of the cells analysed were neuron-rich area OPCs (39 
cells), which have a complex morphology, more stable processes and do not directly 
differentiate into myelinating oligodendrocytes. The rest of the cells (12 cells) were axon-
dendritic area OPCs which have a simpler morphology, more dynamic processes and the 
potential to differentiate in myelinating oligodendrocytes. Both neuron-rich area and axo-
dendritic area OPCs presented mostly GCaMP transients in the process subdomains (61% 
neuron-rich areas; 83% axo-dendritic areas), fewer cells were completely silent (31% neuron-
rich areas; 17% axo-dendritic areas). GCAMP events that spread throughout the entire cell 





Fig. 3.18 GCaMP transients in single OPCs 
A) Quantification of different types of GCaMP transients observed during 10 minutes timelapse in individual 
olig1:GCaMP-CAAX expressing cells. A’) Pie charts with cells from A split between neuron-rich area and axo-
dendritic area OPCs indicating absolute numbers of olig1:GCaMP-CAAX expressing cells showing GCaMP 
transients at the level of process subdomains, entire cells or being silent during a 10 minutes timelapse. (Marisca 
et al., 2020)  
 
To summarise, single cell GCaMP imaging revealed that OPCs can show two different types 
of GCaMP transients restricted to process subdomains or spreading through the whole cell. 
Both types of GCaMP transients display slow dynamics and long duration.  
Both neuron-rich and axo-dendritic area OPCs mostly presented GCaMP transients restricted 
to process subdomains. Sometimes OPCs were completely quiescent, showing no signs of 
GCaMP events. Whole cell GCaMP transients were detected only in neuron-rich area OPCs 





3.2.2 Somatic GCaMP transients at the cell population level 
 
After characterising GCaMP activity in single OPCs, I wondered how calcium dynamics are in 
neighbouring OPCs, as this information is not achievable from the single cell resolution 
imaging. As I previously described, axons run along the whole length of the spinal cord in a 
stereotypic lateral position where also OPCs extend their processes suggesting that 
neighbouring OPCs could contact the same axons. Moreover, OPC processes form a dense 
network in the lateral spinal cord being in close proximity to each other, suggesting also 
possible OPC-OPC interactions. Therefore, I sought to analyse a population of cells to study 
how they relate to neurons and to each other. To investigate GCAMP transients at the cell 
population level and study whether groups of OPCs show different pattern of calcium 
transients, I analysed only somatic calcium events in large volumes of spinal cord. As when 
imaging a tissue where all cells are labelled it would not be possible to have a single cell 
resolution of the calcium transients. I generated a full transgenic line in which cytoplasmic 
GCaMP6m was expressed in OPCs under the olig1 promoter Tg(olig1:GCaMP6m). Analysis 
of the OPCs GCaMP line crossed to a mbp line, where a red fluorescent protein was expressed 
in myelinating oligodendrocytes (Tg(mbp:KillerRed), confirmed that GCAMP6m positive cells 
were OPCs and not myelinating oligodendrocytes, while only 3 out of 360 (1%) cells were 
double positive suggesting they were newly differentiated oligodendrocytes (Fig. 3.19A, B). 
This experiment confirmed that Tg(olig1:GCaMP6m) line is specific to analyse GCaMP 




Fig. 3.19 Characterisation of Tg(olig1:GCaMP6m) line 
A) Dorsal views of Tg(olig1:GCaMP6m), Tg(mbp:KillerRed) transgenic zebrafish at 4 dpf to label OPCs and 
differentiated oligodendrocytes. Dotted box indicates position of zoom-ins in bottom row. Scale bars: 50 μm (top) 
and 20 μm (bottom). B) Quantification of single and double-positive cells from images as shown in A. (Marisca et 
al. 2020) 
 
To study GCAMP transients at the population level I performed light-sheet imaging of the spinal 
cord of a dorsally mounted 4 dpf zebrafish at 1 Hz frequency and I took 2 timelapses of 10 
minutes for each sample (Fig. 3.20 A). High-resolution light-sheet imaging of a stretch of the 
spinal cord allowed the identification of all OPC somata morphology in the field of view (Fig. 
3.20 B). By analysing the z-stack of the imaged spinal cord area, I was able to discriminate 
between neuron-rich and axo-dendritic area OPCs taking into account the soma position and 




Fig. 3.20 OPC cell population GCaMP transients 
A) Experimental paradigm. B) Top: Dorsal widefield view of a zebrafish at 4 dpf. Below: z-projection and z-rotation 
of Tg(olig1:GCaMP6m) in the spinal cord similar to as indicated by the boxed area above. Bottom: projection of 2 
timepoints (baseline: grey, t1: green) showing a GCaMP transient restricted to a single cell in the spinal cord. Scale 
bar: 50 µm. B’) Single plane image taken as indicated by boxed area showing individual OPCs with their soma in 
neuron-rich and axo-dendritic areas. Scale bar: 10 µm. (Marisca et al. 2020) 
 
Population GCaMP imaging revealed different outcomes of somatic GCaMP transients. In 
some cases, during dorsal recording, somatic GCaMP transients could be restricted to a single 
cell in a large volume of zebrafish spinal cord (Fig. 3.21 A). The cell showing GCAMP activity 
was a neuron-rich area OPC, identified by the central cell body location in the spinal cord and 
a rounded shape (Fig. 3.21 A’). This single cell somatic GCaMP transient had a duration of a 
few seconds and from the traces a clear peak is discernible in the active OPC trace (Fig. 3.21 
A’).   
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Fig. 3.21 Single cell somatic GCaMP transient amongst OPC population 
A) Time points of Tg(olig1:GCaMP6m) line showing single cell GCaMP transient (green arrow). Scale bar: 50 µm. 
A’) Top: projection of 2 timepoints (baseline: grey, t1: green) showing the GCaMP transient restricted to a single 
cell in A. Scale bar: 50 µm. Bottom: ∆F/F0 GCaMP transients of all cells shown in the upper panel (in green the 
active soma). (Marisca et al., 2020) 
 
Somatic GCaMP transients could also spread through a subgroup of OPCs that were close to 
each other. This could indicate that group of cells can be coupled amongst each other and that 
not all OPCs participate to this type of interconnection since not all of them showed GCaMP 
signal. GCaMP transients propagated in OPCs within the spinal cord with a head to tail 
direction. Also in this case, GCaMP dynamics were slow and spread in both neuron-rich and 
axo-dendritic areas of the spinal cord (Fig. 3.22).   
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Fig. 3.22 Group of cell somatic GCaMP transient amongst OPC population 
A) Time points of Tg(olig1:GCaMP6m) line showing GCaMP transient spreading throughout a group of 
neighbouring OPCs. Scale bar: 50 µm. A’) ∆F/F0 GCaMP transients of all cells shown in A, in green axo-dendritic 
area OPCs and in grey neuron-rich area OPCs. 
 
More rarely, I could also detect GCaMP transients propagating throughout the entire field of 
view. The directionality of the GCaMP events was always head to tail and GCaMP wave lasted 
for around 10 seconds. Somatic GCaMP transients started in OPCs closer to the head in the 
imaged area and then slowly expanded in the neighbouring OPCs towards the tail. GCaMP 
somatic transients showed all a clear peak and were detected in both OPC subpopulations 
(Fig. 3.23). Looking at this timelapse, one limitation stands out as I could analyse only the cells 
that were within the field of view, but very likely this GCaMP wave also involved OPCs outside 
the imaged area, as the wave involved all the cells in the field of view and presumably it would 




Fig. 3.23 GCaMP transient throughout OPC population in the spinal cord 
A) Several timepoints of a OPC GCAMP6m timelapse showing GCaMP transient spreading throughout the spinal 
cord at 4 dpf. Scale bar: 50 µm. A’) ∆F/F0 GCaMP transients of all cells shown in A, in green axo-dendritic area 
OPCs and in grey neuron-rich area OPCs. 
 
Furthermore, looking at differences between the two OPC subgroups, OPCs with their somata 
in the neuron-rich areas had a higher probability to show somatic GCaMP compared to OPCs 
with their soma residing in the axo-dendritic areas (26% (73/285 cells) neuron-rich areas vs. 
19% (9/48 cells) axo-dendritic areas, p=0.007, two-tailed Wilcoxon matched-pairs signed rank 
test) (Fig. 3.24 A). The percentage of somatic GCaMP transients in neuron-rich area OPCs 
was higher than the one of axo-dendritic area OPCs in all the analysed animals. In most 
timelapses, somatic GCaMP events were detected only in neuron-rich area OPCs suggesting 
that these cells extending their processes in the axonal tracts, might have an enhanced ability 
to sense neuronal activity (Fig. 3.24 A).   
83 
 
Fig. 3.24 GCaMP transient throughout OPC population in the spinal cord  
A) Probability of somatic GCaMP transients of OPC in neuron-rich and axo-dendritic areas at 4 dpf (26% (73/285 
cells) vs. 19% (9/48 cells), p=0.007 (two-tailed Wilcoxon matched-pairs signed rank test); n=8 animals. B) 
Quantification of GCaMP amplitudes measured in somata of OPCs in neuron-rich and axo-dendritic areas at 4 
dpf. Data are expressed as mean ± SD (3.9±1.5 ΔF/F0 vs. 1.8±0.4 ΔF/F0, p<0.001 (two-tailed Welch’s t test), 
n=81/9 cells from 8 animals). C) Table to compare the first and second timelapse of the same OPCs analysed in 
A and B. (Marisca et al. 2020) 
 
Moreover, amplitudes of somatic GCaMP transients were more than 2-fold higher in neuron-
rich area OPCs compared to the axo-dendritic area OPCs (3.9±1.5 ΔF/F0 vs. 1.8±0.4 ΔF/F0, 
p<0.001, two-tailed Welch’s t test). Somatic GCaMP events in neuron-rich areas had highly 
variable amplitudes, reaching in some cases a 7-fold increase compared to their baseline. 
Instead, somatic GCaMP amplitudes of axo-dendritic OPCs showed a maximum of 3- fold 
increase (Fig. 3.24 B). Interestingly, comparing the two 10 minute timelapses of the same 
stretch of the spinal cord, when a somatic GCaMP event was detected in both timelapses, it 
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appeared in the same OPCs (Fig. 3.24 C). This suggests that some OPCs are more sensitive 
than other OPCs to other signalling and show systematic calcium activity as they present 
somatic GCaMP transients at two different time points within 30 minutes.  
In summary, OPCs which reside with their soma in the neuron-rich areas and that are not 
contributing directly to myelination but need to divide to give rise to a cell that can differentiate 
into myelinating oligodendrocytes, are more likely to show GCaMP events. When compared 
to the more rare GCaMP events of axo-dendritic areas, neuron-rich area OPCs have GCaMP 
transients of higher amplitude. This is consistent with the idea that neuron-rich area OPCs 
which have more stable processes, higher post-synaptic marker density and do not directly 




3.2.3 Integrating calcium dynamics in OPCs using CaMPARI 
 
GCAMP cell population analysis revealed that OPCs can have calcium transients spreading 
throughout a group of cells or all cells within the field of view. One limitation of the in vivo 
GCaMP imaging emerged when I focused on the GCaMP imaging timelapse of somatic 
GCaMP events expanding through the spinal cord (Fig. 3.23). Indeed, I could only analyse the 
cells that were in the field of view but it seemed that the GCaMP wave involved also OPCs 
outside this area. To overcome this limitation and to be able to have a wider overview of OPC 
calcium dynamics in the entire animal, I used CaMPARI (Calcium Modulated Photoactivatable 
Ratiometric Integrator). CaMPARI is a photoconvertible protein that enables imaging of the 
integrated calcium activity of large populations of cells over defined time windows (Fosque et 
al., 2015). This calcium integrator is based on a fluorescent protein that changes from green 
to red upon irradiation with UV-light only when high calcium concentration is present while the 
photoconversion light is applied (Fig. 3.25 A). The permanent conversion from green to red 






Fig. 3.25 CaMPARI technique in OPCs  
A) Illustration showing how CaMPARI works. B) CaMPARI experiment paradigm. B’) Example confocal images of 
Tg(olig1:CaMPARI) in different conditions. Right images are from the same group of experiments treated with 
100mW/cm2 UV light for 5 minutes and showing variable photoconversion. Stars depict some example cells that 
show signs of photoconversion. Scale bar: 10 µm. C) Example light-sheet image of Tg(olig1:CaMPARI) line before 
UV-light treatment. Scale bar: 10 µm.  
 
The advantage of using CaMPARI as a tool is to image the total calcium activity of all OPCs 
during defined time windows, determined by the UV-light treatment duration. In addition, I can 
study calcium dynamics in all OPCs, illuminating the whole animal and more animals at a time, 
without having the restriction of a defined field of view as it happened during GCaMP imaging. 
The challenge of using CaMPARI was to establish a suitable setting to perform the experiment 
taking into account two main variables, the UV light intensity and the exposure time. A sufficient 
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UV light intensity to convert a cell from green to red without converting all cells and a UV-light 
treatment time window as wide as possible preventing overexposure were required. After trying 
different combinations and samples, I decided to use 100 mW/cm2 light intensity for 5 minutes 
as there was variability amongst animals treated with the same amount of UV light within the 
same batch of experiment (Fig. 3.25 B-B’). To use CaMPARI and image the entire OPC 
population I made the transgenic line in which CaMPARI labelled all OPCs under the control 
of the olig1 promoter. The untreated fish expressed the green fluorescent protein in all OPCs 
without having any sign of photoconversion (Fig. 3.25 C). Whereas, treated fish showed signal 
of photoconversion in different fish body regions (Fig. 3.26 A). I analysed OPCs located in 4 
different anatomical regions: the telencephalon, the optic tectum, the hindbrain and the spinal 
cord. Animals were imaged and analysed from head to tail. Most OPCs had a red/green ratio 
between 0.3-0.6, while fewer between 0.7-1 and even fewer above 1 meaning that OPCs 
showed different degree of photoconversion and this can reflect different OPC calcium levels 
(Fig. 3.26 B). Variability was detected between different animals, in one case (animal #11) the 
rate of photoconversion was for most of the cells close to 0. In other cases, photoconversion 
was between 0 and 0.5 (animals #2, #4, #7, #9, #12) and in the rest of the animals, 
photoconversion rate resulted higher and close to 1 (animals # 1, #3, #5, #6, #8, #10). 
Interestingly, from the dot plot graph variability within individual animal was also detected, in 
particular some sample show a dot plot with an undulatory trend (Fig. 3.26 B’). One possible 
explanation is that this trend is caused by differences among diverse anatomical body regions 
since the fish was imaged and analysed from head to tail. Moreover, the photoconversion rate 
of neighbouring OPCs seemed to be in the same range reflecting the GCaMP transients in 






Fig. 3.26 Calcium dynamics using CaMPARI  
A) Left: Dorsal widefield view of a zebrafish at 4 dpf with dashed box areas reported on the right. Right-top: 
projection of a light-sheet image showing degrees of photoconversion of the OPCs in the optic tectum after the UV-
light treatment. Right-bottom: projection of a light-sheet image showing degrees of photoconversion of the OPCs in 
the spinal cord after the UV-light treatment. Scale bar: 10 µm.  B) Dot-plot graph showing red/green ratio of each 
OPCs, each color represents and animal (n= 2410 cells from 12 animals). B’) Close up of fish#10 dot plot to show 
the undulatory pattern of red/green ratio. 
 
In summary, I demonstrated that CaMPARI can be used as a powerful technique instead of 
GCaMP imaging allowing us to detect the cumulative calcium levels of the entire animal during 
a determined time-frame and not only of a part of the spinal cord. Therefore, CaMPARI can be 
used to overcome the spatial limitation of in vivo GCaMP imaging and permit to analyse 
calcium activity of different body regions at the same time, resulting in a complete overview of 
OPC calcium dynamics. 
  
90 
3.3 Neuron – OPC interactions 
3.3.1 Neural activity manipulation 
 
Neuron-rich area OPCs presented higher probability of calcium events and higher amplitudes 
compared to the axo-dendritic area OPCs, which are more likely to differentiate. Moreover, cell 
population somatic GCaMP imaging revealed that neighbouring OPCs can show a rise in 
calcium at the same time and I even observed waves of GCaMP transients spreading through 
the whole field of view. Since OPCs extend their processes to the lateral side of the spinal cord 
where also axons run, it would be interesting to investigate whether OPC GCaMP transients 
result as a response to neural activity.  
To study whether GCaMP transients in OPCs correlate with calcium transients in neurons, I 
injected the mApple-based GECIs, R-GECO under the neuron promoter cntn1b in the 
GCaMP6m OPC line (Zhao et al., 2011). I used a modified R-GECO version, jRGECO1a which 
has amplitudes and kinetics similar to that of GCaMP6f (Dana et al., 2016). Using light-sheet 
imaging, I detected a GCaMP wave going through the OPCs which was preceded by RGECO 
transients in the RGECO expressing neurons and axons (Fig. 3.27). The directionality of the 
transients was head to tail, as the one I described in the OPC population GCaMP analysis. 
Moreover, both GCaMP and RGECO transients showed slow kinetics and the transients lasted 
several seconds. This experiment suggests that there is a temporal correlation between the 
OPC somatic GCaMP transients and neural RGECO activity. 
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Fig. 3.27 Correlation between calcium transients in neurons and OPCs  
A) Light-sheet images showing several time points of Tg(olig1:GCaMP6m) injected with cntn1b:jRGECO1a. Scale 
bar: 10 µm. A’) Traces of OPC GCAMP transients and RGECO transients in neurons and axons. B) Light-sheet 
images showing several time points of the close up of the white box in A. GCaMP transients in OPCs arise right 
after calcium transients in neurons. Scale bar: 10 µm. B’) Traces of B, traces are from ROI depicted in B 
(neurons/axons are in red and OPCs in grey). Scale bar: 10 µm.  
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To further study the correlation between these two cell types, neural activity can be 
manipulated to explore how this affects calcium transients and the fate of different OPCs.  
There are different experimental approaches to manipulate neural activity: chemogenetic, 
optogenetic and pharmacological. At first, to induce neural activity, I tried a chemogenetic 
approach using Designer Receptor Exclusively Activated by a Designer Drug (DREADD) which 
are mutated muscarinic receptors that respond to a synthetic ligand called clozapine-N-oxide 
(CNO) and not to their natural ligand, acetylcholine. DREADDs are widely used in mice 
(Armbruster et al., 2007). Recently, a new study showed that it is clozapine, a CNO-derived 
metabolite (rather than CNO itself), which is the DREADD ligand in vivo in rodents (Gomez et 
al., 2017). I was not able to successfully use this chemogenetic approach in zebrafish, similar 
to previous studies, possibly because CNO cannot be metabolised by zebrafish (Chen et al., 
2016). 
Another chemogenetic tool to stimulate neural activity is the expression of the rat TRPV1 
(transient receptor potential cation channel subfamily V member 1) channel in zebrafish, which 
is activated by capsaicin (Fig. 3.28 A) (Caterina MJ, et al. 1997; Chen et al., 2016). TRPV1 is 
a nonselective cationic ligand-gated channel located on cell membranes. It has high 
permeability to Ca2 and once capsaicin is applied, the opening of the channel depolarises the 
cell and increases calcium influx (Fig. 3.28 A). This approach can be used in zebrafish as the 
endogenous TRPV1 channel of zebrafish is insensitive to capsaicin. The sites important for 
capsaicin binding are not conserved in zebrafish allowing the selective stimulation of the cell 
that express the rat TRPV1 channel after capsaicin application (Gau et al.,2013). To test 
functionality of the rat TRPV1 in zebrafish I performed single cell injection of UAS:TRPV1-
tagRFP construct into neurons, using the cntn1b:KalTA4, UAS:GCaMP6s line. Consequently, 
I could follow the calcium activity of neurons before and after capsaicin application, combining 
the sparsely labelled TRPV1-positive neurons with GCaMP (Fig. 3.28 A’). Capsaicin induced 
neuronal depolarisation was restricted to the TRPV1-positive cells. After capsaicin application 
GCaMP activity of TRPV1-positive neurons gradually increased for several minutes until it 
reached a high plateau level where the trace appeared to be stable. The cell was constantly 
93 
depolarised without going back to basal calcium level, suggesting an unhealthy capsaicin 
effect on the neuron (Fig. 3.28 B-B’). Capsaicin application increased the GCaMP transients 
in the OPC processes. The rat TRPV1 positive OPCs showed more frequent GCaMP events 
within 5 minute timelapses compared to the same OPC processes before capsaicin application 
(Fig. 3.28 C-C’). However, the TRPV1-capsaicin tool was difficult to control, as it depends on 
the concentration of capsaicin as well as on the expression level of TRPV1 and high doses 
can be toxic, resulting in apoptosis upon prolonged activation (Chen et al., 2016). Indeed, upon 
prolonged exposure with capsaicin, OPCs showed cell death and defect in cell morphology 
appearing with shorter processes. Therefore, TRPV1 is not appropriate to activate neurons 




Fig. 3.28 Using TRPV1 in neurons and OPCs to manipulate Ca2+ signalling 
A) Illustration explaining TRPV1 mechanism of action. A’) TRPV1 experimental paradigm. B) Confocal image of a 
TRPV1-positive neuron (in red) in between two TRPV1-negative cells in the zebrafish spinal cord. All cells 
express also GCaMP6s (Tg(cntn1b:KalTA4, UAS:GCaMP6s)). Scale bar: 10 µm. B’) GCaMP traces of the 
neurons showed in B before and after capsaicin showing that the TRIPV1-positive neuron (traces in red) is 
depolarised after the treatment. C) Confocal image of a TRPV1-positive OPC (in red) expressing also GCaMP6s 
(Tg(olig1:KalTA4, UAS:GCaMP6s)) in the zebrafish spinal cord. Scale bar: 10 µm. C’) Process GCaMP traces of 
the TRPV1-positive OPC in C before and after capsaicin showing that after capsaicin OPC processes were more 
active. 
 
We decided to use a more general pharmacological approach, to globally enhance neuronal 
excitability by using 4-Aminopyridine (4-AP), a potassium channel blocker (Peña & Tapia, 
1999). 4-AP has been also used to improve motor skills in MS patients (Goodman at al., 2013) 
and it has been shown to induce hyperactivity and seizure-like behaviour in zebrafish when 
used at high doses (Ellis et al., 2012; Winter et al., 2017). 
To investigate the effect of 4-AP in neurons and OPCs I combined the GFP-based GECIs in 
OPCs using the GCaMP6m OPC line with R-GECO expressed in neurons. I generated the 
transgenic line Tg(elavl3:jRGECO1a) to express the m-Apple based calcium indicator in 
neurons. Light-sheet imaging of the double transgenic fish expressing GCaMP6m in OPCs 
and jRECO1a in neurons, after 4-AP treatment showed a neuronal calcium transient going 
through the axonal tracts in the field of view and a subsequent calcium transient in OPC 
somata, displaying a temporal correlation of calcium activity between the two types of cells 
(Fig. 3.29). As 4-AP is a potassium channel blocker, it might act as well directly on OPCs since 
they also express potassium channels (De Biase et al., 2010; Kukley et al., 2010). However, 
neuronal RGECO transients preceded the OPC GCaMP transients after 4-AP manipulation. 
The delay between neuron and OPC transients could highlight a functional connection 




Fig. 3.29 Coupling between neurons and OPCs after 4-AP manipulation 
A) Experiment paradigm. B) Traces of OPC GCaMP (Tg(olig1:GCaMP6m)) transients and neuron R-
GECO(Tg(elavl3:jRGECO1a)) transients expressed in the same animal after 4-AP incubation, traces are from 
ROI depicted in B’ (neurons are in red and OPCs in grey). B’) Light-sheet images showing several time points of 
(Tg(elavl3:jRGECO1a), Tg(olig1:GCaMP6m)) double transgenic line after 4-AP. GCaMP transients in OPCs arise 
right after calcium transients in neurons. Scale bar: 10 µm.  
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3.3.2 Calcium events in OPCs induced by neural stimulation 
 
To further investigate the effects of neural manipulation on OPC calcium activity, I analysed 
calcium transients in OPC processes after 4-AP manipulation and I subsequently used another 
pharmacological approach to block neuronal activity. To prevent action potentials, I applied the 
voltage-gated sodium channel blocker tetrodotoxin (TTX) which has been widely used to block 
neural activity (Gnuegge et al., 2001; Miyazawa et al., 2018). Single plane confocal imaging of 
GCAMP6m expressed in OPCs under the olig1 promoter revealed that 15 minutes after 
application of 0.5 mM 4-AP increased in number of GCaMP events in OPC processes could 
be observed (12.5% ±9.5/18.3 active ROI before 4-AP vs. 42.8%±28.6/78.0 after 4-AP, 
p=0.004, Friedman with Dunn’s multiple comparison test) (Fig. 3.30 A-B’’). Almost all 
processes showed GCaMP events after 4-AP application compared to the baseline traces (Fig. 
3.30 B-B’). This effect was partially blocked and reversed to control levels when subsequent 
10 μM TTX to block action potentials was applied, suggesting that most of the 4-AP induced 
GCAMP transients were dependent on neural activity (12.5% ±9.5/18.3 active ROI before 4-
AP vs. 30% ±14.1/44.1 after 4-AP and subsequent TTX, p=0.23, Friedman with Dunn’s multiple 




Fig. 3.30 Effects on OPC GCaMP transients after neural activity manipulation  
A) Overview of experimental paradigm. B) Time projection timelapses traced in B’ of OPCs expressing GCaMP 
Tg(olig1:GCaMP6m) before and after 4-AP or subsequent TTX incubation at 4 dpf. Scale bar: 10 µm. B’) Example 
GCaMP traces in Tg(olig1:GCaMP6m) before drug application, after treatment with 4-AP, and after addition of 
TTX. B’’) Quantification of GCaMP events (ROI active / ROI total) per fish in the different treatment conditions as 
in B. Data are expressed as median ± interquartile range (12.5% ±9.5/18.3 active ROI before 4-AP vs. 
42.8%±28.6/78.0 after 4-AP, p=0.004 vs. 30% ±14.1/44.1 after 4-AP and subsequent TTX, p=0.23 (Friedman with 
Dunn’s multiple comparison test, test statistics=11.09), n=9 animals. (Marisca et al., 2020) 
I could then replicate the effects of 4-AP and TTX on OPC calcium dynamics using CaMPARI. 
I treated animals with 4-AP, TTX or tricaine (MS-222), a fish anaesthetic which prevents Na2+ 
channel opening, prior and during the 5 minute UV light treatment. Tile scan images of the 
entire fish revealed that red/green ratio of OPCs was significantly higher in 4-AP treated 
animals (control 0.4±0.21vs 0.8±0.36 4-AP, p=0.04, Kruskal-Wallis test) and lower in animals 
treated with TTX or tricaine compared to the control, confirming that CaMPARI is a valid 
technique to study cell resolution calcium dynamics also combined with a pharmacological 




Fig. 3.31 Effects on OPC calcium activity after neural activity manipulation using CaMPARI  
A) Overview of experimental paradigm. B) Example images of Tg(olig1:CaMPARI) animals in the four different 
conditions after UV light treatment. Scale bar: 50 µm. B’) left: red/green ratio of Tg(olig1:CaMPARI) animals after 
UV-light treatment and in different conditions (control, 4-AP, tricaine, TTX). Data are presented as median and 
interquartile range. Right: mean of red/green ratio per fish of control (0.4±0.21), 4-AP (0.8±0.36), tricaine 
(0.3±0.26) and TTX (0.2±0.14), each data point represents an animal. Data are presented as median and 
interquartile range. p = 0.04 (control vs. 4-AP) Kruskal-Wallis test, n=12/5/3/2 animals. 
 
In summary, through in vivo GCaMP imaging I showed that some OPC calcium transients are 
induced by neural activity, since they were enhanced by 4-AP incubation and reverted using 
the action potential blocker TTX. Moreover, this result was confirmed using CaMPARI, showing 
that OPC intracellular calcium was increased and decreased applying 4-AP and TTX or tricaine 
respectively.  
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3.3.3 Neural activity manipulation effects on OPC cell fate 
 
In the previous section, I showed that manipulation of neural activity via 4-AP increases 
GCaMP transients in OPCs. To study how neural activity manipulation affects OPC cell fate, 
we established a long 4-AP treatment protocol. Data presented in this section were the results 
of collaborative efforts between my colleague Laura Hoodless and me. 
In order to test the effects of long-term 4-AP treatment on tissue integrity, we considered 
macrophage infiltration as a sign of inflammation. We needed to find a concentration in which 
4-AP worked without causing cell death and being toxic. Microglia and macrophages were 
identified using a membrane targeting Cerulean fluorescent protein under the control of the 
mfap4 promoter (Walton et al., 2015), a macrophage-specific promoter (Fig. 3.32). 
Macrophage infiltration was assessed via the quantification of macrophages per field of view 
after 4-AP long term incubation at two different concentrations. Upon chronic manipulation 
using 0.5 mM 4-AP, macrophage recruitment was significantly increased in the spinal cord 
compared to control (Fig. 3.32). Therefore, we decided to use 0.1 mM 4-AP for the long-term 
incubation paradigm, since no differences were found in terms of macrophage infiltration 
compared to control condition. 
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Fig. 3.324 Macrophages infiltration after long term 4-AP incubation 
A) Confocal images of Tg(mfap4:memCerulean), Tg(olig1:nls-mApple) zebrafish at 4 dpf after treatment with 0.1 
mM 4-AP, 0.5 mM 4-AP, or Danieau’s solution as control. Transmitted light images to show spinal cord 
morphology and tissue integrity following treatment. Scale bars: 100 μm. The graph shows the number of 
macrophages which accumulate in 400 μM length of spinal cord of Tg(mfap4:memCerulean) zebrafish after 1 day 
of control (2±0.25/2 cells), 0.1 mM (2±1/2 cells), and 0.5 mM (3±0.25/2 cells) 4-AP treatment (median (25%/75% 
percentiles); p=0.43 (control vs. 0.1mM 4-AP), p=0.03 (control vs. 0.5 mM 4-AP) (Kruskal-Wallis test), n=16/19/8 
animals. (Marisca et al., 2020) 
 
To test the efficacy of the long-term pharmacological treatment to induce activity, we first 
looked at swimming behaviour using 4-AP and TTX. We tested the swimming behaviour 
because 4-AP is a well-known convulsant used to induced seizures in mice (Yamaguchi and 
Rogawski, 1992). 4-AP and TTX application clearly increased and blocked respectively 
swimming activity compared to the control. TTX also prevented the effect of 4-AP when the 
two compounds were applied together (Fig. 3.33 A). To confirm 4-AP and TTX effects on neural 
calcium activity I performed single plane GCaMP imaging using GCaMP6s targeted to the 
nuclei and expressed in neuron under the elavl3 promoter. As expected, 4-AP overnight 
application increased numbers of somatic GCAMP transients in neurons which showed mostly 
small and short GCaMP transients along the whole timelapse while before 4-AP incubation 
somata had less frequent GCaMP activity. Moreover, some of the somatic GCaMP transients 
appeared to be synchronised with other neurons both in control and after 4-AP incubation (Fig. 
3.33 B-B’). Instead, TTX completely blocked somatic GCaMP transients in neurons which were 
almost completely silent compared to the ones before TTX incubation (Fig. 3.33 B-B’). 
  
                                               
4 Data shown in this figure are from the work of my colleague Laura Hoodless 
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Fig. 3.33 Effects 4-AP treatment on zebrafish 
A) 5Minimum intensity projections of a two-minute time-lapse of fish freely swimming in a 3 cm petri dish in 
different treatment conditions. B) Traces of GCaMP transients Tg(elavl3:h2b-GCaMP6s) zebrafish at 4 dpf and 
after overnight incubation in 0.1 mM 4-AP, and before / after 10 μM TTX. B’) Time projection timelapses traced in 
B of neurons expressing GCaMP Tg(elavl3:h2b-GCaMP6s) before and after 4-AP or TTX incubation.  Scale bar: 
10 µm. (Marisca et al., 2020)  
 
Now that we found the appropriate protocol for long term neural activity manipulation, we 
wanted to investigate the effect of neural activity on OPC cell fates. At this point, we could have 
different possible outcomes. Enhanced neural activity could increase OPC proliferation or OPC 
                                               
5Data in panel A are from my colleague Laura Hoodless.  
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differentiation, or even both cellular behaviour responses at the same time. Moreover, we 
would expect that neuron-rich area OPCs are the cells affected the most as they integrate 
more neural activity compared to axo-dendritic area OPCs. To quantify OPC proliferation after 
neural manipulation, we used 5-ethynyl-2’-deoxyuridine (EdU). EdU is incorporated into the 
DNA of dividing cells during the S-Phase of the cell cycle. Using Tg(olig1:nls-mApple) 
transgenic fish after a 6 hours 4-AP incubation, we were able to identify an increase in EdU-
positive OPCs, especially those residing in neuron rich areas (9±3.1% vs. 0.08±3.5% increase, 
p=0.02 in neuron-rich areas, two-tailed unpaired t-test) (Fig. 3.34 A-B’’). On the other hand, 
TTX treatment appeared to block the 4-AP effects on proliferation (19.1±1.1% in control vs. 
30.6±1.5% in 4-AP vs. 14.1±2.2% in 4-AP+TTX; p<0.001 (control vs. 4-AP), p<0.001 (4-AP vs. 
4-AP+TTX), one-way ANOVA with Tukey’s multiple comparisons test) (Fig. 3.34 B’). We also 
investigated subsequent changes in number of myelinating oligodendrocytes using the 
Tg(mbp:nls-EGFP) line after a two days of 4-AP treatment and we detected a small increase 
in the number of cells which did not reflect the more pronounced increase in OPC numbers 
(48.9±2.4 cells/field in control vs. 54.6±1.5 in 4-AP, p=0.047, two-tailed unpaired t-test) (Fig. 




Fig. 3.34 6Manipulation of neural activity increases proliferation of OPCs in neuron-rich areas. 
A) Experiments paradigm. B) Representative confocal images of Tg(olig1:nls-mApple), EdU-labelled OPCs at 4 
dpf. Arrows indicate double positive cells. B’) Quantification shows olig1:nls-mApple/EdU double-positive cells in 
different treatment conditions. Data expressed as mean ± 95% confidence interval, (19.1±1.1% in control vs. 
30.6±1.5% in 4-AP vs. 14.1±2.2% in 4-AP+TTX; p<0.001 (control vs. 4-AP), p<0.001 (4-AP vs. 4-AP+TTX) (one-
way ANOVA with Tukey’s multiple comparisons test) n=37/35/9 animals. Scalebar: 50 μm. B’’) Percentage 
increase in EdU-positive OPCs located in neuron-rich and axo-dendritic areas after 4-AP treatment. Data are 
expressed as mean ± 95% confidence interval (9±3.1% vs. 0.08±3.5% increase, p=0.02 in neuron-rich areas, two-
tailed unpaired t-test), n=28 animals. C) Myelinating oligodendrocyte numbers with and without 4-AP treatment. 
Data are expressed as mean ± 95% confidence interval (48.9±2.4 cells/field in control vs. 54.6±1.5 in 4-AP, 
p=0.047, two-tailed unpaired t-test), n=16/21 animals. (Marisca et al., 2020) 
 
Manipulation of neural activity affected OPC calcium levels and cellular behaviour. In 
particular, 4-AP-induced neural activity triggered frequent OPC GCaMP rises as well as OPC 
cell divisions. Therefore, we wondered how important the role of calcium signalling is in 
mediating proliferation induced by 4-AP. To investigate the importance of intracellular calcium 
rises, I expressed in OPCs the plasma membrane Ca2+ pump hPMCA2w/b (CalEx), previously 
used in astrocytes (Yu et al., 2018), which exports cytosolic calcium to reduce intracellular 
calcium signalling (Fig. 35 A). I expressed mCherry-CalEx in OPCs and followed their 
behaviour for 24h. CalEx-positive OPCs showed similar division rates as control, 
                                               
6 Data shown in this figure are from the work of my colleague Laura Hoodless 
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UAS:mScarlet labelled OPCs. However, upon incubation with 4-AP for 24 hours, division 
events in OPCs of control animals were, as expected, significantly increased (15%(9/61 cells) 
in control vs. 45% (25/55 cells) in 4-AP-treated group, p<0.001, two-tailed Fisher’s exact test) 
whereas CalEx-positive OPCs did not show increased proliferation after 4-AP treatment (20% 
(7/35 cells) control vs. 24% (8/33 cells) 4-AP, p=0.77, two-tailed Fisher’s exact test) (Fig. 35 
B-D). Neuronal activity-dependent OPC divisions trigged by 4-AP application relied on high 
OPC calcium levels. When intracellular calcium was extruded from OPCs, the activity-
dependent proliferation enhancement was hindered. This highlights an important role for 





























Fig. 3.35 OPC intracellular calcium signalling is necessary to induce proliferation generated by 4-AP 
incubation. 
A) Illustration explaining CaMPARI. B) Experiments paradigm. C) Confocal images of individual OPCs at 4 dpf 
and 24h post 4-AP treatment. Scale bar: 20μm. Pie charts show the frequency of cell divisions observed in the 
different conditions.15%(9/61 cells) in control vs. 45% (25/55 cells) in 4-AP-treated group, p<0.001, two-tailed 
Fisher’s exact test, n=18/24 animals. D) Confocal images of individual CalEx expressing OPCs at 4 dpf and 24h 
post 4-AP treatment. Scale bar: 20 μm. Pie charts show the frequency of cell divisions observed in the different 
conditions. 20% (7/35 cells) control vs. 24% (8/33 cells) 4-AP, p=0.77, two-tailed Fisher’s exact test, n=11/24 
animals. (Marisca et al., 2020) 
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Taken together, these data show that we can identify two different OPC types in the zebrafish 
spinal cord. OPCs with their somata residing in the neuron-rich areas of the zebrafish spinal 
cord and OPCs with their somata in the axo-dendritic areas. Neuron-rich area OPCs do not 
directly differentiate but they can contribute to myelination after a cell division event whereas, 
axo-dendritic area OPCs can directly differentiate into myelinating oligodendrocytes. 
Moreover, neuron-rich area OPCs are more sensitive to neural activity, they present more 
synaptic sites, have higher GCaMP amplitude and upon enhanced neural activity they 
proliferate more compared to the other group (Fig. 3.36 A). In addition, high intracellular 
calcium levels are necessary to trigger proliferation generated by neural activity via 4-AP 
treatment (Fig. 3.36 B). 
 
 
Fig. 3.36 Summary of OPC characteristic and behaviours in the zebrafish spinal cord upon stimulation of 
neural activity  
A) Illustration summarising neuron-rich area and axo-dendritic area OPCs properties in the zebrafish spinal cord, 
including OPCs interrelation, synaptic densities, GCaMP transients and effect of neural manipulation on cell fate.  
B) Illustration explaining 4-AP induced neural activity on OPCs expressing CalEx.  
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4 DISCUSSION 
4.1 Key questions and findings 
 
Myelination is important to modulate neural circuit function, allowing fast conduction between 
neurons. Myelin sheaths around the axons are made by oligodendrocytes which come from 
the differentiation of oligodendrocyte precursor cells (OPCs). OPCs represent one of the most 
abundant cell population of the central nervous system (CNS) and their number is constantly 
maintained during the whole life, considering that not all OPCs differentiate into 
oligodendrocytes. OPC proliferation and differentiation are both enhanced by several factors 
like social experience, learning and neuronal activity. Indeed, OPCs sense neural activity by 
expressing several neurotransmitter receptors and voltage gated ion channels. One important 
second messenger involved in neuron-OPC signalling is calcium which rises in OPCs in 
response to neural activity. Recently, OPCs have been recognised as a heterogeneous 
population, having diverse electrophysiological properties and different molecular signatures. 
This led to the question whether all OPCs communicate similarly with neurons, and how this 
interaction affects their behaviour and function in regulating myelination. 
To study mechanisms of axon-OPC interaction, I used zebrafish spinal cord as a model 
system. Two distinct OPC subtypes were identified in the zebrafish spinal cord. One group of 
OPCs residing within axo-dendritic areas of the lateral spinal cord, which are characterised by 
a simple cell morphology, fast process dynamics and a high probability to differentiate. The 
other group of OPCs have their soma in the neuron-rich areas of the central spinal cord whilst 
extending their processes into axo-dendritic areas of the lateral spinal cord. These OPCs were 
characterised by a complex morphology, slow process dynamics and without direct 
differentiation potential. Moreover, neuron-rich area OPCs presented more post-synaptic 
densities and were more sensitive to neural activity compare to axo-dendritic OPCs primed to 
differentiation. In my PhD work, I have generated new reagents and lines to perform for the 
first time in vivo calcium imaging of OPC transients. I expressed the genetically encoded 
calcium sensor GCaMP in OPCs and I characterised OPC calcium transients at single and cell 
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population levels. OPCs can display different types of GCaMP transients: transients which are 
restricted to process subdomains, or which spread through the whole cell. Neuron-rich area 
OPCs had higher probability of showing somatic calcium transients and had higher amplitudes 
compared to axo-dendritic area OPCs. OPC population GCaMP imaging revealed that 
sometimes somatic calcium transients spread amongst neighbouring OPCs or even amongst 
all OPCs in the field of view, suggesting a sort of coupling between OPCs. Moreover, I set up 
another tool, CAMPARI, to study cell resolution somatic calcium dynamics amongst the entire 
OPC population of zebrafish. This method highlighted similar calcium concentration and 
boundaries between neighbouring OPCs comparable with the GCaMP imaging results. Finally, 
the pharmacologically manipulation of neural activity demonstrated that part of the calcium 
transients in OPCs are neuron-induced. Use of the EdU assay revealed that neural activity 
induced by pharmacological manipulation triggered OPC proliferation, mostly affecting neuron-
rich area OPCs. Furthermore, intracellular calcium was necessary to trigger division induced 
by neural activity. My work gives new insights about OPC heterogeneity and function in the 
zebrafish spinal cord. Two subgroups of OPCs were identified, one primed for differentiation 
and the other one with possible differentiation potential only after a division event. Moreover, 
one subgroup, the neuron-rich area OPCs integrate more neural activity which induced 




4.2 OPC properties and fates 
 
General morphology and position 
OPCs have been well characterised in rodents and have been found to constitute a 
heterogeneous population depending on age and brain regions (Bonetto et al., 2020). 
However, the function of different OPC subtypes, have been not yet described. Furthermore, 
it is still controversial whether the differences found represent a different subtype, or a different 
cell lineage state along the oligodendrocyte lineage. OPC heterogeneity had not yet been 
studied in zebrafish. As the main question was to study whether all OPCs communicate 
similarly with axons to regulate myelination, at first, I needed to characterise OPCs in zebrafish 
to identify possible diversity. I showed that all OPCs in the zebrafish spinal cord with their 
arborized processes form a dense network in the lateral zebrafish spinal cord. The lateral 
spinal cord, where OPC processes are extended, is constituted by myelinated and 
unmyelinated axons, as well as dendrites. I therefore gave a general description of the position 
of the cells involved in my study, showing that OPC processes have a stereotypical position in 
the zebrafish spinal cord projecting in the lateral spinal cord where also myelinated and 
unmyelinated axons run, and where synaptic contacts are formed. This suggests that all OPCs 
are in contact with the same axons running along the lateral tract of the spinal cord. The lateral 
side of the spinal cord, here referred to as axo-dendritic area, in developing zebrafish 
corresponds to the white matter (WM) described in the adult zebrafish. The central area of our 
system, which I called neuron-rich area, is instead densely filled with cell bodies and 
constitutes the grey matter (GM) in adulthood (Möllmert et al., 2020). Axo-dendritic areas and 
neuron-rich areas cannot be called WM and GM respectively, because they have obvious 
differences comparing these two areas with WM and GM in rodents. We have to take into 
account the difference in tissue size between the developing zebrafish and mice. Indeed, the 
zebrafish spinal cord has a relatively small volume with the spinal cord diameter of about 60μm 
allowing one single OPC to extend the processes in both lateral neuropil regions crossing the 
whole spinal cord. Whereas, the mouse spinal cord is about 3 mm wide and GM and WM are 
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two clearly separated regions (Ong and Wehrli, 2010). In both zebrafish and rodents, the 
myelinated axons are in a region called white matter. In addition, in zebrafish there is a strong 
segregation of cell bodies in the central spinal cord, and axons and dendrites in the lateral 
spinal cord, different than the composition of the grey matter in rodents which contain axons 
and dendrites as well. Therefore, taking into account our study in zebrafish, one hypothesis 
might be that within the grey matter in rodents there might be as well different OPC subtypes, 
depending on the surrounding environment enriched in either cell bodies, or in axons and 
dendrites. 
 
Single cell OPC morphology and process dynamics 
When we looked at single cell OPC morphology we identified differences in terms of 
morphology, process dynamics and soma position amongst OPC population. In particular, 
OPCs with their soma in the axo-dendritic areas showed a simpler morphology compared to 
the OPCs with their soma in the neuron-rich areas. This was in line with what has been 
previously described in the rat CNS, where OPC morphology was different amongst white 
matter and grey matter regions. OPCs in white matter regions showed a typical bipolar 
morphology with simpler process ramification. In grey matter regions, OPCs have a stellate 
morphology with processes extending from all around the cell body (Dawson et al., 2003). 
However, in our system both subtypes of OPCs projected their processes in the later side of 
the spinal cord, suggesting that they share the same environment and that the discriminating 
factor between the two OPCs in term of morphology, is their soma position. Another analogy 
of our study with the work by Dawson et al. takes into account the shape of the soma. Indeed, 
they reported an elongated cell body shape for the OPCs residing in the white matter (WM) 
regions as the soma shape of the axo-dendritic OPCs in our system. Instead, a rounded soma 
shape was described when they looked at OPCs in the grey matter (GM) regions as the cell 
body shape of neuron-dendritic areas in the zebrafish spinal cord.  
111 
Looking at process dynamics of the two subtypes of OPCs, work done by my colleague Tobias 
Hoche, we found that OPCs with their soma residing in the axo-dendritic areas displayed fast 
process remodelling compared to OPC with their soma residing in the neuron-rich areas. As 
already shown in developing zebrafish and mouse, OPC processes extend and retract their 
processes to explore the environment around them (Kirby et al., 2006, Hughes et al., 2013). 
Our finding suggests that OPCs with their soma in the axo-dendritic area explored the 
surrounding axons more actively compared to the neuron-rich area OPCs. This is in line with 
the differentiation potential of the axo-dendritic area OPCs which can directly differentiate to 
give rise to myelinating oligodendrocytes. The fast process remodelling behaviour might be an 
indication to explore surrounding environments and identify the axon that need to be 
myelinated.  
 
Soma position and differentiation potential 
After identifying differences in morphology and soma position comparing spinal cord OPCs, 
we then looked into the cell fate of these two subtypes of OPCs to understand whether both 
OPCs contributed equally to myelination. Long-term longitudinal analysis, done by my 
colleague Tobias Hoche, following both subtypes of OPCs for several days revealed that axo-
dendritic area OPCs in the zebrafish spinal cord were primed to differentiation. These cells 
could directly differentiate into myelinating oligodendrocytes. Instead, neuron-rich area OPCs 
never directly differentiated but they always required a division event to give rise to a cell with 
a differentiation potential. Differences between the two subtypes of OPCs in the zebrafish 
spinal cord have been also confirmed by transcriptome analysis of single cells which I briefly 
mention in the previous section. Our group in collaboration with the Castelo-Branco’s lab 
provided data on the molecular features of the two subgroups of OPCs identified in our system 
using single-cell RNA-seq. In particular, five clusters (#1-#5) have been characterised by the 
expression of oligodendrocyte lineage transcription factors (Marisca et al., 2020). Amongst 
them, four clusters (#1-#4) expressed OPC markers and one cluster (#5) markers for mature 
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oligodendrocytes. In-situ hybridization analysis correlated the differential gene expression 
amongst the clusters with the two OPC subgroups with different soma positions found in the 
live cell imaging. OPCs from cluster #1 were mostly found in the neuron-rich areas and OPCs 
from cluster #4 were instead found in the axo-dendritic areas. The other two clusters were 
found in both areas and expressed cell cycle markers. Interestingly, gene ontology analysis 
revealed that the genes upregulated in cluster #1, representing mostly neuron-rich area OPCs, 
were involved in neurotransmission and transmission across chemical synapses. Cluster #4 
representing the axo-dendritic area OPCs was enriched in genes involved in early 
differentiation like myrf (Marisca et al., 2020). 
Differences in differentiation potential were also found between WM and GM in mammals. The 
majority of the WM OPCs differentiated into mature oligodendrocytes suggesting a role for the 
surrounding environment in determining the differentiation capacity (Viganó et al., 2013). Most 
of the WM OPCs differentiated to give rise to myelinating oligodendrocytes, whereas GM OPCs 
were mostly proliferating (Dimou et al., 2008). To clarify whether the differentiation properties 
were linked to intrinsic cell diversity, rather than to environmental factors, homotopic and 
heterotopic transplantations in the mouse cerebral cortex were performed. WM-derived OPCs 
differentiate more frequently than GM-derived cells, even when transplanted in the GM 
environment (Viganó et al., 2013). This means that there is an intrinsic difference between 
these cells, but at the same time environmental cues could have influenced their nature before 
the transplantation. However, in my work I showed that in the zebrafish spinal cord all OPCs 
are in contact with the same axons running along the lateral side, suggesting that the 
differentiation potential does not depend on the presence of more myelination-competent 
axons. Instead, the cell body position is the feature that determines the fate and differentiation 
potential. One key role for the different behaviour regulated by the soma position, could be 
played by mechanical forces applied to the cell bodies in the two different areas. Indeed, OPCs 
are mechanosensitive, their capacity to proliferate, migrate and differentiate is dependent on 
the stiffness of the substrate in vitro (Jagielska et al., 2012). Mechanical stimuli promote OPC 
differentiation on soft substrates while growth of OPCs on stiff substrates prevents myelination 
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(Tsai and Casaccia 2019). In line with our findings, spinal cord tissue properties 
characterisation both in mammal and in zebrafish revealed that GM tissue is much stiffer 
compared to the WM one (Koser et al., 2015; Möllmert et al., 2020). This suggests that 
mechanical forces could prevent the neuron-rich area OPC to differentiate. Physical 
characteristics of the axonal microenvironments can also influence cell fate decision. Spatial 
constraints of densely packed axons and OPCs promote OPC differentiation. One hypothesis 
is that axons in the lateral spinal cord may compress OPC cell soma, which in the axo-dendritic 
areas present an elongated shape, causing structural rearrangements. Changes in size and 
shape of the nucleus may induce the transcription of genes involved in OPC differentiation 
(Rosenberg et al., 2008). Another factor that can regulate OPC fate could involve signalling 
molecules. The differences in differentiation between axo-dendritic area and neuron-rich area 
OPCs could be due also to cell surface molecules. Indeed, cell-adhesion molecules (CAMs) 
have been shown to play an important role in the signalling between axons and 
oligodendrocytes (Laursen and Ffrench-Constant, 2007). Axo-dendritic OPCs might participate 
in the signalling with axons through surface molecules, as their somata are in close proximity 
to the axons. In addition to cell-adhesion molecules, also the non-synaptic release of 
neurotransmitters along the axons has been shown to be involved in intercellular signalling 
and to induce myelination of active axons (Wake et al., 2015). The idea is that this signalling 
would mostly affect OPCs with their somata in the vicinity of axons, therefore the axon-dendritic 





4.3 Hierarchy between OPC subgroups 
 
Previous findings have also described OPCs as a heterogeneous population with different 
gene profiles and electrophysiological properties. However, an unsolved question was whether 
different OPCs resemble different states of cells along their lineage progression with the same 
function or whether they actually represent different subtypes executing different functions. 
Longitudinal analysis over time of single OPCs revealed that axo-dendritic area OPCs are the 
cells that usually differentiate compared to the neuron-rich area OPCs that contribute to 
myelination only after a division event. 
This was also confirmed when we triggered myelination using splitomicin. Animals treated with 
splitomicin showed increase in oligodendrogenesis. New formed myelinating oligodendrocytes 
came from neuron-rich area OPCs after a division event. This suggests the importance of a 
recent proliferative event to form OPCs with a differentiation potential. Even in the presence of 
an external stimulus to induce myelination, neuron-rich area OPCs continue to require a 
division to create an OPC primed to differentiation.  
Cell fate analysis highlighted the interrelation between the two OPC subgroups. Neuron-rich 
area OPCs need to proliferate to form a new daughter cell with axo-dendritic OPC features, 
primed to differentiate. Moreover, once OPCs get certain features as axo-dendritic or neuron-
rich area OPCs, do not switch towards the other type. For this reason, in my thesis, I always 
referred to the two OPC subgroups as two subtypes and not two states along their lineage 
progression. The neuron-rich area OPCs cannot switch their function and directly differentiate, 
but they can divide and create new OPCs that have differentiation potential creating a 
connection between the two different subgroups (Fig. 4.1). Therefore, in our system, OPC 
subtypes are defined by both extrinsic and intrinsic factors. The extrinsic component is 
represented by the local environment around the soma which for the neuron-rich area OPCs 
is characterised by cell bodies, whereas for the axon-dendritic area OPCs by the neuropil. The 
intrinsic component that gives the differentiation potential to the OPCs is represented by the 
recent cell division which is necessary to make OPCs switch properties and fates. 
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In line with our findings, differentiation of newly divided OPCs has been identified also in the 
postnatal developing mouse brain (Hill et al., 2014). Another recent work showed that fear 
learning experience in young mice triggered OPC proliferation which was followed by an 
increase in OPC differentiation in the following weeks. The newly generated oligodendrocytes 
came from recently divided OPCs (Pan et al., 2020). However, other studies reported a direct 
increase in OPC differentiation in the adult mouse cortex after sensory enrichment and motor 
learning (Hughes et al. 2018; Xiao et al., 2016). A more recent study, reported increase in 
differentiation without increase in OPC proliferation in developmental and in remyelinating 
conditions, showing that motor learning could improve remyelination involving newly 
differentiated and pre-existing oligodendrocytes (Bacmeister et al., 2020). Therefore, it is still 
unclear whether differences in proliferation and differentiation is based on the developmental 
or adult myelination depending on the age of the animals or on the intrinsic age of the cells. 
This indicates that differentiating OPCs in adults are coming from newly divided cells, therefore 
intrinsically young cells. In remyelination, OPCs often fail to differentiate, this could be 
explained by thinking that OPCs need to be intrinsically young and surrounded by an 
appropriate local environment to be able to differentiate. Indeed, remyelination was shown to 
be more efficient in grey matter lesions than in white matter lesions (Albert et al. 2007). Further 
studies to impair specifically OPC proliferation without directly affecting differentiation are 





Fig. 4.1 OPC subtypes interconnection  
Schematic representing the hierarchy between the two types of OPCs identified in the zebrafish spinal cord. OPC 
subtypes and their differentiation potential are controlled by two determinants. The extrinsic determinant is 
represented by the local environment surrounding OPC soma, axon-dendritic area OPCs can differentiate in 
myelinating oligodendrocytes. The intrinsic determinant is the recent cell division which neuron-rich area OPCs 
need to give rise to axo-dendritic area OPCs that are likely to differentiate. Neuron-rich area OPCs cannot switch 
their type and directly differentiate into oligodendrocytes, a division event is always necessary. (Marisca et a., 2020) 
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4.4 Integration of external stimuli by OPCs 
 
Synaptic-like contacts in zebrafish OPCs 
Axon-OPC synaptic contacts have been described for the first time 20 years ago (Bergles et 
al., 2000). However, it remained unclear if synapse-like contacts between axons and OPCs 
exist in zebrafish. From our RNA sequencing data, we know that OPCs express genes involved 
in the post-synaptic machinery, however evidences of expression in OPCs in zebrafish were 
missing. In my results sections, I illustrated some preliminary results about the expression and 
position of pre- and post-synaptic markers in the zebrafish spinal cord. At first, I tried to label 
synapses in the zebrafish spinal cord which, as expected, are mostly located in the lateral side 
where also dendrites and axons are. OPC processes project as well in the lateral spinal cord. 
At first, to endogenously label post-synaptic sites in OPCs I used antibodies to stain spinal 
cord sections. Immunostaining is reliable to detect the expression of endogenous post-synaptic 
proteins in OPCs. However, it was challenging to identify with precision the localisation of the 
post-synaptic puncta in OPCs since post-synaptic expression appeared quite dense in this 
area. Moreover, it was not possible to trace the cells and identify the soma position to 
categorise OPCs in one of the two subgroups. In addition, gene ontology analysis revealed 
that the cluster representing the neuron-rich area OPCs comprised terms related to protein-
protein interaction at synapses. Therefore, I also used an in vivo approach to describe axon-
OPC synaptic contacts in the zebrafish spinal cord. Using this approach, I could characterise 
OPC morphology and I sparsely expressed a post synaptic marker in OPCs, giving us a clearer 
idea of post-synaptic sites of OPCs. On the other hand, the live imaging transgenic approach 
can also induce the expression of post-synaptic proteins in vivo creating an artefact. When I 
combined pre- and post-synaptic markers in neurons and OPCs respectively, the co-
localisation analysis showed that not all post-synaptic densities in OPCs have a pre-synaptic 
site in the proximity. This might be due to the transgenic line and markers used to individualise 
the synaptic contacts. The transgenic line used to label pre-synaptic sites in neurons might be 
not completely accurate in expressing pre-synaptic markers in all the neurons. Further 
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experiments are needed to validate the line. Furthermore, to label post-synaptic site in OPCs, 
I expressed the PSD95-EYFP fusion protein that may fail to properly localise and create false 
positive expressing cells. To confirm the post-synaptic marker expression in OPCs, further 
work is needed using an approach that would combine the antibody approach with the live-cell 
imaging. This is possible using recombinant antibody-like proteins, termed Fibronectin 
intrabodies generated with mRNA display (FingRs) that binds the endogenous PSD95 protein 
(Gross et al., 2013). This method allows the localisation of the endogenous post-synaptic 
proteins in vivo. FingR expression would be more accurate than exogenously expressing 
proteins that can cause morphological changes and not localise specifically as their 
endogenous equivalent. Moreover, FingR expression is transcriptionally controlled by a 
feedback system based on a zinc-finger DNA binding domain that accurately reports its 
endogenous expression level (Gross et al., 2013). 
 
Post-synaptic density differences in OPC subtypes 
PSD95 was differently expressed in the two OPC subgroups. The post-synaptic markers 
revealed a punctate enrichment mostly in OPC processes and were more densely expressed 
in the neuron-rich area OPC processes compared to the axo-dendritic area ones. It is plausible 
that the OPCs that show less process dynamics are able to form more stable synaptic contacts 
with axons, instead the ones that present fast processes remodelling are not capable to 
establish such contacts. In addition, neuron-rich area OPCs present a more complex 
morphology compared to the axo-dendritic OPCs. This morphological feature is consistent with 
the finding that blocking glutamatergic signalling through AMPARs results in a consistent 
reduction in the length of OPC processes and number of branch points (Fannon et al., 2015). 
This implies that synaptic signalling is important to maintain a complex process morphology 
typical of the neuron-rich area OPCs. Expression of PSD95 in OPCs is different than the one 
described in oligodendrocytes in zebrafish where PSD95 appeared either like puncta restricted 
to the ends of myelin sheaths or diffusing amongst the whole cell, or more rarely, puncta 
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localised along the length of sheaths (Hughes and Appel 2019). In addition, in mouse brain 
slices the transition from OPCs to pre-myelinating oligodendrocytes was accompanied by loss 
of synaptic input and a decrease in glutamate receptor expression (De Biase et al., 2010). 
Moreover, myelination of electrically active axons occurred through vesicular release via non-
synaptic axo-glial junctions (Wake et al., 2015). These previous findings are related to my data 
showing that neuron-rich area OPCs form more synaptic contacts than the axo-dendritic area 
OPCs which are primed to differentiation. Axon-OPC synaptic contacts are therefore not 
regulating myelination, since in our system the cells that form synapses and integrate neural 
activity are the ones that are not differentiating into myelinating oligodendrocytes. 
Finally, the result on the higher post-synaptic densities in neuron-rich area OPCs is in line with 
the ability of these OPCs in integrating neural activity and in having higher calcium amplitude 
(Fig. 4.2). Indeed, presynaptic neuron stimulations as well as GABAergic and glutamatergic 
synaptic inputs have been shown to trigger Ca2+ rises in OPCs (Haberlandt et al., 2011; Tong 
et al., 2009; Sun et al., 2016). 
 
Fig. 4.2 Post-synaptic densities in OPC subtypes 
Schematic representing the PSD95 post-synaptic densities in the two OPC subtypes. Neuron-rich area OPCs which 
show high amplitude and frequent GCaMP rises, present more post-synaptic expression along their ramified 
processes. Axo-dendritic area OPCs which present lower amplitude and less frequent GCaMP transients, present 
less dense post-synaptic marker expression and mostly localise in the processes closed to the soma. 
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4.5 OPC calcium dynamics 
 
Single OPC GCaMP features 
In my study, I described GCaMP dynamics in OPCs and I focused on differences between the 
two OPC subtypes that we have fully characterised in terms of morphology, fate behaviour and 
molecular signatures. My analysis identified two patterns of GCaMP events restricted to 
process subdomains or spreading through the whole cell. In line with this, a previous study, 
described GCaMP dynamics along oligodendrocyte differentiation, starting with pre-
myelinating oligodendrocytes and both somatic and process terminal GCaMP events were 
described. Interestingly, process and somatic GCaMP events were less frequent and had 
lower amplitude while the maturation towards oligodendrocytes was progressing (Krasnow et 
al., 2018). This suggests that differentiating oligodendrocytes showed less GCaMP events 
compared to OPCs. Accordingly, my data on differences in GCaMP dynamics between the two 
OPC subtypes revealed that somatic GCAMP events occurred more frequently and exhibited 
higher amplitude in OPCs with their somata residing in the neuron-rich areas, compared to the 
ones in the axo-dendritic areas that will likely differentiate.  
GCaMP transients in OPCs might be elicited by several inputs, including synaptic activity. 
Since the beginning of the 1990s, calcium (Ca2+) channels have been detected in 
oligodendrocyte lineage cells and Ca2+ currents in OPCs through voltage gated calcium 
channels have been recorded in mice slices (Berger et al., 1992). Calcium entry in OPCs can 
be regulated by both glutamatergic and GABAergic synaptic activity. It has been shown that 
calcium rises in OPCs resulted from the activation of Ca2+-permeable AMPA-receptors induced 
by electrical stimulation of pre-synaptic neurons (Bergles et al., 2000). The role of AMPAR in 
mediating intracellular calcium permeability was also proven by a recent work, in which a point 
modification of the AMPAR subunit GluA2 increased the calcium permeability in OPCs (Chen 
et al., 2018). GABAergic activity triggered, as well, Ca2+ rises in OPCs through the activation 
of Na+ channels and Na+/Ca2+ exchangers in OPCs (Tong et al., 2009). In another study, Ca2+ 
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elevations in OPC processes, but not somata, were induced by the electrical stimulation of 
pre-synaptic neurons (Haberlandt et al., 2011). 
In addition, OPC calcium currents appeared to reflect the level of glutamatergic synaptic 
activity in hippocampal slices (Sun et al., 2016). In this study, calcium signals localised to the 
somata and OPC arborisations were described. Both of these types of calcium signals had a 
slow decay time, on the order of seconds, comparable to my GCaMP data (Sun et al., 2016). 
My single cell GCaMP data show that GCaMP transients restricted to process subdomains are 
more frequent than whole cell GCaMP transients. However, when I performed cell population 
GCaMP analysis, I often detected somatic GCaMP transients. The hypothesis is that GCaMP 
rises localised to the processes are synaptic-induced as neuron-OPC synapses were 
described along the processes (Bergles et al. 2000; Kukley et al., 2007). On the other hand, 
somatic GCaMP transients may be explained by taking into account that calcium responses in 
OPCs are neuronal stimulus-dependent. Therefore, to trigger whole cell GCaMP transients, a 
synchronised activity of the synapses localised to OPC processes might be necessary. The 
hypothesis would be that only when the summation of the synaptic activities reaches a certain 
threshold then the intracellular calcium rises in the whole cell. This idea is comparable to the 
action potential in neurons where the dendritic integration of different inputs has to reach a 
threshold to elicit an action potential.  
Moreover, supporting the idea that GCaMP transients are triggered by synaptic activity, 
neuron-rich area OPCs are the cells that showed higher and more frequent somatic GCaMP 
transients. This OPC subgroup presents, as well, higher density of post-synaptic markers 
reflecting the sequencing data, which showed that these cells are enrich in genes involved in 
neurotransmitter signalling.  
Slow GCaMP dynamics described in OPCs restricted to process subdomains or spreading 
through the whole cells are also found in astrocytes (Agarwal et al., 2017; Srinivasan et al., 
2015). GCaMP events in astrocytes in mice have been fully characterised and can last for 
several seconds, similar to the ones I detected in OPCs (Stobart et al., 2016). Moreover, a 
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more recent study illustrated GCaMP dynamics in astrocyte-like cells in the zebrafish spinal 
cord and most of the GCaMP transients had a duration comparable to the ones detected in 
astrocytes in mice (Chen et al., 2020). As these two glia cells have relatively similar GCaMP 
dynamics, an attractive idea would be to study calcium signalling between astrocytes and 
OPCs to understand if there is any type of correlation.  
 
OPC population GCaMP features 
For the first time, my work provided data on GCaMP transients at the level of OPC population. 
This offers new insight to understand how OPCs are related to each other and to axons. My 
results indicate that somatic GCaMP transients spread in neighbouring OPCs with slow 
temporal resolution. GCaMP waves spreading in a group of OPCs or amongst all OPCs, in my 
field of view, suggest that there might be a sort of coupling amongst OPC population. This 
might be due to direct signalling between OPCs, to signalling induced by axonal activity or both 
combined. Indeed, as I described, all OPCs are in contact with the same cohort of axons in the 
lateral side of the zebrafish spinal cord. Calcium waves were identified for the first time 30 
years ago also in astrocytes in culture, following studies showed that calcium waves in 
astrocytes were triggered by neural activity (Cornell-Bell et al.; 1990, Dani et al., 1992). One 
possible pathway by which Ca2+ signals can be transmitted between neighbouring cells is 
through intercellular gap junctions. Calcium waves in astrocytes are elicited by glutamatergic 
signalling and then the propagation amongst neighbouring cells is mediated by gap junctions 
(Finkbeiner, 1992). The idea is that OPC calcium waves and calcium subgroups are triggered 
by neural activity and then spread amongst OPCs in the vicinity via gap junctions (Fig. 4.3). 
To test this hypothesis further experiments are needed, using gap junction blockers combined 
with calcium imaging to visualise whether calcium waves amongst OPCs would be then 
blocked. Not much is known about the connexins forming gap junctions in oligodendrocyte 
lineage cells. Oligodendrocytes express connexin 29 (Cx29), Cx32, Cx45 and Cx47 and they 
are coupled to each other through homotypic gap junctions composed by Cx32 and Cx47 
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(Vejar et al., 2019). No published information is available on the connexins expressed in OPCs, 
but from our sequencing data Cx27.5 appeared highly expressed in the neuron-rich area 
OPCs. Other experiments are needed to confirm the expression and specificity of the Cx 27.5 
in OPCs to understand its role in regulating gap junctions and calcium waves amongst OPC 
population (Fig 4.3). 
 
Fig. 4.3 OPC-OPC coupling hypothesis 
Schematic suggesting a possible mechanism of interconnection between OPCs to explain the calcium spreading 
amongst neighbouring OPCs. The hypothesis is that OPCs sense neural activity through their synaptic contacts 
and then communicate through their gap junctions with OPCs in their proximity. One possible candidate to form 
OPC-OPC gap junction connection is the connexin 27.5 which appear to be highly expressed in neuron-rich area 
OPCs. On the other hand, axon-dendritic OPCs might sense neural activity via non-synaptic vesicle release of 
neurotransmitters and growth factors. 
 
CaMPARI as a technique to study calcium dynamics 
GCaMP analysis of OPCs at the population level highlighted GCaMP transients spreading 
through a group of OPCs or even through all OPCs in the field of view. However, these findings 
emphasised the limitations of this method to look at calcium at the population level, because it 
was clear that the GCaMP signalling might involve OPCs outside of the imaged area. 
Therefore, I used CaMPARI as an alternative method to further study coupling amongst OPCs. 
CaMPARI has been used since 2015 to track calcium activity of neurons in different species 
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(Fosque et al., 2015; Moeyaert et al., 2018; Trojanowski et al., 2021). This calcium integrator 
is based on the photoconversion from green to red, when high intracellular calcium is present 
in the cell while UV light treatment is applied. CaMPARI leaves a permanent trace of Ca2+ rises 
during the time of UV light exposure. My data suggest that this is a reliable technique showing 
variability in the red/green ratio amongst OPCs in the same animal, among different animals 
and conditions. Indeed, zebrafish treated with 4-AP displayed a significant increase in 
red/green ratio. CaMPARI has the great advantage to detect the calcium activity of the whole 
OPC population in a fixed time frame. In addition, more animals can be treated with the UV 
light and no compounds are needed to paralyse the fish. One limitation is the temporal 
resolution that cannot be as precise as the GCaMP imaging which is the method I used at first 
to describe calcium rises in OPCs. In my experiments, I performed the UV light treatment over 
a period of 5 minutes and in case of photoconversion, it is not possible to know when the 
calcium rise happened along the 5 minute time frame. However, this tool is useful to trace the 
overall calcium activity of all OPCs and to detect differences amongst animals and anatomical 
regions, which can tell us more about OPC coupling. Indeed, looking at the photoconvertion 
rates, most animals showed an undulatory trend and neighbouring cells have comparable 
photoconversion rates, reflecting boundaries amongst OPCs. A subsequent experiment could 
be to perform GCaMP imaging across regions where these boundaries were identified to get 
a precise temporal resolution.  
CaMPARI was recently created but already two more versions of this tool are available, 
CaMPARI2 has an improved sensor with brighter green and red fluorescence and decreased 
background photoconversion in low calcium conditions compared to the CaMPARI1 which I 
used for my experiments (Fosque et al., 2015; Moeyaert et al., 2018). However, the application 
of a lower UV-light treatment for my experiments, compared to the one used in the CaMPARI 
first publication, was already useful to reduce the background photoconversion. The newest 
version of this tool, rsCaMPARI, overcomes the irreversibility of the previous version, allowing 
multiple snapshots of neuronal activity of the same sample (Sha et al., 2020). For future 
studies, the OPC CaMPARI line can be combined with behavioural set-ups to study the overall 
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calcium activity in OPCs during diverse behavioural paradigms. This combination will help us 
to understand what is the additional function of OPCs in the neural circuit, considering that 
neuron-rich area OPCs do not contribute to myelination, but integrate neural activity. 
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4.6 Neuronal manipulation effects on OPC  
 
Neuronal manipulation effects on OPC GCaMP transients 
OPCs showed that GCaMP transients spread through group of cells, or even GCaMP waves 
spreading through the spinal cord. Moreover, OPCs showed GCaMP transients both somatic 
and localised to the processes. Therefore, since OPC processes are localised where axons 
run and they make synaptic contact with neurons, I studied whether these GCaMP events in 
OPCs are triggered by neural activity. At first, I have tried two chemogenetic approaches to 
manipulate neural activity. However, Designer Receptor Exclusively Activated by a Designer 
Drug (DREADD), widely used in mice, did not work in zebrafish probably because the CNO, 
its ligand, cannot be metabolise in zebrafish (Armbruster et al., 2007; Chen et al., 2016). The 
second approach, the rat TRPV1 (transient receptor potential cation channel subfamily V 
member 1), activated by the application of capsaicin, resulted to be toxic for the cells upon 
prolonged application (Chen et al., 2016). 
Therefore, I decided to use a pharmacological approach to trigger or block neural activity, using 
4-AP and TTX respectively. 
Pharmacological neural manipulation, to study the effects on OPC calcium dynamics, revealed 
that enhancing neural activity using 4-AP increased the frequency of GCaMP transients in 
OPCs. GCaMP transients, induced by neural activity, were mostly affecting OPC processes. It 
is possible that 4-AP acts directly on OPCs considering that they express K+ channels. 
However, when the action potential blocker TTX was subsequently applied to the same sample 
previously treated with 4-AP, most of GCaMP transients 4-AP-induced were restored to basal 
levels. Moreover, the 4-AP pharmacological approach used in combination with the double 
transgenic line expressing two different calcium indicators in OPCs and neurons induced 
GCaMP transients in OPCs right after calcium transients in neurons depicted by RGECO. This 
suggests that the GCaMP transients in OPCs are neural-induced. These results are in 
accordance with previous electrophysiological studies that reported Ca2+ elevations in OPCs 
triggered by neuronal electrical stimulation through glutamatergic or GABAergic synapses 
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(Tong et al., 2009; Haberlandt et al., 2011; Sun et al., 2016). In addition, our neural 
manipulation results are consistent with the in vivo calcium imaging study from Krasnow et al. 
in which calcium transients of pre-myelinating oligodendrocytes correlated with neuronal 
electrical stimulation and were reduced after TTX injection (Krasnow et al., 2018).  
More studies are necessary to show in vivo calcium correlation between the two subtypes of 
OPCs and axons. An optogenetic approach would be ideal to trigger only single neurons and 
detect calcium responses in surrounding OPCs. The expression of light-sensitive ion channels 
in neurons would allow us to specifically manipulate single neuron activity and to control their 
activation through light pulses. The combination of this approach with GCaMP imaging in 
OPCs would permit to identify GCaMP transients that are activated by the induced neural 
activity. This would give us a direct evidence that GCaMP transients, or at least a part of them, 
are induced by neural activity. Moreover, this method will be helpful to further investigate 
differences between the two subgroups of OPCs in sensing neural activity. 
 
Induced neural activity trigger OPC proliferation 
Neural activity is a key regulator of myelination and has been shown to modulate both OPC 
proliferation and differentiation. Raff and Barres carried out the first experiment in which 
electrical axon disruption caused a decrease in OPC proliferation (Barres and Raff, 1993). A 
more recent work reported OPC proliferation, oligodendrogenesis and myelination after 
optogenetic stimulation of neural activity (Gibson et al., 2014). Another study reported OPC 
proliferation and differentiation after pharmacological neural stimulation of axons in mice 
(Mitew et al., 2018). Data on the modulation of myelination are controversial, considering that 
enhanced neural activity triggers proliferation and differentiation of OPCs, and it is complicated 
to dissociate one effect from the other in vivo. However, our model is very useful to carry out 
timeline analysis following single cells over days, to delineate the cell fate and behaviour. Our 
data showed that neural activity induced by 4-AP treatment primarily enhances OPC 
proliferation and that this effect affected mostly neuron-rich area OPCs. This is in agreement 
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with our GCaMP analysis in which these cells appeared to be more sensitive to neural activity. 
A subsequent increase in myelinating oligodendrocytes was also detected after the 4-AP 
treatment, suggesting that the direct effect of neural activity on OPCs concerns OPC division, 
and differentiation is a later stage effect. When 4-AP was combined with TTX, there was no 
increment in OPC proliferation. Live imaging following neuron-rich area OPCs before and after 
4-AP treatment highlighted the proliferation effect of neural activity on OPCs, even if a direct 
effect of 4-AP on OPCs cannot be excluded. Interestingly, the effects induced by 4-AP in OPCs 
relied on intracellular calcium in OPCs. Intracellular calcium is necessary to trigger proliferation 
4-AP-induced. Further studies are needed to investigate the signalling pathway involved in 
regulating OPC behaviour through synaptic signalling. Indeed, glutamatergic synapses have 
been shown to trigger OPC differentiation (Gautier et al., 2015). In addition, proliferation and 
differentiation have been found to be regulated by different firing of neural activity (Nagy et al., 
2017). One hypothesis is that the calcium-mediated proliferation induced by neural activity 
might involve the AMPA receptors. Increasing the calcium permeability of AMPA receptors 
triggered OPC proliferation and reduced the differentiation (Chen et al., 2018). However, 
interestingly loss of AMPA receptors resulted in no effects on OPC proliferation 
(Kougioumtzidou et al., 2017). The role of another type of receptor, NMDA receptors, needs 
to be further investigated as it might compensate the role of AMPAR. It is known that NMDAR 
ablation, caused increased Ca2+ mediated by AMPAR (De Biase et al. 2011). In addition to 
glutamatergic signalling, the role of GABAergic synapses should be considered as it was 
shown that loss of GABAA receptor increased OPC proliferation and delayed OPC 
differentiation in vivo (Zonouzi et al., 2015). Therefore, GABAergic activity seems to have the 
opposite effects on OPC behaviour, compared to the glutamatergic one, reducing OPC 
proliferation and promoting their differentiation. To further investigate the roles of the different 
neurotransmitters in regulating OPC fate and behaviour, both pharmacological and 
optogenetic approaches could be used. Compounds like GABAzine or PTZ can be applied to 
inhibit GABAergic receptors and follow OPC responses in terms of proliferation and 
differentiation in vivo. However, this pharmacological manipulation will affect also other cell 
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types. Therefore, a more precise method to specifically manipulate neurotransmitter release 
from neurons, is offered by optogenetics. 
Expressing opsins in neurons using drivers specific for different signalling by neurotransmitters 
like glutamate, GABAA, aspartate and glycine would permit to specifically modulate one type 
of neuron signalling and explore the effects on OPCs. This approach would allow us to directly 




4.7 Future perspective 
 
OPCs constitute a large population of the CNS and in the last years they have been 
characterised as a heterogeneous population with differences in gene profiles and 
electrophysiological properties amongst different brain regions and ages. In addition, OPCs 
can sense neuronal activity which affects both OPC proliferation and differentiation to 
myelinating oligodendrocytes. OPC heterogeneity and their ability to integrate neural activity 
lead to the question whether neural activity regulates differently the fates of heterogeneous 
OPCs. 
My results show that in the zebrafish spinal cord there are two different OPC subgroups. One 
subgroup is primed to differentiation and the other does not directly contribute to myelination. 
Interestingly, this second subgroup is able to integrate more neural activity which triggers the 
proliferation of these OPCs. 
This suggests that their main function is not myelination but being open to other functions. One 
idea is that they play additional important roles contributing to the neural circuit in a myelin-
independent manner. Further work is needed to investigate this idea. One possible idea is to 
ablate OPCs and perform visual-motor behavioural assays to investigate their role in 
integrating different external stimuli.  
Moreover, it would be interesting to understand how these two OPC subgroups respond to 
injury conditions. In demyelinating diseases, OPCs respond by differentiation but often fail to 
differentiate into oligodendrocyte inducing chronic demyelinated conditions (Duncan et al., 
2009, Wolswijk et al. 1998). It is important to find the right target to restore myelination. In our 
system it seems that targeting OPCs sensitive to neural activity might be a good strategy 
considering that division events lead to subsequent differentiation. The intrinsic factor that 
gives OPCs the potential to differentiate in our system is represented by a recent cell division. 
This is in agreement with a new study in mice in which proliferation is defined as a requirement 
to induce OPC differentiation in remyelinating conditions (Foerster et al., 2020). 
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Another aspect that emerged from my analysis is that OPCs seem to create boundaries 
amongst themselves at cell population level, and it would be useful to understand what is the 
mechanism involved in their formation. In addition to that, it would be interesting to further 
explore the function of these boundaries to understand whether OPCs form networks in parallel 
to the neural ones. One idea is that specific calcium patterns might be correlated to different 
animal behaviours, which can be tested by combining GCaMP imaging with visual-motor 
behaviour experiments. 
Our study points out the importance of characterising differences amongst the oligodendrocyte 
lineage population to get new insights on their normal role in brain physiology, and to identify 
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